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Abstract 
Glycosyl transfer within the active site of an enzyme involves the arrangement of the gly-
cosyl donor and glycosyl acceptor in close proximity to each other.  To mimic this pro-
cess, intramolecular glycosylations are carried out where the donor and acceptor are 
linked together via a spacer. Correct orientation, rigidity and position of the spacer play a 
vital role in the selectivity and yield of reactions in this “molecular clamp method”.  
Though current methodologies show promising results in terms of yield and selectivity, 
the need to synthesize different complexes to ensure selectivities in all types of glycosidic 
linkages is a large deterrent to the wide spread use of this technique. 
Reported herein is a new molecular clamp method for the synthesis of oligomeric carbo-
hydrates, based on a bis-phenol A (BPA) template, which allowed us to place the glyco-
syl donor and acceptor counterparts in the correct orientation to each other using with dif-
ferent length linkers (L1 and L2) for exceptional facial α-selectivity.  This has been 
demonstrated in a majority of applications, particularly those involving glycosylation of 
the secondary glycosyl acceptors; exceptional selectivity for the synthesis of challenging 
α-linked disaccharides has been achieved. We have also demonstrated that a modified 
bis-phenol-A template allows for connection of multiple building blocks to perform in-
tramolecular oligosaccharide synthesis.  
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Chapter 1 Review of Intramolecular Glycosylation 
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1.1 Introduction   
Carbohydrates, once only seen as energy storage materials and structural components, 
were unknown to have complex biological functions. Only recently, carbohydrates have 
been shown to play crucial roles in a wide variety biological functions such as cell 
growth, cell-cell adhesion, signal transduction, and fertilization. Since many glycans are 
found on the surface of cells, they can also act as mediators in bacterial and viral 
infections, inflammation, development and growth of cancers, septicemia, and many 
other diseases. Owing to the complex structure and variety of carbohydrates found in 
nature, the study of the biological role of carbohydrates is limited by the availability of 
pure isolates. As a consequence, the systematic study of these molecules often relies on 
synthetic chemistry to provide pure compounds in significant quantities.  
While understanding the structure and function of carbohydrates is difficult, it is 
glycosylation, the fundamental reaction performed between two monosaccharide units, 
that has proven particularly challenging to chemists. Nature flawlessly executes this 
reaction to yield complex glycans.
1,2
 Chemical glycosylation, however, remains 
cumbersome even with the aid of modern technologies and recent breakthroughs.
3-17
 The 
formation of many glycosidic bonds can now be achieved, but it is the inability to control 
the stereoselectivity that has proven to be the major hurdle. There are many complexities 
to consider when depicting the mechanism of glycosylation, and often a clear delineation 
between SN1 and SN2 reactions is obscured.
18,19
 Nevertheless, today it is generally 
presumed that the reaction conditions favor that of a unimolecular SN1 mechanism, and 
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the reaction is thought to proceed through a total of four distinct steps depicted in Scheme 
1.1.
18
 
Scheme1.1 The mechanistic outline of the chemical glycosylation reaction 
 
The goal of stereocontrolling glycosylation has been approached in a variety of ways and 
much effort dedicated to the optimization of the reaction conditions. We know that LGs, 
PGs, temperature, promoter/additives, and the reaction solvent may have a significant 
effect on the reactivity of the reactants and the stereoselectivity of glycosylation.
20
 
However, since these factors still often fail to adequately control the outcome of many 
glycosylations that tend to proceed via the oxacarbenium ion, studies are refocusing on 
gaining a better understanding of the reaction mechanism and other aspects such as 
conformation, configuration, stereoelectronics of the starting material, and key reaction 
intermediates.
18,21-43
  
A large number of synthetic methods for linking sugars together have been developed to 
ensure the enhanced facial selectivity for the acceptor attack, not all the challenges 
associated with the glycoside formation have been satisfactorily solved.
16,44-46
  Of this 
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strategy, three general approaches have been explored: leaving group-based methods, 
intramolecular aglycone delivery (IAD), and “molecular clamp” concept (approaches A-
C, Figure 1.1). Beyond early attempts dealing with orthoester rearrangement 
glycosylations by Bengt
47
 and Kochetkov
48
 and the decarboxylative glycosylations by the 
Ishido group,
49
 Barresi and Hindsgaul were the first to apply the idea of intramolecular 
glycosylation, which was used for the synthesis of β-mannosides.50 Overall, 
intramolecular glycosylations are two-three-stage processes: first, formation of the 
intermolecular tether between the glycosyl donor and free hydroxyl of the glycosyl 
acceptor; second, intramolecular structurally restricted glycosylation; and third, in the 
molecular clamp approach, the tether is removed. The payoff for this extra investment 
into additional synthetic manipulations is in the synthesis of hard to make carbohydrate 
linkages with high stereoselectivity. 
Figure 1.1 Outline of the Intramolecular Glycosylation Approaches 
 
In leaving group based intramolecular glycosylation, the glycosyl acceptor is linked to 
the leaving group of the glycosyl donor.  This method uses spatial proximity to direct 
stereo-selectivity during glycosylation reactions.  The applicability of these techniques is 
still relatively unexplored, yet, it has been proposed that these reactions tend to be 
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intermolecular rather than intramolecular.
51,52
 This trend was reflected in compromised 
stereoselectivity in many different examples. 
The second method is intramolecular aglycon delivery (IAD), where the glycosyl 
acceptor is linked to a bifunctional group that is attached to a non-reacting hydroxyl of 
the glycosyl donor.  These functional groups fall either under ketal, silyl, or acetal 
functionalities.  This method is generally used for the synthesis of 1,2-cis glycosidic 
linkages and is applied towards the synthesis of β-mannosides.  Further developments 
using newer tethers such as naphthylmethyl ether (NAP), generally provides significantly 
higher yields in comparison to those of traditional approaches.   
The third method is the “molecular clamping (cyclo glycosylation)” method.  This 
involves the arrangement of the glycosyl donor and acceptor in a specific orientation 
relative to each other before glycosylation.  This method is similar to the approach used 
by enzymes, where the glycosyl donor and acceptor are held in close proximity and 
orientation in a binding pocket to ensure regio- and diastereo-selective bond formation.  
To mimic this, the attachment of the glycosyl donor and acceptor with a spacer not 
connected to the reactive centers was developed using a variety of linkers and conditions. 
With recent advances in all fields of glycosciences, the demand for reliable and 
stereocontrolled glycosylation methods has now increased, thus elevating the priority for 
improving our synthetic capabilities. Development of efficient general methods to control 
glycosylations is timely and significant because glycosidic linkage is the only means to 
connect simple monosaccharides into complex oligomeric networks. This chapter will 
discuss recent developments in the field of intramolecular glycosylations. Since LG-
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based methods tend to be non-stereoselective and IAD methods have recently been 
reviewed, the main emphasis on this chapter will be placed on overviewing of the 
developments of the molecular clamping approach that also has become the basis of the 
studies described in the subsequent chapters of this dissertation.  
1.2 Leaving group methods   
1.2.1 Decarboxylation methods 
The first example of this type of intramolecular glycosylation was reported by Yoshiharu 
Ishido and coworkers in 1973 for the synthesis of phenyl-ß-D glucopyranoside (Scheme 
1.2).
49
  They hypothesized that the replacement of the alkoxy moiety of the alkyl aryl 
carbonates with a hemiacetal moiety might bring about considerable enhancement in 
reactivity.   
Scheme 1.2 Decarboxylative glycosylation of phenyl tetra-acetyl glucose 
 
Later, stoichiometric Lewis acids such as TMSOTf and SnCl4/AgClO4 decreased the 
temperature requirements to ambient temperatures.
53
  Recently Ikegami et al. has found 
Zr(OTf)2 or Hf(OTf)4 catalyzes the reaction with very low catalyst loadings (Scheme 
1.3).
54
  Although cross over experiments and selectivities similar to intermolecular 
reactions suggest that the actual mechanism favors a dissociative pathway rather than an 
intramolecular one.  
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Scheme 1.3 Lewis acid catalyzed decarboxylative glycosylation 
 
A decarboxylative variant of the intramolecular glycosylation carried out at 125 C only 
produced the desired product in very low yields.  Addition of Lewis acids such as AlCl3, 
TMSOTf, and BF3OEt2 did not increase yields.   
1.2.2 DISAL Leaving group 
Jensen et al. developed an anomeric leaving group using methyl 3,5-dinitrosalicylate 
(DISAL).
55
  Different from the decarboxylative method, the ortho substitution pattern 
was thought to increase the preference towards the intramolecular mechanism using a 
glycosylation strategy involving a 1,9-glycosyl shift under mild conditions (heating to 40 
- 60 ˚C).   Addition of Lewis acids greatly reduce the reaction time and temperature 
required, but they also increase the formation of hydrolysis products and reduces overall 
stereoselectivity (Scheme 1.4).  Glycosylation under elevated temperatures over 15 h 
gave the best results 37% yield for the glucose donor, and 58% yield for the mannose 
derivative with modest stereoselectivities.  The yields were greatly hampered due to the 
formation of the 1-OH product. 
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Scheme 1.4 Proposed mechanism of disaccharide formation through expulsion of 
3,5-dinitrosalicylate 
 
Crossover experiments with 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose showed only 
intramolecular glycosylation disaccharides.  However, when crossover experiments with 
cyclohexanol were conducted, the intermolecularly formed cyclohexyl glycoside was 
found to be the major product (5.2 to 1) compared to the intramolecular glycosylation 
product.  While the mechanism has been shown to not to be a concerted SN
2
 like 
substitution, the reaction does occur within the solvent coordination sphere unless in the 
presence of a much better nucleophile (i.e. water which leads to the formation of 
undersired hydrolysis product.)   
1.2.3 1,2-trans-1dihydroxyboryl benzyl thioglycoside 
Recently, X. Liu et al. explored the use of o-dihydroxyboryl substituted aryl S-glucosides 
as a delivery method for leaving group based intramolecular glycosylation.
56
  They 
hypothesized that the boronic ester would form when the boronic acid is treated with the 
acceptor alcohol.  Upon activation of the sulfide, one of the oxygen nucleophiles on the 
boronate ester would attack the C-1 center on the opposite side resulting in enhanced 
stereo-selectivity.  Initial trials with 3-methylbenzyl alcohol showed good selectivity 
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when boronic acid was present, while control experiements with thiophenyl or thiobenzyl 
leaving group showed reduced selectivities as well as slight reduction in yield (Table 
1.1).  The addition of triflic acid or silver triflate resulted in significant reduction of 
selectivity so further trials were done in the absence of metal or acid reagents.  
Table 1.1 Boronic Acid as a directing group in leaving group based glycosylation 
method. 
 
Entry ROH Promoter Yield (%)(αβ) 
1 
 
NBS  
(2.2 equiv.) 
55 (4.8:1) 
2 
 
IBr  
(2.2 equiv.) 
65 (1:10) 
3 EtOH 
NBS (5.0 
equiv.) 
47 (α only) 
4 
 
NBS (5.0 
equiv.) 35 (8.5:1) 
5 
 
 
NBS (5.0 
equiv.) 
54 (9.8:1) 
Surprisingly, when IBr was used as a promoter the selectivity reversed resulting in 1 to 
10 α/β ratio in 65% yield.  The selectivity also reverses when the reaction is carried out in 
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a coordinating solvent (acetonitrile); a 1 to 4 α/β ratio in 51% yield.  When using less 
than three equivalents of acceptor to donor ratio, the yield drastically drops giving 
evidence the borate plays an important role in the stereo-selection of the newly formed 
glycosidic bond.  This is supported by the reduced yield and selectivity when the boronic 
acid is replaced by a hydrogen or halogen.   
1.3 Intramolecular Aglycon Delivery (IAD) 
Intramolecular aglycon delivery was initially developed by Barresi and Hindsgaul, used 
an isopropylidine ether which was treated with acid in the presence of the desired 
glycosyl acceptor to form a dimethyl ketal linker.  Activation of the thioethyl leaving 
group with N-iodosuccinimide resulted in good yields of the desired β-mannoside.57,58 
However, the use of hindered glycosyl acceptors resulted in low yields for both the ketal 
and β-mannoside formation.  An alternative linker was developed by Ito and Ogawa 
using a p-methoxybenzyl protecting group on the C-2 position.   Treatment of this 
compound with DDQ in the presence of an alcohol oxidatively formed the desired acetal 
linkage.
59
  This method was initially applied to glycosyl fluorides and later improved by 
its development with thioglycosides
60
 and a 2-napthylmethyl group
61
 which allowed a 
greater range of hindered glycosyl acceptors to be glycosylated in good yield.  The Stork 
group used dichlorodimethylsilane to link the 2-hydroxy manosyl donor and a hydroxyl 
acceptor resulting in a dimethylsilyl-linker.
62
  The thio leaving group of the silyl-linked 
compounds is oxidized to the sulfoxide by m-CPBA, and subsequent treatment with Tf2O 
provided the β-mannoside as the only isolated anomer.  A report using the same 
dimethylsilyl-linked strategy was simultaneously reported by Bols in the synthesis of α-
glucosides.
63
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1.3.1 Long range Intramolecular Aglycon delivery.   
The Bols group broadened the scope of intramolecular aglycon delivery to include long 
range intramolecular glycosylation.
64
  Allowing for the possibility to select 1,2-trans 
linkages depending on the placement of the linking functional group.  Bols et al. used 
partially benzylated thioglycosides with one position open to coordinate 
dimethylsilylacetal as tether and 1-octanol as the acceptor.  While successes were seen 
using IAD from 5-O tethered ribofuranosyl donor resulting in complete stereo-selective 
formation of the 1,4-cis product in 63% yield.  However, application of long range IAD 
towards glucopyranose moieties through the attachment of silyl moieties on C-3, 4, or 6 
positions of the glycosyl donor were not as successful.  IAD from the 3-position was not 
completely selective, giving the octyl glycoside as a mixture of stereoisomers, while 
tethering from 6-position gave predominantly the 1,6 anhydro product.  Only IAD from 
the C-4 position showed some promise with the formation of the 1,4-cis products in 45% 
yield. 
Later Montgomery et al. expanded on this idea of long range IAD with the use of 
bidentate protecting groups.
65
  They hypothesized that installation of a conformational 
bias that prevents chair– chair interconversion should position the C-6 oxygen away from 
the developing oxocarbenium, thereby circumventing the formation of the bridged 
bicyclic product.  To this end, the C-3,4 trans-diol of a thioglycoside was protected via a 
cyclic bisacetal which provided a convenient handle to allow late stage introduction of 
the silyl tether to the 6 position.   
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Primary acceptors underwent glycosylation readily with high β selectivity (>1/32) with 
good yields in the case of aliphatic alcohols.  Secondary and hindered acceptors such as 
menthol underwent glycosylation to give low to moderate yields.  Donor moieties 
including 2-benzyloxy, 2-azido, and 2-deoxy sugars were tolerated.  With primary 
glycosyl acceptors, yields were slightly diminished due to homocoupling product 
resulting from partial hydrolysis of the sugar silane reagent.  Secondary alcohol acceptors 
more hindered than cyclohexanol, such as menthol and C-2 hydroxyl acceptors gave low 
to moderate yields.  
This method was also applied towards C-2 delivery of acceptors (Table 1.2).  This 
position tolerated a wider range of acceptor substrates and formed showing excellent 
stereoselectivity with secondary acceptors such as cholesterol, and 2-hydroxypinanone 
with high yields (> 96% and selectivities (32/1 α/β).  This method also allows 
glycosylation of C-2 of mannose in 89% yield and complete β-selectivity, however, other 
more hindered secondary glycosyl acceptors were not as successful.   
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Table 1.2 Long range intramolecular delivery via dimethylsilane 
 
Entry R
1
 R
2
 Yield (α/β) 
1 OBn  93% (>1/32) 
2 N3  80% (>1/32) 
3 H  75% (>1/32) 
4 OBn 
 
74% (>1/32) 
5 OBn 
 
93% (>1/32) 
1.3.2 Arylboronic esters as linkages for IAD 
Arylboronic esters have been used as a linkage for the intramolecular aglycon delivery 
method.
66
  The arylboronic sugar derivatives can be easily obtained via reflux in toluene 
of the arylboronic acid with 4,6-diol sugar moieties (Scheme 1.5).  The resulting 
arylboronic esters are reacted with three equivalents of 1,2-anhydro glycosyl donor where 
the boronic ester activates the epoxide to form the oxocarbenium ion with a tetra-
coordinated boronate ester moiety, concomitant glycosylation results from the less-
hindered boron-oxygen bond.  In the case where glucose, mannose, glucosaminide, and 
glucal were used, the 1,4- linkage was formed exclusively with high α-selectivity (82%, 
92%, 77%, and 72%, respectively).  When a 4,6-diol galactose acceptor was used the α 
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(1,6) linkage product was formed in 70% yield.  In the case of 3,4 diol galactose acceptor, 
the α(1,4) linkage was formed (65%) with a small amount of the α(1,3) isomer (7%).  
When 2,3-diol mannoside was treated with arylboronic acid followed by glycosylation, 
the α (1,3) disaccharide was formed exclusively in 70% yield.   
Scheme 1.5 Origin of selectivity in boronic ester derived intramolecular delivery 
 
The high regio-selectivity can be explained due to the steric hindrance of the anomeric 
proton of the donor with the benzene ring of the boronic ester during the activation of the 
1,2-anhydro glycosyl donor.   
This concept has recently been applied towards the synthesis of β-mannosides (Scheme 
1.6).  High selectivity and yields were obtained using a diphenyl boronic acid derived 
glycosyl acceptor.  A tetracoordinate borinate ester will form with the 1,2-anhydro-
mannose, resulting in a oxocarbenium ion.  The acceptor is then delivered 
intramolecularly to the β-face of the mannose donor. 
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Scheme 1.6 Aryl boronic acids applied towards the synthesis of β-mannosides 
 
1.3.3 Hydrogen bond mediated aglycon delivery (HAD)  
Previously, Demchenko et al. reported the use of 2-picoloyl group at the C-2 position can 
be used as an armed participating group (Figure 1.2).
67
  When the picoloyl group was 
placed at remote positions they found glycosylation occurred syn rather than anti with 
respect to the location of picoloyl group.  The selectivity is presumably due to initial 
coordination of the nucleophile with the picoloyl group through a hydrogen bond 
followed by delivery of the nucleophile towards the oxocarbenium ion by the picoloyl 
group.  Studies show that if acceptor and donor were allowed to mix for 1h before the 
addition of promoter, α/β ratios were significantly higher, >25/1 vs. 11.3/1 in the case of 
4-picoloyl SEt donor.  The mechanism was further explored through the addition of 
additives (DMSO, TfOH, and excess DMTST) that disrupt hydrogen bond formation; this 
resulted in reduced selectivities 1/4.9 – 1/9.8.  While replacing the acceptor with a TMS-
protected glycosyl acceptor resulted in very low stereo-selectivity (1/2.1)  
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Figure 1.2 Facial selectivity during HAD 
 
This method has been applied towards the synthesis of β-mannosides68 and β-
rhamnosides (Scheme 1.7).   In the case of mannosides, primary acceptors show high β-
selectivity with dilution of the reaction being an important factor in reaction time and 
selectivity (Table 1.3).  It was shown that secondary acceptors generally proceeded with 
high yields albeit slightly reduced selectivities.  This was applied towards the synthesis of 
a tri-mannoside with complete β selectivity.   
Scheme 1.7 α-selective rhamnosylation using HAD 
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Table 1.3 Concentration dependence of HAD 
 
 
1.3.4 Palladium catalyzed-glycosylation 
The use of alternative delivery methods has expanded into the realm of organometallics.  
Liu and Xiang has developed the use of catalytic amounts palladium to control stereo-
selectivity in glycosylations via a palladium π-allyl intermediate.69  Previously, the 
application of this technique to glycosidic bond formation has been hampered by the 
difficulty in the formation of the palladium π-allyl intermediates and their poor reactivity 
in the electron-rich glycal systems.  To overcome this challenge the Liu group explored 
the application of palladium π-allyl intermediates to O-glycosylation through the use of a 
picoloyl group to direct palladium binding at the C-3 position. Glycosylation results show 
two reaction pathways with differing in the selectivity outcome based on the hard soft 
properties of the nucleophiles (Scheme 1.8).  Soft nucleophiles undergo substitution from 
the opposite face of the palladium, and hard nucleophiles coordinate to the palladium and 
are delivered to the same face as that of the palladium.   
Entry Concentration Time Yield, α/β 
1 50 mM 7 h 73% 1/5.0 
2 5 mM 2 h 50 min 91%, 1/18.5 
3 1 mM 2 h 80%, 1/14.0 
 18 
 
Scheme 1.8 Possible mechanisms to explain α and β selectivity in palladium 
catalyzed glycosylation 
 
In both pathways, the first step involves initial coordination of palladium towards the β 
face of the glycosyl donor as directed by the picoloyl group.  With softer nucleophiles 
such as phenol, the nucleophilic attack is directed away from the steric bulk of the 
palladium to give α-glycosides.  When the acceptor is a hard nucleophile, the complex 
undergoes displacement of the picoloyl group to generate the palladium π-allyl complex.  
The resulting π-allyl palladium ion is considered a hard Lewis acid while the allylic 
carbocation site is considered a soft Lewis acid.  The harder nucleophiles tend to prefer to 
coordinate to the palladium site followed by intramolecular nucleophilic delivery to form 
the β-anomer (Table 1.4).   
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Table 1.4 Palladium catalyzed delievery of a glycosyl acceptor 
 
Entry  R =  Yield (α:β) 
1 
 
84% (β only) 
2 
 
69% (β only) 
 
3 
 
75% (β only) 
4 
 
81% (1:16) 
A new iteration of this method replaced the picoloyl group with an ethyl carbonate 
functional group.
70
  It was shown that this carbonate favors the formation of the 
palladium π-allyl species through the release of CO2 (Scheme 1.8).  In the presence of an 
external nucleophile, the ethoxide, undergoes a proton transfer and is released as ethanol, 
while the external nucleophile is directed by the palladium to the β face of the glycosyl 
donor.   This new method allows for β selective synthesis for previously soft nucleophiles 
which preferred nucleophilic substitution opposite of the π-allyl intermediate.   
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Scheme 1.9 Ethyl carbonate effect on the stereochemical outcome of glycosylation 
 
1.4 Molecular Clamping Method 
This method was initially developed by Ziegler using succinoyl linkers to link the 
glycosyl donor and acceptor at positions not directly involving glycosylation reaction.  
Variation upon this method involves the modification of macrocycle ring size, rigidity of 
the spacer, and position of linker.  Generally it has been found that more rigid the 
spacers, and smaller the macrocycle formed during glycosylation, the more selective the 
reaction is.   
For a detailed review on the molecular clamping method and the various modifications 
up to 2000 refer to Schmidt’s review on intramolecular o-glycoside formation.44  
Developments since 2000 are as follows. 
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1.4.1 Click Chemistry as Templates 
To simplify the procedure of the synthesis of the template sugar moiety, triazole-forming 
click chemistry was combined with rigid spacers to attempt to simplify the synthesis of 
the template system.  To vary the size of the macrocycle formed during the glycosylation, 
rigid spacers αα’ dibromo ortho-and meta-xylene were used (Scheme 1.10).71  A D-
glucose donor containing an alkyne moiety and a D-glucofuranose acceptor with an azide 
containing protecting group was linked via click chemistry.  Upon treatment with NIS 
with catalytic triflic acid, complete β-selectivity was obtained when ortho-xylyl group 
(15-membered ring), versus 1:3 α/β selectivity when meta-xylene group was used.  
Scheme 1.10  Effect of ring on glycosylation with a furanose 
 
Template orientation Macrocyclic Ring size Yield % α:β 
Meta 16 65 1:3 
Ortho 15 58 β only 
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When 6-hydroxy-glucopyranose acceptor was used the results were mixed. Placing the 
template on various positions on the acceptor to form 16 or 17 membered macrocycles 
after glycosylation, yields of 90% and 82% respectively were obtained, but the selectivity 
of the reactions were low, 3:1 and 1:2.  With the observation that selectivity is 
dramatically influenced by ring size, a pyranose system with the acceptor linked to the 
donor via the O-3 position (Scheme 1.11).  Following NIS/TMSOTf promoted 
glycosylation, the α-anomer was formed exclusively in 55% yield. 
Scheme 1.11 Fourteen membered macrocycle  
 
With the varying anomeric selectivities and yields, it was hypothesized that the benzylic 
CH2 may be to blame due to increased rotational freedom between the triazolyl and 
benzyl residues.  Investigations with o-azido benzyl protecting groups were used to 
reduce the degrees of freedom and also to form smaller ring sizes.
72
  Interestingly, when 
the template was attached to O-2 followed by glycosylation by the 3-hydroxyl group, the 
reaction proceeded with high β-selectivity, while reversing the positions of template and 
hydroxyl led to a reversal of the selectivity to 8:1 α/β, showing that the adjacent 
functional groups to the accepting hydroxyl group seem to be an important factor 
influencing the outcome of glycosylation (Scheme 1.12).  
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Scheme 1.12 Substitution effect on stereoselectivity 
 
1.4.2 Peptide based templates 
One of the types of templated synthesis is the use of amino acids.  Initially hoping to 
apply the benefits of easy coupling as well as the use of solid phase methods to facilitate 
the synthesis and purification of the resulting oligosaccharides, Fairbanks et al. used 
several amino acids as templates to influence the stereo- and regio-selectivities of the 
glycosylation reactions (Scheme 1.13).
73,74
  Using a peptide coupling reactions involving 
dicyclohexylcarbodiimide (DCC), asparagine attached to O-6 of mannose donor and a 
trihydroxy-mannose acceptor.  Intramolecular glycosylation was carried out with 
NIS/TfOH, resulting in a mixture of disaccharide products showing slight bias towards 1-
3 linkages while the stereo-selectivies of these linkages can vary.  Further development of 
this methodology placed the template on a solid resin support.
75
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Scheme 1.13 Stereochemical outcome of peptide based linkers 
 
At the same time, Warriner et al. chose to use a more ridgid peptide structure, 
hydroxyproline (HyP) (Table 1.5).
76
  The solid supported peptide was linked to the 6-
hydroxy group of the sugar units using a carbonate linkage.  The HyP linked donor and 
acceptor were not able to be directly coupled due to steric interactions. A glycine residue 
was necessary as a spacer to separate the two bulky HyP moieties.  Glycosylation with 
NIS and TMSOTf resulted in the formation of the 1-4-linked disaccharide in 80% yield 
with remarkable α selectivity (α/β = 8:1).  Interestingly, when the donor and acceptor 
positions on the peptide were reversed, the reaction gave a 75% yield of a 1:1 mixture of 
anomers.   This result was reproduced in the case of 4-hydroxygalactose acceptors where 
the position of the donor and acceptor on the peptide dramatically influenced the stereo-
selectivity of the glycosylation (1.8:1 vs 9:1).   
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Table 1.5 Positioning effect of donor and acceptor in peptide templated synthesis 
 
Entry A B Yield % (α/β) 
1 
  
80 (8/1) 
2 
  
75 (1/1) 
3 
  
79 (1.8/1) 
4 
  
81 (9/1) 
5 
  
86 (2:1) 
6 
  
82 (2/1) 
Using this peptide based templating, a 12-membered disaccharide library was 
synthesized.  This library was synthesized with an extra glycine residue inserted to reduce 
steric interactions between the solid support and the sugar moieties.
77
  However, the 
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selectivies were generally in favor of the α-isomer at a ratio of around 3/1.  This shows a 
slight reduction of selectivity when compared to the pentapeptide template.  No 
explanations were given to the reason for selectivity, but presumably it is due to the 
peptide conformation or folding.   
1.4.3 Rigid Template 
The first synthesis of α–cyclodextrin was achieved using maltose (Scheme 1.14).78  After 
synthesis of disaccharide fragments two coupling glycosylations  resulted in 79 % and 61 
% yields with approximately 2/1 α/β mixture which had to be separated.  The final 
cyclization using glycosyl fluoride under Mukaiyama conditions gave the benzyl 
protected α-cyclodextrin in 21% yield.   
Scheme 1.14 First synthesis of α-cyclodextrin 
 
To improve the selectivity during the intermediate synthesis as well as the macro-
cyclization, the clamping method was applied to the synthesis of the α-cyclodextrin.79  
Again maltose was used as the starting material as an initial source of α linked 
glucosides.  Stepwise chain elongation was controlled by the molecular clamp method 
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using phthaloyl linkers followed by a macro-lactonization using DCC, DMAP, in 
refluxing 1,2-dichloroethane under high dilution (0.04 M) to give the cyclic ester in 79 % 
yield.  The high yield of the cyclization might be attributed to the two phthaloyl groups 
on the ring holding the oligosaccharide in a favorable conformation.  After hydrolyzing 
the anomeric protecting group, several conditions were tried to close the ring.  
Dehydrative glycosylation using triflic anhydride and trimethylsilyl perchlorate in initial 
in test with a phthaloyl bridge disaccharide gave complete α-selectivity, 61 and 63%. The 
same dehydrative glycosylations applied to the macrocylic ester for ring closing 
glycosylation gave very low yields 15 – 18 % (Table 1.6) with much of the starting 
material recovered.  Conversion of the anomeric hydroxyl to trichloroacetimidate in the 
test disaccharide system followed by glycosylation using trimethylsilyl triflate gave 
excellent yields (97%) with 89:11 α: β selectivity.  When the macrocyclic ester was 
glycosylated under the same conditions, the α-linked product was formed exclusively in 
66 % yield.  A nine membered δ-cyclodextrin was also synthesized with the same 
procedure using maltotriose subunits with high yield and selectivity using the same 
techniques.
79
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Table 1.6 Templated assisted synthesis of α-cyclodextrin 
 
R  Conditions Yield %  α:β 
OH 1.2 eq Tf2O, 0.2 eq 
TMSClO4 
15 100 : 0 
OH 1.5 eq Tf2O, 0.2 eq 
TMSOTf 
18 100 : 0 
Cl3CCN 0.1 eq TMSOTf 66 100 : 0 
1.4.4 Reiterative intramolecular glycosylation 
The use of intermolecular glycosylation can improve the selectivity of difficult glycosidic 
linkages, the extension of this to oligosaccharide synthesis have been carried out using 
larger building blocks.  Examples of using commercially available disaccharides have 
been demonstrated using maltose ( α 1-4 linked di-glucose) and lactose (galactose β 1-4 
linked with glucose) (Scheme 1.15).   
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Scheme 1.15 Tetrasaccharide synthesis using rigid xylyl linker 
 
Reiterative methods have been developed to synthesize oligosaccharides, m-xylene was 
used to link two glucose derivatives via the 3’-and the 6-positions.80  NIS/TfOH was used 
to glycosylate the two sugar units to give the α-disaccharide (84%, α:β = 85:15) followed 
by selective de-protection of the 6’ position and introduction of a second donor moiety.  
After deprotection of the 4’ hydroxyl group, NIS/TfOH promoted glycosylation was 
carried out to yield the trisaccharide (75%, α-only).  Removal of the template and benzyl 
protecting groups using palladium catalyzed hydrogenation followed by acetylation 
resulted in the formation of acetylated maltotriose.   
Scheme 1.16 Reiterative templated synthesis using a xylyl linker 
 
Unsymmetrical rigid templates have also been developed in order to provide more 
flexibility in the synthesis of more complicated oligosaccharides (Scheme 1.6).
81
 A 3-
bromobenzyl protected glucose donor was treated with t-butyllithium and diisopropylsilyl 
dichloride.  This was then attached to an acceptor under basic conditions.  Glycosylation 
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with NIS/TfOH resulted in 90% yield of a 1:1 mixture for the intramolecular 
glycosylation product.  Methyltriflate mediated glycosylation resulted in the selective 
formation of the α-anomer in 70% yield.   
Scheme 1.17 Glycosylation using an unsymmetrical template 
 
Tert-Butyl 5-(bromomethyl)-2-methylbenzoate has also been explored as an 
unsymmetrical ridgid template, with the 2-methyl group limiting the rotation between the 
aryl-carbonyl bond through steric interactions (Figure 1.3).  The template was used in the 
synthesis of a trisaccharide through reiterative template synthesis.   
Figure 1.3 Limited rotation due to steric interactions 
 
Here the second glycosylation was done with iodine in methanol to cleave benzylidene 
concurrently with activation of the ethanethiol leaving group resulting in the formation of 
the 14-membered ring (Scheme 1.8, 83 %, α only).  After a second treatment with sodium 
methoxide in methanol, results in the cleavage of the ester template bond revealing the 
6’’-hydroxyl group, which can be used for further synthesis.   
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Scheme 1.18 Synthesis of a trisaccharide  
 
1.5 Conclusions 
Intramolecular glycosylation has seen dramatic advancements in the past sixteen years.  
New templates and methodologies have advanced the synthesis of difficult glycosyl 
linkages.  Easier synthesis of starting materials has also made these methodologies more 
attractive for use in more complicated syntheses.  Despite the advancements made, there 
are still no definitive rules on why changing small factors affects the stereochemical 
outcomes so dramatically.  There is a greater need to study the underlying concepts and 
rules governing the use of templates and how to apply them to new systems. 
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Chapter 2 The Linker Effect on Stereoselectivity of 
Glycosylation 
  
 38 
 
2.1 Introduction 
The issue of controlling stereoselectivity of glycosylations has been approached in a vari-
ety of modes.
1,2
 For instance, intramolecular approaches occupy an important niche 
amongst other methods available. Many attractive intramolecular glycosylation methods 
have emerged during the past two decades as discussed in Chapter 1.
3-6
 An underlying 
concept is that the two glycosylation components, glycosyl donor and acceptor, are teth-
ered together using a cleavable linker. The purpose of this tethering is to achieve an effi-
cient facial selectivity due to steric or geometric constraints that may help to control the 
stereoselectivity of glycosylations. These techniques are classified into three major sub-
groups: intramolecular aglycone delivery (IAD), leaving group-based methods, and the 
“molecular clamp” concept (Approaches A-C, Figure 2.1). 
The “Molecular clamp” concept7 links the glycosyl donor and acceptor away from the 
reaction sites. Currently, this approach is predominantly applied to glycosylation of a hy-
droxyl adjacent to the tether on the acceptor site. An example of this approach is the use 
of a rigid xylylene tether which can be conveniently removed concomitantly with deben-
zylation.
8
 Overall, the molecular clamp-directed glycosylation is a three-step process: 1) 
formation of the intermolecular tether between the glycosyl donor and free hydroxyl of 
the glycosyl acceptor; 2) intramolecular structurally restricted glycosylation; and 3) re-
moval of the tether. The investment in the additional steps is often compensated by the 
ability to access the challenging glycosidic bonds that are otherwise hard to accomplish 
by direct protocols. 
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Figure 2.1 Three general concepts for the intramolecular glycosylation reaction 
 
After careful review of past developments in intramolecular glycosylation, we felt that 
there is significant room for improvement.  We turned our efforts towards developing a 
new molecular clamp method. We chose the molecular clamp method due to two key fac-
tors: 1) the tethering is achieved away from the reactive sites, allowing glycosylation of 
different hydroxyls, not only those adjacent to the tether; 2) it provides exceptional α-
selectivity and allows for connecting multiple building blocks for oligosaccharide synthe-
sis. The general outline of a templated synthesis is shown in Scheme 2.1. If the synthesis 
of a disaccharide is targeted (Scheme 2.1A), a glycosyl donor equipped with linker 1 is 
connected to a glycosyl acceptor bearing linker 2 via a template. The resulting donor-
acceptor tethered pair then is subjected to glycosylation conditions and the disaccharide is 
cleaved off the template. In cases when the synthesis of an oligosaccharide is attempted, a 
series of building blocks equipped with various linkers are connected via a template in a 
sequential manner (Scheme 2.1B). The resulting tethered donor-acceptor network is then 
subjected to glycosylation. Finally, the resulting oligosaccharide is cleaved off the tem-
plate. 
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Scheme 2.1 The outline of the concept of templated glycosylation (A) and oligosac-
charide synthesis (B). 
 
2.2 Results and Discussion 
To execute this concept, we considered the following. To be practical for synthetic appli-
cations, the linkers and the template itself should be easy to install and remove. In addi-
tion, by varying the length of the linker it should be possible to control the stereoselec-
tivity of the subsequent glycosylation. For instance, if the linker connecting the acceptor 
is longer than that of the donor, this should facilitate the delivery of the nucleophile from 
the bottom (α) face of the donor.  Having learned from previous work by Fairbanks and 
co-workers,
9,10
 and Warriner,
11
 as well as our own experimentation with flexible peptide-
based templates,
12
 we anticipated that the rigidity of the template would critically affect 
the stereoselection. With these considerations in mind, we prepared various donor-
acceptor conjugates based on bis-phenol A (BPA) as the rigid template.  
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The first series of conjugates 2.1, 2.3 and 2.5 were designed to deliver the glycosyl ac-
ceptor from the bottom face. In this case the donor linker was shorter than that of the ac-
ceptor, succinoyl (Suc) vs. glutaryl (Glt), respectively. The key results of this study are 
summarized in Table 2.1. When per-benzylated donor tethered with 4-OH acceptor 2.1 
was activated with MeOTf, a mild activator for thioglycosides,
13
 followed by the ester 
bond cleavage under Zemplen conditions (NaOMe) and standard acetylation 
(Ac2O/pyridine), disaccharide 2.2 was isolated in 81% yield with complete α-selectivity 
(entry 1, Table 2.1); no traces of the β-linked diastereomer were detected. It should be 
noted that many other promoters for the activation of thioglycosides including dimethyl 
(thiomethyl) sulfonium triflate (DMTST)
14
 and NIS/TfOH gave faster reactions times but 
yields were lowered due to competing hydrolysis. When MeOTf-promoted activation was 
applied to glycosylation of the tethered 3-OH acceptor 2.3, disaccharide 2.4 was obtained 
in 73% yield and with complete α-selectivity (entry 2). Glycosylation of the tethered 6-
OH acceptor 2.5 provided disaccharide 2.6 in 63% yield. Again, the preference was for 
formation of the α-linked product, although the presence of the other diastereomer was 
also evident (α/β = 9.2/1, entry 3). It is possible that the compromised stereoselectivity in 
this case is related to the fact that the primary 6-hydroxyl is more flexible and can reach 
both from the bottom and from the top face of the activated donor (oxacarbenium ion in-
termediate).
15
 
Having controlled α-stereoselectivity with the longer acceptor linker, we were curious to 
investigate the stereoselectivity of glycosylations with spacers of equal length. For this 
purpose we obtained a template with succinoyl linkers for both the glycosyl donor and 
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acceptor attachment (2.7). Complete α-stereoselectivity was still maintained in glycosyla-
tions of acceptors with secondary hydroxyl, and disaccharide 2.2 was obtained in 76% 
yield (entry 4). With good reaction yields and excellent α-stereoselectivity achieved in 
most template-mediated glycosylations, we also investigated a template wherein the gly-
cosyl acceptor would be expected to be delivered from the top (β-) face. For this purpose, 
the glycosyl donor was attached to the donor counterpart via a longer linker (glutaryl) 
than that of the glycosyl acceptor (succinoyl). In the case of compound 2.8, however, 
practically no selectivity was achieved. Entry 5 clearly shows a typical outcome, which 
implied that the synthesis of β-linked derivatives could not be accomplished using this 
approach.  
We postulated that enhanced rigidity might provide a more stringent acceptor delivery 
mode and, hence, help to improve the stereoselectivity for primary glycosyl acceptors. To 
investigate this, we prepared the tethered compounds 2.9 and 2.10, which were subjected 
to the same reaction conditions. The tethered 4-OH acceptor 2.9 gave disaccharide 2.2 in 
an impressive 90% yield with complete α-selectivity (entry 6). Even more importantly, 
MeOTf-promoted synthesis of the (16)-linked disaccharide 2.6 from the tethered do-
nor-acceptor 2.10 also resulted in an excellent yield of 89% with complete α-selectivity 
(entry 7).  
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Table 2.1 The linker effect on the stereoselectivity of glycosylation. 
entry donor-acceptor
a
 
time 
(h)
b
 
product 
(yield,% 
α/β 
ratio) 
1 
 
18 
2.2 
(81, α-
only) 
2 
 
18 
2.4 
(73, α-
only) 
3 
 
20 
2.6 
(63, 
9.2/1) 
4 
 
18 
2.2 
(76, α-
only) 
5 
 
20 
2.2 
(71, 
2.8/1) 
6 
 
22 
2.2 
(90, α-
only) 
7 
 
18 
2.6 
(89, α-
only) 
8 
 
40 
2.12 
(84, β-
only) 
a
 – Suc = succinoyl; Glt = glutaryl   
b
 – Performed in 1,2-dichloroethane in the presence of MeOTf and molecular sieves 3 
Å at 0 °C 
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Having achieved excellent yields and complete stereocontrol in all the syntheses of α-
linked disaccharides, we were curious to see whether essentially the same approach could 
be used for the synthesis of β-linked disaccharides. For this purpose we prepared a ben-
zoylated glycosyl donor that was tethered with a 3-OH acceptor 2.11. MeOTf-promoted 
glycosylation was rather sluggish (40 h) perhaps due to the disarmed nature of per-
benzoylated donor used herein.
16
 Nevertheless, the reaction smoothly progressed and di-
saccharide 2.12 was obtained in 84% yield with complete β-stereoselectivity (entry 8). 
The rate of this coupling could be significantly enhanced in the presence of NIS/TfOH 
(10 min), but the isolated yield of disaccharide 2.12 was reduced. Interestingly, when the 
respective benzylated donor was glycosylated in MeCN, a reaction solvent that is known 
to enhance β-selectivity,17 still, only the α-linked disaccharide was obtained. This result 
implies that the effect of the intramolecular tethering on stereoselectivity of glycosylation 
is significantly stronger than that of the reaction solvent.  
We next explored the possibility of extending the one-step glycosylation reactions to 
multi-step processes for synthesis of a longer oligosaccharide sequence. For this purpose, 
donor-linker-template conjugate 2.13 was reacted with trimellitic anhydride in the pres-
ence of EDC and DMAP. The resulting intermediate 2.14 was obtained in 98% yield 
(Scheme 2.2). It was reacted with building block 2.15 to afford a tethered donor-acceptor 
pair 2.16 in 95% yield (combined yield for 2.16 and its meta-linked regioisomer). Differ-
ently from the previously executed reactions with simple linkers, the intermediate 2.16 
could be used for further template elongation via the carboxyl group. Indeed, BPA-
conjugated glycosyl acceptor 2.17 could be linked to compound 2.16 using DCC/DMAP-
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mediated coupling reaction to obtain the templated conjugate 2.18 in 82% yield. The syn-
thesis of compound 2.18 clearly demonstrated that all additional steps required for the 
installation of the template tethering could be achieved effectively and in a very high 
yield. 
The templated compound 2.18 was designed so that the unit on the left-hand-side could 
act as the glycosyl donor only. The unit on the right-hand-side ccould act as the glycosyl 
acceptor only, whereas the central building block could act either as the glycosyl acceptor 
or the donor upon demand.  With a number of possibilities available, so far, we have only 
explored the one shown in Scheme 2.3. First, activation of the S-ethyl leaving group in 
compound 2.18 was achieved with MeOTf and the glycosylation of the middle building 
block took place with concomitant removal of the p-methoxybenzyl (PMB) group. The 
latter could be also removed as a separate step prior to glycosylation, but in our hands the 
one-pot procedure provided a slightly higher yield. It should be noted that essentially the 
same principle for direct glycosylation of hydroxyls masked with temporary PMB protec-
tion created a basis for the development of the reverse orthogonal approach.
18
 Second, the 
o-allylphenyl leaving group
19,20
 was activated with NIS/TfOH, and again the PMB group 
of the acceptor was removed during the glycosylation step. The resultant tethered trisac-
charide was released from the template by reaction with NaOMe in MeOH to afford 
compound 2.19 in 58% overall yield with complete stereoselectivity for both glycosidic 
linkages. 
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2.3 Conclusions 
In conclusion, we have developed a new concept for intra-molecular glycosylation and 
oligosaccharide synthesis. Complete stereoselectivities have been achieved in a majority 
of applications. In particular, the rigid bis-phenol A template and phthaloyl linkers permit 
highly stereoselective glycoside bond formation for both primary and secondary glycosyl 
acceptors. Efficient intramolecular glycosylation with glycosyl donors equipped with a 
non-participating benzyl group at the C-2 position led to the exclusive formation α-linked 
disaccharides. α-Selectivity can be lower in case of primary glycosyl acceptors and flexi-
ble linkers. We also demonstrated that β-linked glycosides could be efficiently formed 
with the aid of a participatory effect of the neighboring ester group. We also demonstrat-
Scheme 2.2 The templated synthesis of α,α-linked trisaccharide 2.19. 
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ed a possibility of extending the template to the synthesis of a trisaccharide, which was 
also obtained with complete α-stereoselectivity for both glycosylation steps. 
 
2.4 Experimental 
2.4.1 General remarks  
The reactions were performed using commercial reagents (Aldrich and Acros) and sol-
vents used for reactions purified in accordance with standard procedures.  Column chro-
matography was performed on silica gel 60 (EM Science, 70-230 mesh), reactions were 
monitored by TLC on Kieselgel 60 F254 (EM Science). The compounds were detected by 
examination under UV light and by charring with 10% sulfuric acid in methanol. Sol-
vents were removed under reduced pressure at <40 
o
C. Methylene Chloride and 1,2-
dichloroethane (DCE) were distilled from CaH2 directly prior to application. Molecular 
sieves (3 Å), used for reactions, were crushed and activated in vacuo at 390 °C for 8 h in 
the first instance and then for 2-3 h at 390 °C directly prior to application. Optical rota-
tions were measured on a ‘Jasco P-1020’ polarimeter. 1H NMR spectra were recorded at 
300 MHz, 
13
C  NMR spectra were recorded at 75 MHz (Bruker Avance) unless noted 
otherwise. The 
1
H NMR chemical shifts are referenced to the signal of the residual 
CHCl3 (δH = 7.27 ppm) for solutions in CDCl3. The 
13
C NMR chemical shifts are refer-
enced to the central signal of CDCl3 (δC = 77.23 ppm) for solutions in CDCl3. HRMS de-
terminations were obtained with the use of the JEOL MStation (JMS-700) Mass Spec-
trometer.  
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2.4.2 Introduction of the Succinoyl Linker: Preparation of Building Blocks 2.21 and 
2.23 
Ethyl 2,3,4-tri-O-benzyl-6-O-(3-hydroxycarbonylpropanoyl)-1-thio-β-D-
glucopyranoside (2.21). Succinic anhydride (401 mg, 3.40 mmol) was added to a solu-
tion of ethyl 2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (2.20,21 560 mg, 1.13 mmol) 
in dry pyridine (5.0 mL) and the resulting mixture was stirred under argon for 16 h at rt. 
After that, the reaction mixture was concentrated under reduced pressure. The residue 
was dissolved in dichloromethane (~100 mL) and washed with water (3 x 20 mL). The 
organic phase was separated, dried over MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate - hexane gradient elu-
tion) to afford the title compound in 90% yield (610 mg, 1.03 mmol) as a white amor-
phous solid. Analytical data for 2.21 were the same as reported previously.
22
 
 
Methyl 2,3-di-O-benzyl-6-O-(3-hydroxycarbonylpropanoyl)-α-D-glucopyranoside 
(2.23).  Succinic anhydride (402 mg, 4.02 mmol) was added to a solution of methyl 2,3-
di-O-benzyl-α-D-glucopyranoside (2.22,23 425 mg, 1.14 mmol) in dry pyridine (5.0 mL) 
and the resulting mixture was stirred under argon for 16 h at rt. After that, the reaction 
mixture was concentrated under reduced pressure. The residue was dissolved in di-
 49 
 
chloromethane (~100 mL) and washed with water (3 x 20 mL). The organic phase was 
separated, dried over MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford 
compounds 2.23 in 84% yield (563 mg, 0.948 mmol) as a colorless syrup. Analytical data 
for 2.23 were the same as reported previously.
24
 
2.4.3 Introduction of the Glutaryl Linker: Preparation of Building Blocks 2.24, 2.25, 
2.27, and 2.29. 
 
Ethyl 2,3,4-tri-O-benzyl-6-O-(4-hydroxycarbonylbutanoyl)-1-thio-β-D-
glucopyranoside (2.24).  4-N,N-Dimethylaminopyridine (DMAP, 21 mg, 0.17 mmol) 
and glutaric anhydride (298 mg, 2.61 mmol) was added to a solution of 2.20 (423 mg, 
0.87 mmol) in dry pyridine (4.0 mL) and the resulting mixture was stirred under argon 
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for 16 h at rt. After that, the reaction mixture was concentrated under reduced pressure. 
The residue was dissolved in dichloromethane (~100 mL) and washed with water (3 x 20 
mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate – hexane 
gradient elution) to afford the title compound in 98% yield (521 mg, 0.85 mmol) as a 
white amorphous solid. Analytical data for 2.24: Rf = 0.55 (methanol/dichloromethane, 
1/9, v/v); []D
25
 +13.8 (c = 1, CHCl3); 
1H NMR: δ, 1.28 (t, 3H, J = 14.9 Hz, SCH2CH3), 
1.91, 2.34 (2m, 6H, CH2CH2CH2COOH), 2.67 (m, 2H, SCH2CH3), 3.39 (dd, 1H, J2,3 = 
9.4 Hz, H-2), 3.46-3.51 (m, 2H, H-4, 5), 3.61-3.69 (m, 1H, H-3), 4.12 (dd, 1H, J5,6a = 4.7 
Hz, J6a,6b = 12.0 Hz, H-6a), 4.34 (d, 1H, H-6b), 4.43 (d, 1H, J1,2 = 9.8 Hz, H-1), 4.67 (dd, 
2H, 
2
J = 10.9 Hz, CH2Ph), 4.79 (dd, 2H, 
2
J = 10.2 Hz, CH2Ph), 4.86 (dd, 2H, 
2
J = 15.1 
Hz, CH2Ph), 7.18-7.33 (m, 15H, aromatic), 8.60 (d, 1H, J = 1.6 Hz, COOH) ppm; 
13
C 
NMR (75 MHz): δ, 15.2, 19.8, 25.2, 33.1 (x2), 63.4, 75.2, 75.6, 75.9, 76.9, 77.7, 81.8, 
85.2, 86.7, 127.9 (x3), 128.0, 128.1, 128.2 (x2), 128.4 (x2), 128.5 (x2), 128.6 (x4), 137.7, 
137.9, 138.4, 172.6, 179.0 ppm; HR-FAB MS [M+Na]
+
 calcd for C34H40 NaO8S 
631.2342, found 631.2340.  
 
Methyl 2,3-di-O-benzyl-6-O-(4-hydroxycarbonylbutanoyl)-α-D-glucopyranoside 
(2.25).  Glutaric anhydride (945 mg, 8.24 mmol) was added to a solution of 2.22 (1.03 g, 
2.76 mmol) in dry pyridine (5.0 mL) and the resulting mixture was stirred under argon 
for 16 h at rt. After that, the reaction mixture was concentrated under reduced pressure. 
The residue was dissolved in dichloromethane (~100 mL) and washed with water (3 x 20 
 51 
 
mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate – hexane 
gradient elution) to afford the title compound in 66% yield (887 mg, 1.82 mmol) as a col-
orless syrup. Analytical data for 2.25: Rf = 0.50 (ethyl acetate); []D
24
 +8.4 (c = 1, 
CHCl3); 
1H NMR: δ, 1.94 (m, 2H, COCH2CH2CH2CO), 2.42 (m, 4H, 
COCH2CH2CH2CO), 3.38 (s, 3H, OCH3), 3.44 (dd, 1H, J4,5 = 9.6 Hz, H-4), 3.51 (dd, 1H, 
J2,3 = 9.5 Hz, H-2), 3.72-3.83 (m, 2H, H-3, 5), 4.25 (dd, 1H, J5,6a = 1.6 Hz, H-6a), 4.39 
(dd, 1H, J5,6b = 4.6 Hz, J6a,6b = 12.1 Hz, H-6b), 4.62 (d, 1H, J1,2 = 3.5 Hz, H-1), 4.64-5.06 
(m, 4H, 2 x CH2Ph), 7.27-7.37 (m, 10H, aromatic) ppm; 
13C NMR (75 MHz): δ, 20.1, 
33.3, 55.5, 63.5, 69.4, 70.1, 73.4, 75.8, 79.8, 81.4, 98.4, 128.1, 128.2, 128.3 (x4), 128.7 
(x2), 128.8 (x2), 138.1, 138.8, 173.4 ppm; HR-FAB MS [M+Na]
+
 calcd for C26H32NaO9 
511.1944, found 511.1924.  
Methyl 2,4-di-O-benzyl-6-O-(4-hydroxycarbonylbutanoyl)-α-D-glucopyranoside 
(2.27).  Glutaric anhydride (871 mg, 7.64 mmol) was added to a solution of methyl 2,4-
di-O-benzyl-α-D-glucopyranoside (2.26,25 950 mg, 2.54 mmol) in dry pyridine (5.0 mL) 
and the resulting mixture was stirred under argon for 2 h at rt. After that, the reaction 
mixture was concentrated under reduced pressure. The residue was dissolved in di-
chloromethane (~100 mL) and washed with water (3 x 20 mL). The organic phase was 
separated, dried over MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate – hexane gradient elution) to afford 
the title compound in 70% yield (861 mg, 1.76 mmol) as a colorless syrup. Analytical 
data for 2.27: Rf = 0.50 (methanol/dichloromethane, 1/9, v/v); []D
25
 +55.8 (c = 1, 
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CHCl3); 
1H NMR: δ, 1.95, 2.45 (2m, 6H, CH2CH2CH2COOH), 3.33 (s, 3H, OCH3), 3.38-
3.46 (m, 2H, H-2, 4), 3.81 (m, 1H, H-5), 4.13 (dd, 1H, J3,4 = 8.9 Hz, H-3), 4.26 (dd, 1H, 
J5,6a = 4.7 Hz, J6a,6b = 11.9 Hz, H-6a), 4.34 (dd, 1H, J5,6b = 2.3 Hz, H-6b), 4.61-4.76 (m, 
3H, H-1, CH2Ph), 4.82 (dd, 2H, 
2
J = 11.2 Hz, CH2Ph), 7.27-7.43 (m, 10H, aromatic), 
8.66 (d, 1H, J = 4.4 Hz, COOH) ppm; 
13
C NMR (75 MHz): δ, 19.9, 32.9, 33.1, 55.4 (x2), 
63.3, 68.3, 73.2, 73.7, 74.7, 79.8, 97.5, 127.9, 128.0, 128.1, 128.3 (x3), 128.6 (x2), 128.8, 
137.5, 138.0, 138.2, 172.7, 178.3 ppm; HR-FAB MS [M+Na]
+
 calcd for C26H32NaO9 
511.1944, found 511.1954.  
 
Methyl 2,3-di-O-benzyl-4-O-(4-hydroxycarbonylbutanoyl)-6-O-triphenylmethyl-α-
D-glucopyranoside (2.29).  Glutaric anhydride (449 mg, 4.49 mmol) was added to a so-
lution of methyl 2,3-di-O-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside (2.28,26 606 
mg, 1.34 mmol) in dry pyridine (5.0 mL) and the resulting mixture was stirred under ar-
gon for 16 h at rt. After that, the reaction mixture was concentrated under reduced pres-
sure. The residue was dissolved in dichloromethane (~100 mL) and washed with water (3 
x 20 mL). The organic phase was separated, dried over MgSO4, and concentrated in vac-
uo. The residue was purified by column chromatography on silica gel (ethyl acetate – 
hexane gradient elution) to afford the title compound in 71% yield (511 mg, 0.70 mmol) 
as a white amorphous solid. Analytical data for 2.29: Rf = 0.43 (ethyl acetate/toluene, 2/3, 
v/v); []D
25
 +3.0
o
 (c = 1, CHCl3); 
1H NMR: δ, 1.60 (m, 2H, CH2CH2CH2COOH), 1.94 
(m, 4H, CH2CH2CH2COOH), 3.01 (dd, 1H, J5,6a = 1.7 Hz, J6a,6b = 10.1 Hz, H-6a), 3.10 
(dd, 1H, J5,6b = 6.3 Hz, H-6b), 3.50 (s, 3H, OCH3), 3.62 (dd, 1H, J2,3 = 9.6 Hz, H-2), 3.87 
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(m, 1H, H-5), 3.90 (dd, 1H, J3,4 = 9.4 Hz, H-3), 4.73 (dd, 2H, 
2
J = 11.6 Hz, CH2Ph), 4.65-
4.82 (m, 3H, J1,2 = 3.6 Hz, 
2
J = 12.1 Hz, H-1, CH2Ph), 4.92 (dd, 1H, J4,5 = 10.0 Hz, H-4), 
7.16-7.43 (m, 25H, aromatic) ppm; 
13C NMR (75 MHz): δ, 19.6, 19.8, 32.9, 55.2, 62.8, 
69.2, 70.4, 73.5, 75.4, 79.5, 79.9, 86.6, 97.9, 127.0 (x3), 127.7, 127.8 (x4), 127.9 (x3), 
128.0, 128.2 (x3), 128.4 (x3), 128.6 (x3), 128.8 (x4), 138.1, 138.5, 143.7 (x3), 171.4, 
178.5 ppm; HR-FAB MS [M+Na]
+
 calcd for C45H46NaO9 753.3040, found 753.3040.  
2.4.4  Introduction of the Phthaloyl Linker: Preparation of Building Blocks 2.30-2.33 
and 2.35 
 
Ethyl 2,3,4-tri-O-benzyl-6-O-(2-hydroxycarbonylbenzoyl)-1-thio-β-D-
glucopyranoside (2.30).  DMAP (82 mg, 0.67 mmol) and phthalic anhydride (794 mg, 
5.36 mmol) were added to a solution of 2.20 (660 mg, 1.33 mmol) in dry pyridine (5.0 
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mL) and the resulting mixture was stirred under argon for 24 h at 50 
o
C. After that, the 
volatiles were removed under reduced pressure, the residue was dissolved in dichloro-
methane (~100 mL) and washed with water (3 x 20 mL). The organic phase was separat-
ed, dried over MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate/hexane, 1/1, v/v) to afford the title compound 
in 94% yield (810 mg, 1.26 mmol) as a white amorphous solid. Analytical data for 2.30: 
Rf = 0.45 (methanol/dichloromethane, 1/9, v/v); []D
22
 +15.2
o
 (c = 1, CHCl3); 
1
H NMR: 
δ, 1.28 (t, 3H, J = 7.8 Hz, SCH2CH3), 2.76 (m, 2H, SCH2CH3), 3.53-3.73 (m, 4H, H-2, 3, 
4, 5), 4.33 (dd, 1H, J6a,6b = 11.8 Hz, H-6a), 4.52-4.62 (m, 3H, H-1, 6b, CH2Ph), 4.74-4.96 
(m, 5H, CH2Ph), 7.22-7.75 (m, 19H, aromatic) ppm; 
13C NMR (75 MHz): δ, 15.2, 25.3, 
64.3, 75.2, 75.8, 75.9, 76.6, 81.6, 85.0, 86.6, 127.9 (x3), 128.1 (x2), 128.4 (x3), 128.5 
(x3), 128.6 (x6), 129.0, 129.6, 131.2, 131.7, 137.7, 138.0, 138.5, 161.2, 170.5 ppm; HR-
FAB MS [M+Na]
+
 calcd for C37H38NaO8S 665.2185, found 665.2184.  
 
Methyl 2,3-di-O-benzyl-6-O-(2-hydroxycarbonylbenzoyl)-α-D-glucopyranoside 
(2.31). DMAP (90 mg, 0.73 mmol) and phthalic anhydride (868 mg, 5.61 mmol) were 
added to a solution of 2.22 (547 mg, 1.46 mmol) in dry pyridine (5.0 mL) and the result-
ing mixture was stirred under argon for 24 h at 50 
o
C. After that, the volatiles were re-
moved under reduced pressure, the residue was dissolved in dichloromethane (~100 mL) 
and washed with water (3 x 20 mL). The organic phase was separated, dried over MgSO4, 
and concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (ethyl acetate/hexane, 1/1, v/v) to afford the title compound in 79% yield (602 mg, 
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1.15 mmol) as a white amorphous solid. Analytical data for 2.31: Rf = 0.28 (metha-
nol/dichloromethane, 1/9, v/v); []D
22
 +39.9
o
 (c = 1, CHCl3); 
1
H NMR (75 MHz, DMSO-
d6): δ, 3.26 (s, 3H, OCH3), 3.37-3.46 (m, 2H, H-2, 4), 3.60 (dd, 1H, J3,4 = 3.2 Hz, H-3), 
3.68 (m, 1H, H-5), 4.32 (dd, 1H, J5,6a = 5.7 Hz, J6a,6b = 11.8 Hz, H-6a), 4.43 (dd, 1H, J5,6b 
= 1.6 Hz, H-6b), 4.60 (s, 2H, CH2Ph), 4.74-4.85 (m, 3H, H-1, CH2Ph), 7.24-7.81 (m, 
14H, aromatic) ppm; 
13
C NMR (300 MHz, DMSO-d6): δ, 54.4, 64.3, 69.6, 69.8, 71.6, 
74.0, 79.0, 80.9, 97.1, 123.9, 127.1, 127.4, 127.5 (x2), 127.6 (x2), 128.0 (x2), 128.2 (x2), 
129.0, 130.0, 130.3, 136.2, 138.6, 139.3, 149.6, 168.7, 169.0 ppm; HR-FAB MS 
[M+Na]
+
 calcd for C29H30NaO9 545.1788, found 545.1784.  
 
Methyl 2,4-di-O-benzyl-6-O-(2-hydroxycarbonylbenzoyl)-α-D-glucopyranoside 
(2.32).  DMAP (66 mg, 0.54 mmol) and phthalic anhydride (640 mg, 4.32 mmol) were 
added to a solution of 2.26 (403 mg, 1.08 mmol) in dry pyridine (5.0 mL) and the result-
ing mixture was stirred under argon for 24 h at 50 
o
C. After that, the volatiles were re-
moved under reduced pressure, the residue was dissolved in dichloromethane (~100 mL) 
and washed with water (3 x 20 mL). The organic phase was separated, dried over MgSO4, 
and concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (ethyl acetate/hexane, 1/1, v/v) to afford the title compound in 70% yield (394 mg, 
0.754 mmol) as a colorless syrup. Analytical data for 2.32: Rf = 0.38 (metha-
nol/dichloromethane, 1/9, v/v); []D
21
 +46.4
o
 (c = 2, CHCl3); 
1H NMR: δ, 3.33 (s, 3H, 
OCH3), 3.40 (dd, 1H, J2,3 = 9.6 Hz, H-2), 3.51 (dd, 1H, J4,5 = 8.9 Hz, H-4), 3.89 (m, 1H, 
J5,6a = 3.7 Hz, J5,6b = 3.2 Hz, H-5), 4.13 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.54 (m, 2H, H-6a, 
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6b), 4.64 (m, 3H, J1,2 = 3.5 Hz, H-1, CH2Ph), 4.81 (dd, 2H, 
2
J = 11.1 Hz, CH2Ph), 7.23-
7.84 (m, 14H, aromatic) ppm; 
13C NMR (75 MHz): δ 55.4, 64.7, 68.5, 73.2, 73.8, 74.7, 
77.4, 79.7, 97.5, 128.0, 128.2 (x3), 128.3 (x2), 128.6 (x2), 128.7, 128.8 (x2), 129.3, 
129.8, 131.3, 131.8, 132.5, 138.0, 138.3, 168.0, 170.7 ppm; HR-FAB MS [M+Na]
+
 calcd 
for C29H30NaO9 545.1788, found 545.1781.  
 
Methyl 2,3-di-O-benzyl-4-O-(2-hydroxycarbonylbenzoyl)-6-O-triphenylmethyl-α-D-
glucopyranoside (2.33).  DMAP (63 mg, 0.52 mmol) and phthalic anhydride (612 mg, 
4.13 mmol) were added to a solution of 2.28 (636 mg, 1.03 mmol) in dry pyridine (5.0 
mL) and the resulting mixture was stirred under argon for 24 h at 50 
o
C. After that, the 
volatiles were removed under reduced pressure, the residue was dissolved in dichloro-
methane (~100 mL) and washed with water (3 x 20 mL). The organic phase was separat-
ed, dried over MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate/hexane, 1/1, v/v) to afford the title compound 
in 90% yield (681 mg, 0.93 mmol) as a colorless syrup. Analytical data for 2.33: Rf = 
0.63 (methanol/dichloromethane, 1/9, v/v); []D
25
 +6.4
o
 (c = 1, CHCl3); 
1H NMR: δ, 
3.21-3.30 (m, 2H, H-6a, 6b), 3.46 (s, 3H, OCH3), 3.65 (dd, 1H, J2,3 = 9.5 Hz, H-2), 3.96 
(m, 1H, H-5), 4.03 (dd, 1H, J3,4 = 9.3 Hz, H-3), 4.73 (dd, 2H, 
2
J = 12.1 Hz, CH2Ph), 4.67-
4.81 (m, 3H, J1,2 = 3.6 Hz, H-1, CH2Ph), 5.15 (dd, 1H, J4,5 = 9.7 Hz, H-4), 7.07-7.73 (m, 
29H, aromatic), 8.58 (d, 1H, J = 4.3 Hz, COOH) ppm; 
13C NMR (75 MHz): δ, 55.3, 62.9, 
69.4, 71.2, 73.6, 75.5, 79.4, 79.8, 86.7, 98.0, 124.4, 127.0 (x2), 127.5, 127.8 (x5), 128.0, 
128.2 (x4), 128.3 (x2), 128.6 (x2), 128.8 (x5), 129.0, 129.4, 130.1, 130.2, 131.6, 134.3, 
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137.7, 138.2, 138.5, 143.9 (x2), 148.1 (x2), 165.8, 170.5 ppm; HR-FAB MS [M+Na]
+
 
calcd for C48H44NaO9 787.2883, found 787.2881.  
 
Ethyl 2,3,4-tri-O-benzoyl-6-O-(2-hydroxycarbonylbenzoyl)-1-thio-β-D-
glucopyranoside (2.35).  DMAP (111 mg, 0.91 mmol) and phthalic anhydride (1.68 g, 
7.30 mmol) were added to a solution of ethyl 2,3,4-tri-O-benzoyl-1-thio-β-D-
glucopyranoside (2.34,
27
 964 mg, 1.82 mmol) in dry pyridine (5.0 mL) and the resulting 
mixture was stirred under argon for 24 h at 50 
o
C. After that, the volatiles were removed 
under reduced pressure, the residue was dissolved in dichloromethane (~100 mL) and 
washed with water (3 x 20 mL). The organic phase was separated, dried over MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate/hexane, 1/1, v/v) to afford the title compound in 85% yield (1.11 g, 1.62 
mmol) as a white amorphous solid. Analytical data for 2.35: Rf = 0.55 (metha-
nol/dichloromethane, 1/9, v/v); []D
21
 +6.0
o
 (c = 2, CHCl3); 
1H NMR: δ, 1.21 (t, 3H, J = 
7.4 Hz, SCH2CH3), 2.76 (m, 2H, SCH2CH3), 4.20 (m, 1H, H-5), 4.50 (dd, 1H, J5,6a = 6.1 
Hz, J6a,6b = 12.1 Hz, H-6a), 4.63 (dd, 1H, J5,6b = 2.9 Hz, H-6b), 4.85 (d, 1H, J1,2 = 10.0 
Hz, H-1), 5.53-5.62 (m, 2H, H-2, 4), 5.92 (dd, 1H, J3,4 = 9.5 Hz, H-3), 7.15-7.95 (m, 19H, 
aromatic), 8.70 (d, 1H, J = 4.4 Hz, COOH) ppm; 
13C NMR (75 MHz): δ, 15.0, 24.3, 64.2, 
69.8, 70.6, 74.3, 76.2, 83.8, 124.7, 125.5, 128.4, 128.5 (x4), 128.6 (x2), 128.9 (x2), 129.2, 
129.3, 129.5, 129.9 (x2), 130.0 (x2), 131.2, 131.5, 133.4, 133.5, 133.6, 147.8, 165.3, 
165.6, 165.9, 167.8, 170.5 ppm; HR-FAB MS [M+Na]
+
 calcd for C37H32NaO11S 
707.1563, found 707.1558.  
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2.4.5 Coupling of a Linker to 4,4’-Bisphenol A: Preparation of Building Blocks 2.36-
2.42. 
 
Methyl 2,3-di-O-benzyl-6-O-(α,α,α-p-hydroxyphenyldimethyltolyl succinate)-α-D-
glucopyranoside (2.36).  A solution of N,N’-dicyclohexylcarbodiimide (DCC, 90 mg, 
0.44 mmol) in dry dichloromethane (1.0 mL) was added dropwise (over 5 min) to a solu-
tion of 2.23 (124 mg, 0.26 mmol) and 2,2-bis(4-hydroxyphenyl)propane (BPA, 50 mg, 
0.22 mmol) in dry dichloromethane (2.0 mL) at 0 
o
C. The resulting mixture was allowed 
to warm to rt over 2 h. After that, the reaction mixture was diluted with dichloromethane 
(~30 mL) and washed with water (3 x 10 mL). The organic phase was separated, dried 
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over MgSO4, and concentrated in vacuo. The residue was purified by column chromatog-
raphy on silica gel (ethyl acetate/toluene, 1/1, v/v) to afford the title compound in 65% 
yield (116 mg, 0.17 mmol) as a colorless syrup. Analytical data for 2.36: Rf = 0.50 (ethyl 
acetate/toluene, 3/7, v/v); []D
21
 +5.86 (c = 1, CHCl3); 
1H NMR: δ, 1.57 (s, 6H, 
C(CH3)2), 2.64-2.70, 2.78-2.84 (m, 2H, COCH2CH2CO), 3.34 (s, 3H, OCH3), 3.51 (dd, 
1H, J2,3 = 9.5 Hz, H-2), 3.56 (dd, 1H, J4,5 = 9.0 Hz, H-4), 3.80 (dd, 1H, J3,4 = 9.3 Hz, H-
3), 3.85 (m, 1H, H-5), 4.31 (d, 1H, J = 8.0 Hz, OH), 4.45 (dd, 1H, J5,6a = 2.0 Hz, J6a,6b = 
12.1 Hz, H-6a), 4.62 (dd, 1H, J5,6b = 3.6 Hz, H-6b), 4.65-4.80 (m, 3H, J1,2 = 3.5 Hz, H-1, 
CH2Ph), 4.86 (dd, 2H, 
2
J = 11.4 Hz, CH2Ph), 6.60-7.28 (m, 18H, aromatic) ppm; 
13
C 
NMR(75 MHz): δ, 25.2, 25.8, 29.0, 29.5, 29.6, 30.0, 31.2, 34.0, 42.5, 49.5, 55.6, 63.7, 
68.2, 73.0, 73.8, 74.7, 79.9, 97.4, 115.0, 121.0 (x2), 128.0 (x3), 128.1, 128.3 (x3), 128.4 
(x2), 128.7, 128.8, 138.2, 142.8, 148.3, 148.5, 148.7, 153.7, 171.0, 172.0 ppm; HR-FAB 
MS [M+Na]
+
 calcd for C40H44NaO10 707.2832, found 707.2830.  
 
Methyl 2,3-di-O-benzyl-6-O-(α,α,α-p-hydroxyphenyldimethyltolyl glutarate)-α-D-
glucopyranoside (2.37).  A solution of DCC (1.22 g, 5.91 mmol) in dry dichloromethane 
(2.0 mL) was added dropwise (5 min) to a solution of 2.25 (575 mg, 1.17 mmol) and 
BPA (540 mg, 2.33 mmol) in dry dichloromethane (4.0 mL) at 0 
o
C. The resulting mix-
ture was allowed to warm to rt over 2 h. After that, the reaction mixture was diluted with 
dichloromethane (~30 mL) and washed with water (3 x 10 mL). The organic phase was 
separated, dried over MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate/toluene, 1/1, v/v) to afford the title 
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compound in 61% yield (504 mg, 0.72 mmol) as a colorless syrup. Analytical data for 
2.37: Rf = 0.53 (ethyl acetate/toluene, 3/7, v/v); []D
24
 +2.71 (c = 1, CHCl3); 
1H NMR: δ, 
1.63 (s, 6H, C(CH3)2), 2.05 (m, 2H, COCH2CH2CH2CO), 2.45-2.63 (m, 4H, 
COCH2CH2CH2CO), 3.37 (s, 3H, OCH3), 3.40-3.48 (m, 1H, H-4), 3.51 (dd, 1H, J2,3 = 9.6 
Hz, H-2), 3.72-3.82 (m, 2H, H-3, 5), 4.27 (dd, 1H, J6a,6b = 12.1 Hz, J5,6a = 2.1 Hz, H-6a), 
4.46 (dd, 1H, J5,6b = 4.8 Hz, H-6a), 4.66 (d, 1H, J1,2 = 3.5 Hz, H-1) 4.76 (dd, 2H, 
2
J = 
12.1 Hz, CH2Ph), 4.92 (dd, 2H, 
2
J = 11.3 Hz, CH2Ph), 5.65 (br. s, 1H, OH), 6.75-7.42 (m, 
18H, aromatic) ppm; 
13C NMR (75 MHz): δ, 20.1, 23.6, 31.1, 33.1, 33.4, 42.2, 42.4, 55.4, 
63.4, 69.3, 70.0, 73.4, 75.7, 79.6, 81.2, 98.3, 114.9 (x2), 120.9 (x2), 127.9 (x2), 128.0 
(x2), 128.1, 128.2 (x5), 128.6 (x2), 128.8 (x2), 138.7, 142.5, 148.4, 148.7, 153.9, 171.8, 
173.3 ppm; HR-FAB MS [M+Na]
+
 calcd for C41H46NaO10 721.2989, found 721.2982.  
 
Methyl 2,4-di-O-benzyl-6-O-(α,α,α-p-hydroxyphenyldimethyltolyl glutarate)-α-D-
glucopyranoside (2.38).  A solution of DCC (571 mg, 2.77 mmol) in dry dichloro-
methane (2.0 mL) was added dropwise (5 min) to a solution of 2.27 (540 mg, 1.1 mmol) 
and BPA (505 mg, 2.2 mmol) in dry dichloromethane (4.0 mL) at 0 
o
C. The resulting 
mixture was allowed to warm to rt over 2 h. After that, the reaction mixture was diluted 
with dichloromethane (~30 mL) and washed with water (3 x 10 mL). The organic phase 
was separated, dried over MgSO4, and concentrated in vacuo. The residue was purified 
by column chromatography on silica gel (ethyl acetate/toluene, 1/1, v/v) to afford the title 
compound in 61% yield (462 mg, 0.66 mmol) as a colorless syrup. Analytical data for 
2.38: Rf = 0.58 (ethyl acetate/toluene, 2/3, v/v); []D
24
 +37.0 (c = 1, CHCl3); 
1H NMR: δ, 
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1.65 (s, 6H, C(CH3)2), 2.06, 2.45, 2.63 (3dd, 6H, COCH2CH2CH2CO), 3.34 (s, 3H, 
OCH3), 3.40 (dd, 1H, J2,3 = 9.6 Hz, H-2), 3.43 (dd, 1H, J4,5 = 8.9 Hz, H-4), 3.82 (m, 1H, 
H-5), 4.13 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.28 (dd, 1H, J5,6a = 4.7 Hz, H-6a), 4.37 (dd, 1H, 
J5,6b = 2.4 Hz, J6a,6b = 11.9 Hz, H-6b), 4.63 (d, 1H, J1,2 = 3.5 Hz, H-1), 4.67 (m, 2H, 
CH2Ph), 4.80 (dd, 2H, 
2
J = 11.2 Hz, CH2Ph), 6.76-7.37 (m, 18H, aromatic) ppm; 
13
C 
NMR (75 MHz): δ, 25.0, 31.2, 33.2, 33.5, 34.0, 42.2, 49.4, 55.4, 63.4, 68.4, 73.3, 73.8, 
74.7, 79.8, 97.5, 115.1 (x2), 120.9 (x2), 128.0 (x4), 128.3 (x6), 128.7 (x2), 128.8 (x2), 
138.0, 138.2, 142.3, 148.5, 148.8, 154.1, 171.8, 172.8 ppm; HR-FAB MS [M+Na]
+
 calcd 
for C41H46NaO10 721.2989, found 721.2982.  
 
Methyl 2,3-di-O-benzyl-4-O-(α,α,α-p-hydroxyphenyldimethyltolyl glutarate)-6-O-
triphenylmethyl-α-D-glucopyranoside (2.39).  A solution of DCC (288 mg, 1.40 mmol) 
in dry dichloromethane (1.0 mL) was added dropwise (5 min) to a solution of 2.29 (400 
mg, 0.56 mmol) and BPA (191 mg, 0.85 mmol) in dry dichloromethane (1.0 mL) at 0 
o
C. 
The resulting mixture was allowed to warm to rt over 2 h. After that, the reaction mixture 
was diluted with dichloromethane (~30 mL) and washed with water (3 x 10 mL). The or-
ganic phase was separated, dried over MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate/toluene, 1/1, v/v) to 
afford the title compound in 56% yield (289 mg, 0.31 mmol) as a colorless syrup. Analyt-
ical data for 2.39: Rf = 0.63 (ethyl acetate/toluene, 1/4, v/v); []D
24
 +3.32
o
 (c = 1, CHCl3); 
1H NMR: δ, 1.64 (s, 6H, C(CH3)2), 1.70, 1.94, 2.34 (3dd, 6H, COCH2CH2CH2CO), 3.03 
(dd, 1H, J5,6a = 1.8 Hz, H-6a), 3.12 (dd, 1H, J5,6b = 6.3 Hz, J6a,6b = 10.6 Hz, H-6b), 3.51 
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(s, 3H, OCH3), 3.63 (dd, 1H, J2,3 = 9.5 Hz, H-2), 3.86 (m, 1H, H-5), 3.91 (dd, 1H, J3,4 = 
9.5 Hz, H-3), 4.72 (d, 1H, J1,2 = 3.6 Hz, H-1), 4.74 (dd, 2H, 
2
J = 11.6 Hz, CH2Ph), 4.75 
(dd, 2H, 
2
J = 12.1 Hz, CH2Ph), 4.94 (dd, 1H, J4,5 = 9.5 Hz, H-4), 6.72-7.43 (m, 33H, ar-
omatic) ppm; 
13C NMR (75 MHz): δ, 32.9, 33.5, 41.8, 42.2, 55.4, 60.8, 62.9, 69.2, 70.6, 
73.7, 75.5, 77.4, 79.6, 80.0, 86.7, 98.1, 114.8 (x4), 115.0, 120.9, 127.1 (x2), 127.8, 127.9 
(x3), 128.0 (x2), 128.1 (x6), 128.2, 128.3 (x2), 128.5 (x2), 128.7 (x2), 128.9 (x3), 138.1, 
138.6, 142.7, 143.3 (x2), 143.8 (x2), 148.4, 148.7, 153.6 (x2), 153.8, 171.5, 171.7 ppm; 
HR-FAB MS [M+Na]
+
 calcd for C60H60NaO10 963.4084, found 963.4080.  
 
Methyl 2,3-di-O-benzyl-6-O-(α,α,α-(4-hydroxyphenyl)dimethyltolyl phthalate)-α-D-
glucopyranoside (2.40).  A solution of DCC (238 mg, 1.16 mmol) in dry dichloro-
methane (1.0 mL) was added dropwise (5 min) to a solution of 2.29 (249 mg, 0.46 mmol) 
and BPA (158 mg, 0.69 mmol) in dry dichloromethane (1.0 mL) at 0 
o
C. The resulting 
mixture was allowed to warm to rt over 2 h. After that, the reaction mixture was diluted 
with dichloromethane (~30 mL) and washed with water (3 x 10 mL). The organic phase 
was separated, dried over MgSO4, and concentrated in vacuo. The residue was purified 
by column chromatography on silica gel (ethyl acetate/toluene, 1/1, v/v) to afford the title 
compound in 60% yield (202 mg, 0.28 mmol) as a colorless syrup. Analytical data for 
2.40: Rf = 0.30 (ethyl acetate/toluene, 1/4, v/v); []D
24
 +61.2
o
 (c = 1, CHCl3); 
1H NMR: δ, 
1.63 (s, 6H, C(CH3)2), 3.35 (s, 3H, OCH3), 3.50 (dd, 1H, J2,3 = 9.5 Hz, H-2), 3.56 (dd, 
1H, J4,5 = 9.0 Hz, H-4), 3.81 (dd, 1H, J3,4 = 9.3 Hz, H-3), 3.85 (m, 1H, H-5), 4.31 (d, 1H, 
= 8.0 Hz, OH), 4.48 (dd, 1H, J5,6a = 2.0 Hz, J6a,6b = 12.1 Hz, H-6a), 4.60 (dd, 1H, J5,6b = 
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3.6 Hz, H-6b), 4.62-4.78 (m, 3H, J1,2 = 3.5 Hz, H-1, CH2Ph), 4.87 (dd, 2H, 
2
J = 11.4 Hz, 
CH2Ph), 6.71-8.00 (m, 22H, aromatic) ppm; 
13C NMR (75 MHz): δ, 31.2, 34.0, 42.2, 
55.5, 64.7, 69.4, 70.1, 73.4, 75.7, 79.7, 81.3, 98.3, 115.0, 115.1 (x2), 120.9 (x2), 121.1, 
128.0 (x5), 128.1 (x4), 128.2 (x2), 128.6 (x2), 128.7 (x2), 129.2, 129.7, 131.5, 131.9, 
132.5, 138.1, 138.9, 148.7, 149.1, 166.3, 167.8 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C44H44NaO10 755.2832, found 755.2825. 
 
Methyl 2,4-di-O-benzyl-6-O-(α,α,α-(4-hydroxyphenyl)dimethyltolyl phthalate)-α-D-
glucopyranoside (2.41).  A solution of DCC (355 mg, 1.72 mmol) in dry dichloro-
methane (1.0 mL) was added dropwise (5 min) to a solution of 2.29 (450 mg, 0.86 mmol) 
and BPA (393 mg, 1.72 mmol) in dry dichloromethane (3.0 mL) at 0 
o
C. The resulting 
mixture was allowed to warm to rt over 2 h. After that, the reaction mixture was diluted 
with dichloromethane (~30 mL) and washed with water (3 x 10 mL). The organic phase 
was separated, dried over MgSO4, and concentrated in vacuo. The residue was purified 
by column chromatography on silica gel (ethyl acetate/toluene, 1/1, v/v) to afford the title 
compound in 70% yield (491 mg, 0.67 mmol) as a colorless syrup. Analytical data for 
2.41: Rf = 0.25 (ethyl acetate/toluene, 1/4, v/v); []D
24
 +40.7
o
 (c = 0.8, CHCl3); 
1
H NMR: 
δ, 1.70 (s, 6H, C(CH3)2), 3.35 (s, 3H, OCH3), 3.43 (dd, 1H, J2,3 = 9.6 Hz, H-2), 3.52 (dd, 
1H, J4,5 = 9.0 Hz, H-4), 3.95 (m, 1H, H-5), 4.17 (dd, 1H, J3,4 = 9.3 Hz, H-3), 4.62 (m, 2H, 
H-6a, 6b), 4.68-4.79 (m, 3H, J1,2 = 3.4 Hz, H-1, CH2Ph), 4.85 (dd, 2H, 
2
J = 11.0 Hz, 
CH2Ph), 6.78-7.93 (m, 22H, aromatic) ppm; 
13C NMR (75 MHz): δ, 31.2, 34.0, 42.2, 
55.3, 64.5, 68.4, 73.2, 73.8, 74.7, 77.4, 79.7, 97.4, 115.0 (x2), 120.9 (x2), 127.9 (x2), 
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128.0 (x4), 128.2 (x2), 128.3 (x3), 128.6 (x2), 128.7 (x2), 129.2, 129.4, 131.6, 131.9, 
132.1, 138.0, 138.2, 142.4, 148.7, 148.9, 154.0, 166.4, 167.1 ppm; HR-FAB MS 
[M+Na]
+
 calcd for C44H44NaO10 755.2832, found 755.2828.  
 
Methyl 2,3-di-O-benzyl-4-O-(α,α,α-(4-hydroxyphenyl)dimethyltolyl phthalate)-6-O-
triphenylmethyl-α-D-glucopyranoside (2.42).  A solution of DCC (88 mg, 0.43 mmol) 
in dry dichloromethane (1.0 mL) was added dropwise (5 min) to a solution of 2.33 (130 
mg, 0.17 mmol) and BPA (58 mg, 0.26 mmol) in dry dichloromethane (1.0 mL) at 0 
o
C. 
The resulting mixture was allowed to warm to rt over 2 h. After that, the reaction mixture 
was diluted with dichloromethane (~30 mL) and washed with water (3 x 10 mL). The or-
ganic phase was separated, dried over MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate/toluene, 1/1, v/v) to 
afford the title compound in 78% yield (129 mg, 0.133 mmol) as a colorless syrup. Ana-
lytical data for 2.42: Rf = 0.58 (ethyl acetate/toluene, 1/4, v/v); []D
24
 +24.5
o
 (c = 2, 
CHCl3); 
1H NMR: δ, 1.66 (s, 6H, C(CH3)2), 3.18 (dd, 1H, J5,6a = 6.2 Hz, J6a,6b = 10.5 Hz, 
H-6a), 3.30 (dd, 1H, J5,6b = 1.4 Hz, H-6b), 3.55 (s, 3H, OCH3), 3.74 (dd, 1H, J2,3 = 9.5 
Hz, H-2), 4.05 (m, 1H, H-5), 4.12 (dd, 1H, J3,4 = 9.5 Hz, H-3), 4.68-4.89 (m, 5H, J1,2 = 
3.6 Hz, H-1, 2 x CH2Ph), 5.30 (dd, 1H, J4,5 = 10.2 Hz, H-4), 6.76 (m, 4H, aromatic), 
7.05-7.73 (m, 33H, aromatic) ppm; 
13C NMR (75 MHz): δ, 31.1, 31.2, 41.7, 42.2, 55.4, 
69.4, 71.8, 73.7, 75.5, 79.3, 79.7, 86.7, 98.1, 114.9 (x3), 115.0, 121.0, 126.9 (x2), 127.5, 
127.8 (x3), 127.9 (x2), 128.0 (x3), 128.1 (x2), 128.2, 128.3 (x6), 128.5, 128.6 (x2), 128.7 
(x4), 129.0, 129.9, 130.5, 132.2, 134.2, 138.1 (x2), 142.5, 143.1, 143.7 (x2), 148.6, 148.7, 
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153.7, 153.8 (x2), 164.3, 167.3 ppm; HR-FAB MS [M+Na]
+
 calcd for C63H58NaO10 
997.3928, found 997.3935.  
 
2.4.6 Synthesis of Tethered Donor-Acceptor Pairs 2.1, 2.3, 2.5, 2.7-2.11 
Tethered compound 2.1.  A solution of DCC (35 mg, 0.16 mmol) and DMAP (3 mg, 
0.024 mmol) in dry dichloromethane (1.0 mL) was added dropwise to a stirring solution 
of  2.37  (63 mg, 0.079 mmol) and 2.21 (46 mg 0.095 mmol) in dry dichloromethane (2.0 
mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. After that, the re-
action mixture was diluted with dichloromethane (~30 mL) and washed with water (3 x 
10 mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate - toluene 
gradient elution) to afford tethered compound 1 in 75% yield (7 mg, 0.07 mmol) as a col-
orless syrup. Analytical data for 1: Rf = 0.60 (ethyl acetate/toluene, 1/4, v/v); []D
24
 
+25.9
o
 (c = 2, CHCl3); 
1H NMR: δ, 1.23 (t, 3H, J = 7.4 Hz, SCH2CH3), 1.58 (s, 6H, 
C(CH3)2), 2.00 (m, 2H, COCH2CH2CH2CO), 2.35, 2.58 (2dd, 4H, COCH2CH2CH2CO), 
2.60-2.85 (m, 6H, SCH2CH3, COCH2CH2CO), 3.31 (s, 3H, OCH3), 3.35-3.50 (m, 5H, H-
2, 2’, 4, 4’, 5’), 3.60-3.79 (m, 3H, H-3, 3’, 5), 4.12 (dd, 1H, J5’,6a’ = 4.7 Hz, H-6a’), 4.26 
(dd, 1H, J5’6b’ = 2.0 Hz, J6a’,6b’ = 12.0 Hz, H-6b’), 4.35-4.40 (m, 2H, H-6a, 6b), 4.43 (d, 
1H, J1’,2’ = 9.8 Hz, H-1’), 4.50-4.70 (m, 5H, H-1, 2 x CH2Ph), 4.72-4.95 (m, 6H, 3 x 
CH2Ph), 6.94-7.35 (m, 33H, aromatic) ppm; 
13C NMR (75 MHz): δ, 15.0, 20.2, 25.1, 
29.0, 29.5, 31.2, 33.4, 42.6 (x2), 55.3 (x2), 63.5, 63.9, 69.2, 70.0, 73.2, 75.3, 75.7, 76.0, 
77.0, 77.8, 79.7, 81.3, 81.9, 85.1, 86.8, 98.2, 121.0 (x2), 121.1 (x2), 127.9 (x3), 127.9 
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(x3), 128.1 (x3), 128.2 (x2), 128.2 (x3), 128.2 (x2), 128.4 (x3), 128.5 (x2), 128.6 (x2), 
128.7 (x2), 128.7 (x2), 128.7 (x2), 128.8 (x2), 137.7, 138.1 (x2), 138.4, 138.8, 148.1, 
148.1, 148.7, 171.0, 171.5, 172.5, 172.6 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C74H82NaO11S 1297.5170, found 1297.5166. 
 
Tethered compound 2.3.  A solution of DCC (57 mg, 0.27 mmol) and DMAP (5.0 mg, 
0.04 mmol) in dry dichloromethane (1.0 mL) was added dropwise (5 min) to a stirring 
solution of 2.21 (97 mg, 0.17 mmol) and 2.38 (96 mg, 0.14 mmol) in dry dichloro-
methane (3.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - toluene gradient elution) to afford tethered compound 2.3 in 75% yield 
(131 mg, 0.11 mmol) as a colorless syrup. Analytical data for 2.3: Rf = 0.53 (ethyl ace-
tate/toluene, 3/7, v/v); []D
24
 +35.9
o
 (c = 2, CHCl3); 
1H NMR: δ, 1.31 (t, 3H, J = 7.4 Hz, 
SCH2CH3), 1.65 (s, 6H, C(CH3)2), 2.04 (m, 2H, COCH2CH2CH2CO), 2.44, 2.62 (2dd, 
4H, COCH2CH2CH2CO), 2.71-2.86 (m, 6H, SCH2CH3, COCH2CH2CO), 3.32 (s, 3H, 
OCH3), 3.37 (dd, 1H, J2,3 = 6.2 Hz, H-2), 3.39 (m, 1H, H-4), 3.44 (dd, 1H, J2’,3’ = 9.8 Hz, 
H-2’), 3.52-3.58 (m, 2H, H-4’, 5’), 3.71 (dd, 1H, J3’,4’ = 8.5 Hz, H-3’), 3.80 (m, 1H, H-5), 
4.10 (dd, 1H, J3,4 = 9.3 Hz, H-3), 4.23-4.41 (m, 4H, H-6a, 6b, 6a’, 6b’), 4.48 (d, 1H, J1’,2’ 
= 9.8 Hz, H-1’), 4.56-4.68 (m, 5H, J1,2 = 3.2 Hz, H-1, 2 x CH2Ph), 4.72-4.98 (m, 6H, 3 x 
CH2Ph), 6.96-7.37 (m, 33H, aromatic) ppm; 
13C NMR (75 MHz): δ, 15.3, 20.2, 25.4, 
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29.2, 29.4, 31.1, 33.1, 33.5, 42.6 (x2), 55.4 (x2), 63.4, 63.9, 68.4, 73.3, 73.8, 74.7, 75.3, 
75.7, 75.9, 77.1, 77.7, 79.8, 81.8, 85.4, 86.8, 97.5, 121.1 (x3), 127.9 (x3), 128.0 (x2), 
128.0 (x2), 128.1, 128.1, 128.1, 128.3 (x2), 128.3 (x6), 128.3 (x2), 128.4, 128.5 (x2), 
128.6 (x2), 128.7 (x5), 128.8 (x2), 137.8, 138.1, 138.3, 138.5, 148.1, 148.1, 148.6, 171.5, 
171.9, 172.1, 172.7 ppm; HR-FAB MS [M+Na]
+
 calcd for C74H82NaO11S 1297.5170, 
found 1297.5180.  
 
Tethered compound 2.5.  A solution of DCC (47 mg, 0.23 mmol) and DMAP (4.0 mg, 
0.034 mmol) in dry dichloromethane (1.0 mL) was added dropwise (5 min) to a stirring 
solution of 2.21 (0.11 mmol) and 2.39 (90 mg, 0.11 mmol) in dry dichloromethane (2.0 
mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. After that, the re-
action mixture was diluted with dichloromethane (~30 mL) and washed with water (3 x 
10 mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The crude mixture was dissolved in dichloromethane (2.0 mL), 10% soln. of trifluoroace-
tic acid in wet dichloromethane (1.5 mL) was added dropwise (1 min) and the resulting 
mixture was stirred for 1 h at rt. After that, the reaction mixture was diluted with di-
chloromethane (~30 mL), washed with water (~10 mL), sat. aq. NaHCO3 (2 x 10 mL) 
and water (~10 mL). Organic phase was separated, dried over MgSO4, and concentrated 
in vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate 
- hexane gradient elution) to afford tethered compound 2.5 in 78% yield (112 mg, 0.11 
mmol, over 2 steps) as a colorless syrup. Analytical data for 2.5: Rf = 0.37 (ethyl ace-
tate/toluene, 1/4, v/v); []D
24
 +15.4 (c = 1, CH3Cl); 
1H NMR: δ, 1.30 (t, 3H, J = 7.4 Hz, 
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SCH2CH3), 1.64 (s, 6H, C(CH3)2), 1.91-2.02 (m, 2H, COCH2CH2CH2CO), 2.24-2.40, 
2.50-2.58 (2m, 4H, COCH2CH2CH2CO), 2.69-2.87 (m, 6H, SCH2CH3, COCH2CH2CO), 
3.38 (s, 3H, OCH3), 3.43 (dd, 1H, J2’,3’ = 9.2 Hz, H-2’), 3.49-3.64 (m, 6H, H-2, 4’, 5, 5’, 
6a’, 6b’), 3.70 (dd, 1H, J3’,4’ = 8.7 Hz, H-3’), 3.99 (dd, 1H, J3,4 = 9.5 Hz, H-3), 4.25 (dd, 
1H, J5,6a = 4.5 Hz, J6a,6b = 11.9 Hz, H-6a), 4.38 (dd, 1H, H-6b), 4.47 (d, 1H, J1’,2’ = 9.8 
Hz, H-1’), 4.55-4.72 (m, 5H, H-1, 2 x CH2Ph), 4.74-4.96 (m, 7H, H-4, 3 x CH2Ph), 6.95-
7.35 (m, 33H, aromatic) ppm; 
13C NMR(75 MHz): δ, 15.0, 20.1, 25.3, 28.8, 29.0, 31.0, 
33.1, 33.5, 42.5, 55.7, 61.0, 63.3, 69.4, 71.0, 73.6, 75.2, 75.4, 75.6, 75.7, 77.1, 77.5, 77.8, 
79.0, 79.6, 81.9, 85.2, 86.7, 98.4, 120.8 (x2), 121.0 (x2), 127.7 (x2), 127.9 (x2), 128.0 
(x2), 128.0 (x3), 128.1 (x2), 128.2, 128.2 (x3), 128.4 (x2), 128.5 (x2), 128.6 (x4), 128.6 
(x2), 128.7 (x4), 137.5, 138.0 (x2), 138.5, 138.9, 148.0, 148.1, 148.6 (x2), 171.0, 171.6, 
172.7 (x2) ppm; HR-FAB MS [M+Na]
+
 calcd for C74H82NaO11S 1297.5170, found 
1297.5160.  
 
Tethered compound 2.7.  A solution of DCC (29 mg, 0.14 mmol) and DMAP (2.6 mg, 
0.021 mmol) in dry dichloromethane (1.0 mL) was added dropwise (5 min) to a stirring 
solution of 2.36 (48 mg, 0.071 mmol) and 2.21 (50 mg, 0.085 mmol) in dry dichloro-
methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - toluene gradient elution) to afford tethered compound 7 in 72% yield (64 
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mg, 0.051 mmol) as a colorless syrup. Analytical data for 2.7: Rf = 0.48 (ethyl ace-
tate/toluene, 3/7, v/v); []D
24
 +3.0 (c = 1, CHCl3); 
1H NMR: δ, 1.25 (t, 3H, J = 7.4 Hz, 
SCH2CH3), 1.57 (s, 6H, C(CH3)2), 2.64-2.74 (m, 6H, SCH2CH3, COCH2CH2CO), 2.74-
2.81 (m, 4H, COCH2CH2CO), 3.31 (s, 3H, OCH3), 3.34-3.52 (m, 5H, H-2, 2’, 4, 4’, 5’), 
3.62-3.76 (m, 3H, H-3, 3’, 5), 4.17-4.24 (m, 2H, H-6a’, 6b’), 4.31-4.41 (m, 2H, H-6a, 
6b), 4.41 (d, 1H, J1’,2’ = 9.5 Hz, H-1’), 4.50-4.69 (m, 5H, H-1, 2 x CH2Ph), 4.70-4.95 (m, 
6H, 3 x CH2Ph), 6.90-7.32 (m, 33H, aromatic) ppm; 
13C NMR (75 MHz): δ, 1.28, 15.4, 
25.4, 29.3, 29.5 (x2), 31.2, 42.7, 55.6, 63.9, 64.0, 69.5, 70.2, 73.5, 75.3, 75.8 (x2), 76.0, 
77.1, 77.8, 79.8, 81.4, 81.9, 85.5, 86.9, 98.5, 121.1 (x4), 128.0 (x6), 128.2 (x3), 128.3, 
128.8 (x3), 128.4 (x4), 128.6 (x3), 128.7 (x4), 128.8 (x4), 128.9 (x2), 137.9, 138.1, 138.2, 
138.6, 138.9, 148.1, 148.2, 148.8, 171.1 (x2), 172.1, 172.6 ppm; HR-FAB MS [M+Na]
+
 
calcd for C73H80NaO11S 1283.5014, found 1283.5008 
 
Tethered compound 2.8.  A solution of DCC (74 mg, 0.36 mmol) and DMAP (7 mg, 
0.054 mmol) in dry dichloromethane (1.0 mL) was added dropwise to a stirring solution 
of 2.36 ( 123 mg, 0.180 mmol) and 2.24 (129 mg, 0.216 mmol) in dry dichloromethane 
(1.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. After that, the 
reaction mixture was diluted with dichloromethane (~30 mL) and washed with water (3 x 
10 mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate - toluene 
gradient elution) to afford tethered compounds 2.8 in 68% yield (154 mg, 0.122 mmol) as 
a colorless syrup. Analytical data for 2.8: Rf = 0.53 (ethyl acetate/hexane, 1/1, v/v); []D
24
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+25.7 (c = 2, CH3Cl); 
1H NMR: δ, 1.26 (t, 3H, J = 7.4 Hz, SCH2CH3), 1.58 (s, 6H, 
C(CH3)2), 1.99 (m, 2H, COCH2CH2CH2CO), 2.39, 2.56 (2dd, 4H, COCH2CH2CH2CO), 
2.65-2.83 (m, 6H, SCH2CH3, COCH2CH2CO), 3.32 (s, 3H, OCH3), 3.36 (dd, 1H, J2’,3’ = 
9.7 Hz, H-2’), 3.41-3.52 (m, 4H, H-2, 4, 4’, 5’), 3.62-3.77 (m, 3H, H-3, 3’, 5), 4.14 (dd, 
1H, J5’,6a’ = 4.7 Hz, H-6a’), 4.24 (dd, 1H, J5’6b’ = 2.0 Hz, J6a’,6b’ = 12.0 Hz, H-6b’), 4.35-
4.40 (m, 2H, H-6a, 6b), 4.43 (d, 1H, J1’,2’ = 9.8 Hz, H-1’), 4.52-4.70 (m, 5H, H-1, 2 x 
CH2Ph), 4.71-4.96 (m, 6H, 3 x CH2Ph), 6.92-7.33 (m, 33H, aromatic) ppm; 
13
C NMR (75 
MHz): δ, 15.3, 20.2, 25.3, 29.2, 29.5, 31.1, 33.5, 42.6 (x2), 55.5 (x2), 63.5, 63.8, 69.4, 
70.1, 73.4, 75.3, 75.7, 76.0, 77.1, 77.9, 79.7, 81.3, 81.9, 85.3, 86.8, 98.4, 121.0 (x2), 
121.1 (x2), 127.9 (x7), 128.1 (x2), 128.2 (x7), 128.3 (x3), 128.5 (x2), 128.6 (x2), 128.7 
(x6), 128.8 (x2), 137.8, 138.1 (x2), 138.5, 138.8, 148.0, 148.1, 148.7, 171.0, 171.6, 172.5, 
172.7 ppm; HR-FAB MS [M+Na]
+
 calcd for C74H82NaO11S 1297.5170, found 
1297.5166. 
 
Tethered compound 2.9.  A solution of DCC (88 mg, 0.42 mmol) and DMAP (8 mg, 
0.066 mmol) in dry dichloromethane (1.0 mL) was added dropwise (5 mins) to a stirring 
solution of 2.40 (162 mg, 0.22 mmol) and 2.31 (168 mg, 0.27 mmol) in dry dichloro-
methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - toluene gradient elution) to afford tethered compound 2.9 in 81% yield 
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(113 mg, 0.178 mmol) as a colorless syrup. Analytical data for 2.9: Rf = 0.63 (ethyl ace-
tate/toluene, 3/7, v/v); []D
24
 +25.6 (c = 0.5, CH3Cl); 
1H NMR: δ, 1.29 (t, 3H, J = 7.4 Hz, 
SCH2CH3), 1.66 (s, 6H, C(CH3)2), 2.73 (m, 2H, SCH2CH3), 3.35 (s, 3H, OCH3), 3.40-
3.63 (m, 5H, H-2, 2’, 4, 4’, 5’), 3.70-3.90 (m, 3H, H-3, 3’, 5), 4.43-4.74 (m, 8H, H-1, 1’, 
6a, 6b, 6a’, 6b’, CH2Ph), 4.75-5.06 (m, 8H, 4 x CH2Ph), 7.05-7.96 (m, 41H, aromatic) 
ppm; 
13C NMR (75 MHz): δ, 15.3, 25.2, 29.9 (x2), 31.2, 42.7, 55.5, 64.7, 69.4, 70.2, 
73.4, 75.3, 75.7, 76.0, 77.1, 77.4, 78.0, 79.8, 81.4, 81.9, 85.2, 86.8, 98.4, 121.1 (x2), 
121.2 (x2), 128.0 (x5), 128.1 (x8), 128.2 (x2), 128.3 (x5), 128.5 (x2), 128.6 (x2), 128.7 
(x5), 128.8 (x2), 129.3, 129.4 (x2), 129.7, 131.5, 131.7, 131.8, 131.9, 132.3, 132.5, 137.8, 
138.1, 138.2, 138.5, 138.9, 148.2, 148.4, 148.9, 149.0, 166.2, 166.5, 166.9, 167.7 ppm; 
HR-FAB MS [M+Na]
+
 calcd for C81H80NaO17S 1379.5014, found 1379.5008.  
 
Tethered compound 2.10.  A solution of DCC (23 mg, 0.11 mmol) and DMAP (2 mg, 
0.017 mmol) in dry dichloromethane (1.0 mL) was added dropwise (5 min) to a stirring 
solution of 2.30 (43 mg, 0.067 mmol) and 2.42 (55 mg, 0.056 mmol) in dry dichloro-
methane (1.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The crude mixture was dissolved in dichloromethane (2.0 mL), 10% 
soln. of trifluoroacetic acid in wet dichloromethane (1.5 mL) was added dropwise (1 min) 
and the resulting mixture was stirred for 1 h at rt. After that, the reaction mixture was di-
luted with dichloromethane (~30 mL), washed with water (~10 mL), sat. aq. NaHCO3 (2 
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x 10 mL) and water (~10 mL). Organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to afford tethered compound 2.10 (68 mg, 0.05 
mmol, 77% yield). Analytical data for 2.10: Rf  = 0.45 (ethyl acetate/toluene, 3/7, v/v); 
[]D
24
 -5.8 (c = 1, CHCl3); 
1H NMR: δ, 1.25 (t, 3H, J = 7.4 Hz, SCH2CH3), 1.68 (s, 6H, 
C(CH3)2), 2.62-2.78 (m, 2H, SCH2CH3), 3.34 (s, 3H, OCH3), 3.45 (dd, 1H, J2’,3’ = 9.3 Hz, 
H-2’), 3.54-3.74 (m, 7H, H-2, 3’, 4’, 5, 5’, 6a’, 6b’), 4.12 (dd, 1H, J3,4 = 9.5 Hz, H-3), 
4.45 (m, 1H, H-6a), 4.47 (d, 1H, J1’,2’ = 9.9 Hz, H-1’), 4.56-4.71 (m, 6H, H-1, 6b, 2 x 
CH2Ph), 4.74-4.96 (m, 6H, 3 x CH2Ph), 5.17 (dd, 1H, J4,5 = 9.5 Hz, H-4), 7.12-7.88 (m, 
41H, aromatic) ppm; 
13C NMR (75 MHz): δ, 15.3, 25.1, 31.2, 34.0, 42.7, 55.6, 61.2, 64.7, 
69.7, 72.0, 73.7, 75.3, 75.6, 75.7, 76.0, 77.0, 77.9, 78.8, 79.8, 81.8, 85.2, 86.7, 98.4, 121.0 
(x2), 121.1 (x2), 127.7, 128.0 (x4), 128.1 (x3), 128.2 (x3), 128.3 (x2), 128.4 (x6), 128.5 
(x2), 128.6 (x2), 128.7 (x7), 129.4 (x2), 129.5, 129.6, 131.2, 131.5, 131.6, 131.7 (x2), 
132.0, 132.2, 132.3, 137.7, 138.0 (x2), 138.4, 148.2, 148.4, 148.8, 148.9, 166.3, 166.5, 
166.9, 167.2 ppm; HR-FAB MS [M+Na]
+
 calcd for C81H80NaO17S 1379.5014, found 
1379.5008.  
 
Tethered compound 2.11.  A solution of DCC (92 mg, 0.45 mmol) and DMAP (8.2 mg, 
0.067 mmol) in dry dichloromethane (1.0 mL) was added dropwise (5 min) to a stirring 
solution of 2.41 (198 mg, 0.22 mmol) and 2.34 (140 mg, 0.27 mmol) in dry dichloro-
methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
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with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - toluene gradient elution) to afford tethered compound 2.11 in 60% yield 
(186 mg, 0.132 mmol) as a colorless syrup. Analytical data for 2.11: Rf = 0.38 (ethyl ace-
tate/ toluene, 1/4, v/v); []D
24
 +22.4 (c = 0.2, CHCl3); 
1H NMR: δ, 1.19 (t, 3H, J = 7.4 
Hz, SCH2CH3), 1.66 (s, 6H, C(CH3)2), 2.71 (m, 2H, SCH2CH3), 3.28 (s, 3H, OCH3), 3.35 
(dd, 1H, J2,3 = 9.6 Hz, H-2), 3.45 (dd, 1H, J4,5 = 9.8 Hz, H-4), 3.88 (m, 1H, H-5), 4.10 
(dd, 1H, J3,4 = 9.4 Hz, H-3), 4.13 (m, 1H, H-5’), 4.50-4.61 (m, 5H, J1,2 = 3.5 Hz, H-1, 6a, 
6b, 6a’, 6b’), 4.61-4.65 (s, 2H, CH2Ph), 4.75 (dd, 2H, 
2
J = 11.1 Hz, CH2Ph), 5.37 (d, 1H, 
J1’,2’ = 8.0), 5.55 (dd, 1H, J2’3’ = 9.6 Hz, H-2’), 5.61 (dd, 1H, J4’,5’ = 9.8 Hz, H-4’), 5.89 
(dd, 1H, J3’,4’ = 9.5 Hz, H-3’), 7.14-7.95 (m, 41H, aromatic); 
13
C NMR (75 MHz): δ, 
14.9, 21.6, 24.3, 31.1, 42.7, 55.3, 64.0, 64.5, 68.4, 69.6, 70.6, 73.1, 73.8, 74.2, 74.7, 76.2, 
77.4, 79.7, 83.9, 97.4, 121.1 (x2), 125.5 (x2), 128.0 (x3), 128.1 (x2), 128.2 (x5), 128.4 
(x4), 128.5 (x4), 128.6 (x2), 128.7 (x2), 128.8, 128.9, 129.2 (x3), 129.4, 129.8 (x2), 129.9 
(x2), 130.0 (x2), 131.5 (x2), 131.6, 131.7, 131.8, 131.9, 132.1, 133.4 (x2), 133.6, 138.0, 
138.2, 148.2 (x2), 148.8, 148.9, 165.3, 165.4, 165.9, 166.2, 166.3, 166.9, 167.0 ppm; HR-
FAB MS [M+Na]
+
 calcd for C81H74NaO20S 1421.4392, found 1421.4388.  
 
2.4.7 Synthesis of Disaccharides 2.2, 2.4, 2.6 and 2.12. 
Methyl 4-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-6-O-acetyl-2,3-di-O-
benzyl-α-D-glucopyranoside (2.2).  A mixture of 2.9 (22 mg, 0.017 mmol) and freshly 
activated molecular sieves (3 Å, 100 mg) in 1,2-dichloroethane (0.5 mL) was stirred un-
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der argon for 16 h at rt. The mixture was cooled to 0 
oC, MeOTf (6 μL, 0.052 mmol) was 
added, and the reaction mixture was stirred at 0 
o
C until the disappearance of the starting 
material, as indicated by TLC. After that, the solid was filtered off through a pad of 
Celite and rinsed successively with dichloromethane. The combined filtrate (~30 mL) 
was washed with sat aq. NaHCO3 (~10 mL) and water (3 x 10 mL). The organic phase 
was separated, dried over MgSO4, concentrated in vacuo and dried. The residue was dis-
solved in dry methanol (1.0 mL), 1N soln. of NaOMe in MeOH (0.5 mL) was added and 
the resulting mixture was stirred for 4 h at rt. After that, the reaction mixture was neutral-
ized with Dowex (H
+
), the resin was filtered off and washed successively with MeOH. 
The combined filtrate was concentrated in vacuo. The residue was dissolved in pyridine 
(1.0 mL), acetic anhydride (0.2 mL) was added dropwise (1 min), and the resulting mix-
ture was stirred for 16 h at rt. After that, the reaction was quenched with methanol (~2.0 
mL) and the volatiles were evaporated in vacuo. The residue was co-evaporated with tol-
uene and the residue was purified by column chromatography on silica gel (ethyl acetate - 
hexane gradient elution) to afford the title compound in 90% yield (13 mg, 0.014 mmol, 
α only) as a clear film.  The title compound was also obtained from 2.1 (81% yield, α on-
ly), 7 (76% yield, α only), or 2.8 (71% yield, α/β = 2.8/1).  Analytical data for 2.2: Rf = 
0.55 (ethyl acetate/toluene, 3/7, v/v); []D
21
 +38.3 (c = 0.5, CHCl3); 
1H NMR: δ, 2.02, 
2.07 (2s, 6H, 2 x COCH3), 3.37 (s, 3H, OCH3), 3.44-3.50 (m, 2H, H-2’, 4’), 3.53 (dd, 1H, 
J2,3 = 9.6 Hz, H-2), 3.79-3.90 (m, 3H, H-4, 5, 5’), 3.96 (dd, 1H, J3’,4’ = 9.3 Hz, H-3’), 
4.07 (dd, 1H, J3,4 = 8.2 Hz, H-3), 4.16-4.28 (m, 3H, H-6a, 6a’, 6b’), 4.42-4.79 (m, 8H, H-
1, 6b, 3 x CH2Ph), 4.81-5.06 (m, 4H, 2 x CH2Ph), 5.58 (d, 1H, J1’,2’ = 3.8 Hz, H-1’), 7.17-
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7.32 (m, 25H, aromatic) ppm; 
13C NMR (75 MHz): δ, 21.1 (x2), 55.5, 63.2, 63.5, 68.2, 
69.9, 73.5, 73.7, 74.5, 74.6, 75.2, 75.8, 79.5, 80.2, 81.7, 82.1, 97.5, 97.8, 126.7 (x2), 
127.3, 127.7 (x2), 127.8, 127.9, 128.1 (x2), 128.2, 128.3 (x2), 128.4 (x4), 128.5 (x2), 
128.6 (x2), 128.7 (x5), 138.0, 138.1, 138.6, 139.2, 170.8, 170.9 ppm; HR-FAB MS 
[M+Na]
+
 calcd for C52H58NaO13 913.3775, found 913.3780. 
 
Methyl 3-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-6-O-acetyl-2,4-di-O-
benzyl-α-D-glucopyranoside (2.4).  A mixture of 2.3 (25 mg, 0.019 mmol) and freshly 
activated molecular sieves (3 Å, 100 mg) in 1,2-dichloroethane (0.5 mL) was stirred un-
der argon for 16 h at rt. The mixture was cooled to 0 
oC, MeOTf (7 μL, 0.060 mmol) was 
added, and the reaction mixture was stirred at 0 
o
C until the disappearance of the starting 
material, as indicated by TLC. After that, the solid was filtered off through a pad of 
Celite and rinsed successively with dichloromethane. The combined filtrate (~30 mL) 
was washed with sat aq. NaHCO3 (~10 mL) and water (3 x 10 mL). The organic phase 
was separated, dried over MgSO4, concentrated in vacuo and dried. The residue was dis-
solved in dry methanol (1.0 mL), 1 N soln. of NaOMe in MeOH (0.5 mL) was added and 
the resulting mixture was stirred for 4 h at rt. After that, the reaction mixture was neutral-
ized with Dowex (H
+
), the resin was filtered off and washed successively with MeOH. 
The combined filtrate was concentrated in vacuo. The residue was dissolved in pyridine 
(1.0 mL), acetic anhydride (0.2 mL) was added dropwise (1 min), and the resulting mix-
ture was stirred for 16 h at rt. After that, the reaction was quenched with methanol (~2.0 
mL) and the volatiles were co-evaporated with toluene and the residue was purified by 
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column chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford 
the title compound in 73% yield (12 mg, 0.013 mmol, α-only) as a clear film.  Analytical 
data for 2.4: Rf = 0.53 (ethyl acetate/toluene, 3/7, v/v); []D
24
 +51.0
o
 (c = 1, CHCl3); 
1
H 
NMR: δ, 2.03, 2.06 (2s, 6H, 2 x COCH3), 3.31 (s, 3H, OCH3), 3.47-3.65 (m, 4H, H-2, 2’, 
4, 4’), 3.81 (m, 1H, H-5), 4.01-4.10 (m, 2H, H-3’, 6a’), 4.13-4.30 (m, 4H, H-3, 6a, 6b, 
6b’), 4.46 (m, 1H, H-5’), 4.50-4.56 (m, 1H, CH2Ph), 4.61-4.71 (m, 4H, H-1, CH2Ph), 
4.70 (dd, 2H, CH2Ph), 4.73 (dd, 2H, 
2
J = 11.5 Hz, CH2Ph), 4.89 (dd, 2H, CH2Ph), 5.53 
(d, 1H, J1’,2’ = 3.5 Hz, H-1’), 7.13-7.37 (m, 25H, aromatic) ppm; 
13C NMR(75 MHz): δ, 
21.1, 29.9, 55.3, 63.1, 63.3, 68.2, 69.1, 73.2, 74.0, 75.1, 75.8, 78.0, 78.7, 78.8, 79.8, 82.5, 
97.5, 97.5, 127.3 (x2), 127.8, 127.8 (x2), 127.9, 128.0 (x2), 128.1 (x2), 128.1 (x2), 128.3, 
128.5 (x2), 128.5 (x2), 128.6 (x2), 128.6 (x2), 128.7 (x2), 128.9 (x2), 137.9, 137.9, 138.0, 
138.3, 138.7, 170.9, 171.0 ppm; HR-FAB MS [M+Na]
+
 calcd for C52H58NaO13 913.3775, 
found 913.3780. 
 
Methyl 6-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-4-O-acetyl-2,3-di-O-
benzyl-α-D-glucopyranoside (2.6).  A mixture of 2.10 (15 mg, 0.011 mmol) and freshly 
activated molecular sieves (3 Å, 100 mg) in 1,2-dichloroethane (0.5 mL) was stirred un-
der argon for 16 h at rt. The mixture was cooled to 0 
oC, MeOTf (7 μL, 0.060 mmol) was 
added, and the reaction mixture was stirred at 0 
o
C until the disappearance of the starting 
material, as indicated by TLC. After that, the solid was filtered off through a pad of 
Celite and rinsed successively with dichloromethane. The combined filtrate (~30 mL) 
was washed with sat aq. NaHCO3 (~10 mL) and water (3 x 10 mL). The organic phase 
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was separated, dried over MgSO4, concentrated in vacuo and dried. The residue was dis-
solved in dry methanol (1.0 mL), 1 N soln. of NaOMe in MeOH (0.5 mL) was added and 
the resulting mixture was stirred for 4 h at rt. After that, the reaction mixture was neutral-
ized with Dowex (H
+
), the resin was filtered off and washed successively with MeOH. 
The combined filtrate was concentrated in vacuo. The residue was dissolved in pyridine 
(1.0 mL), acetic anhydride (0.2 mL) was added dropwise (1 min), and the resulting mix-
ture was stirred for 16 h at rt. After that, the reaction was quenched with MeOH (~2.0 
mL) and the volatiles were co-evaporated with toluene and the residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford 
the title compound  in 89% yield (8.8 mg, 0.099 mmol, α-only) as a clear film.  The title 
compound was also obtained from 2.5 (63% yield, α/β = 9.2/1). Analytical data for α-2.6: 
Rf = 0.58 (ethyl acetate/toluene, 3/7, v/v); []D
24
 +33.7 (c = 1, CHCl3);  
1H NMR: δ, 1.91, 
1.96 (2s, 6H, 2 x COCH3), 3.37 (s, 3H, OCH3), 3.39-3.54 (m, 5H, H-2, 2’, 4, 4’, 6a), 3.60 
(dd, 1H, J5,6b  = 6.9 Hz, J6a,6b = 10.9 Hz, H-6b), 3.84-3.99 (m, 4H, H-3, 3’, 5, 5’), 4.17-
4.20 (m, 2H, H-6a’, 6b’), 4.52-4.90 (m, 10H, 5 x CH2Ph), 4.58 (d, 1H, J1,2 = 3.6 Hz, H-
1), 4.68 (d, 1H, J1’,2’ = 3.5 Hz, H-1’), 7.20-7.35 (m, 25H, aromatic) ppm; 
13
C NMR(75 
MHz): δ, 21.0, 21.1, 55.6, 63.2, 67.3, 68.6, 68.9, 71.0, 73.2, 73.6, 74.9, 75.6, 75.8, 77.4, 
79.5, 79.9, 80.1, 81.9, 97.0, 98.0, 127.8, 127.9, 128.0 (x5), 128.1 (x2), 128.2 (x3), 128.3 
(x3), 128.6 (x8), 128.7 (x3), 138.1, 138.3, 138.4, 138.8, 170.0, 170.9 ppm; HR-FAB MS 
[M+Na]
+
 calcd for C52H58NaO13 913.3775, found 913.3780. 
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Methyl 6-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-6-O-acetyl-2,4-di-O-benzyl-
α-D-glucopyranoside (2.12).  A mixture of 2.11 (24 mg, 0.017 mmol) and freshly acti-
vated molecular sieves (3 Å, 100 mg) in 1,2-dichloroethane (0.5 mL) was stirred under 
argon for 16 h at rt. The mixture was cooled to 0 
oC, MeOTf (6 μL, 0.05 mmol) was add-
ed, and the reaction mixture was stirred at 0 
o
C until the disappearance of the starting ma-
terial, as indicated by TLC. After that, the solid was filtered off through a pad of Celite 
and rinsed successively with dichloromethane. The combined filtrate (~30 mL) was 
washed with sat aq. NaHCO3 (~10 mL) and water (3 x 10 mL). The organic phase was 
separated, dried over MgSO4, concentrated in vacuo and dried. The residue was dissolved 
in dry methanol (1.0 mL), 1 N soln. of NaOMe in MeOH (0.5 mL) was added and the 
resulting mixture was stirred for 2-16 h at rt. After that, the reaction mixture was neutral-
ized with Dowex (H
+
), the resin was filtered off and washed successively with MeOH. 
The combined filtrate was concentrated in vacuo. The residue was dissolved in pyridine 
(1.0 mL), acetic anhydride (0.2 mL) was added dropwise (1 min), and the resulting mix-
ture was stirred for 16 h at rt. After that, the reaction was quenched with methanol (~2.0 
mL) and the volatiles were evaporated in vacuo. The residue was co-evaporated with tol-
uene and the residue was purified by column chromatography on silica gel (ethyl acetate - 
hexane gradient elution) to afford the title compound was obtained as a clear film in 84% 
(10.7 mg, 0.017mmol, β-only). Analytical data for 2.12: Rf = 0.52 (acetone/toluene, 1/5, 
v/v); []D
28
 +269.3 (c = 1, CHCl3); 
1H NMR: δ, 1.91-2.05 (m, 15H, 5 x COCH3), 3.27 (s, 
3H, OCH3), 3.40 (dd, J4,5 = 10.1 Hz, H-4), 3.44 (dd, 1H, H-2), 3.62 (m, 1H, J5’,6b’ = 2.2 
Hz, H-5’), 3.73 (m, 1H J5,6a = 3.6 Hz, H-5), 3.88 (m, 1H, H-5), 4.00 (dd, 1H, J6a’,6b’ = 
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12.4 Hz, H-6a), 4.16-4.32 (m, 4H, H-3, 6a, 6b, 6b’), 4.44-4.51 (m, 3H, J1,2 = 3.6 Hz, H-1, 
CH2Ph), 4.74 (d, 1H, 
2
J = 11.4 Hz, ½ CH2Ph), 4.98 (d, 1H, 
2
J = 10.8 Hz, ½ CH2Ph), 
5.04-5.27 (m, 4H, J4’,5’ = 9.9 Hz, H-1’, 2’, 3’, 4’), 7.19-7.34 (m, 10H, aromatic) ppm; 
13
C 
NMR (75 MHz): δ, 20.8 (x2), 20.8, 21.0, 21.1, 55.4, 62.1, 63.2, 68.3, 68.5, 71.8, 72.2, 
73.3, 74.0, 74.8, 75.2, 77.4, 78.9, 81.1, 97.5, 100.5, 128.0, 128.5, 128.6 (x5), 128.9 (x2), 
137.6, 138.2, 169.6, 169.7, 170.5, 170.9 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C37H46NaO16 769.2684, found 769.2702. 
2.4.8 Preparation of the key Building Block 2.15. 
 
 
2-Allylphenyl 4,6-O-benzylidene-β-D-glucopyranoside (2.44).  Benzaldehyde dimethyl 
acetal (2.3 mL, 11.8 mmol) and 10-camphorsulfonic acid (CSA, 89 mg, 0.38 mmol) were 
added to the solution of 2-allylphenyl β-D-glucopyranoside (2.43,20 2.2 g, 7.64 mmol) in 
dry MeCN (20 mL) and the resulting mixture was stirred under argon for 1 h at rt. Then, 
the reaction was neutralized with TEA (~0.1 mL) and the volatiles were evaporated. The 
residue was dissolved in dichloromethane (~250 mL) and washed with water (2 x 50 
mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
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The residue was purified by precipitation from dichloromethane and hexanes to yield 
2.44 as a white powder (2.76 g, 89%). Analytical data for 2.44: Rf = 0.58 (metha-
nol/dichloromethane, 1/9, v/v); []D
30
 -71.3 (c = 1, CHCl3);  
1H NMR: δ, 2.81 (br. s, 1H, 
OH), 3.34 (dd, 1H, J5,6a = 5.0 Hz, H-6a), 3.45-3.71 (m, 3H, H-4, 5, 6b), 3.79-3.97 (m, 3H, 
H-2, CH2CH=), 4.41 (dd, 1H, J3,4 = 4.7 Hz, H-3), 4.99 (d, 1H, J1,2 = 7.7 Hz, H-1), 5.01-
5.17 (m, 2H, CH=CH2), 5.58 (s, 1H, CHPh), 5.97-6.11 (m, 1H, CH=CH2), 7.02-7.27 (m, 
4H, aromatic), 7.38-7.65 (m, 5H, aromatic) ppm; 
13C NMR (75 MHz): δ, 35.1, 66.8, 68.8, 
73.2, 74.6, 80.5, 102.0, 102.2, 114.9, 115.5, 123.4, 126.5 (x2), 128.1, 128.6 (x2), 129.1, 
129.6, 130.9, 137.0, 138.3, 155.4 ppm; HR-FAB MS [M+Na]
+
 calcd for C22H24NaO6 
407.1471, found 407.1465. 
 
2-Allylphenyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside (2.45).  NaH 
(60% in mineral oil, 0.78 g, 19.5 mmol) was added portionwise to a stirring solution of 
2.44 (1.92 g, 4.34 mmol) in DMF (15.0 mL) and benzyl bromide (1.56 mL, 13.0 mmol) 
at 0
o
C. The resulting mixture was allowed to gradually warm to rt and stirred for addi-
tional 1 h at rt. After that, the reaction was quenched by ice water (~50 mL). The organic 
phase was extracted with ethyl acetate/diethyl ether (1/1, v/v, 3 x 60 mL). The combined 
organic extract was separated, dried over MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate - hexane gradient elu-
tion) to afford 2.45 (2.53 g, 94%) as a white amorphous solid. Analytical data for 2.45: Rf 
= 0.70 (ethyl acetate/hexanes, 2/3, v/v); []D
30
 -42.1 (c = 1, CHCl3); 
1H NMR: δ, 3.44-
3.64 (m, 3H, H-4, 6a, CH2CH=), 3.81-3.96 (m, 4H, H-2, 5, 6b, CH2), 4.41 (dd, 1H, J3,4 = 
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10.5 Hz, H-3), 4.85-5.12 (m, 6H, 2 x CH2Ph, CH=CH2), 5.21 (d, 1H, J1,2 = 7.5 Hz, H-1), 
5.65 (s, 1H, CHPh), 5.95-6.08 (m, 1H, CH=CH2), 7.04-7.55 (m, 19H, aromatic) ppm; 
13
C 
NMR (75 MHz): δ, 34.2, 66.3, 68.9, 75.3, 75.8, 81.3, 81.6, 82.0, 101.4, 101.8, 115.4, 
116.1, 123.1, 126.2 (x3), 127.6, 127.9, 128.5 (x2), 128.2 (x4), 128.6 (x4), 129.2, 129.9, 
130.3, 136.8, 137.4, 138.2, 138.5, 154.8 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C36H36NaO6 587.2410, found 587.2404. 
 
2-Allylphenyl 2,3-di-O-benzyl-β-D-glucopyranoside (2.46).  Water (1.0 mL) and tri-
fluoroacetic acid (2.5 mL) were added to a solution of 2.45 (2.53 g, 4.07 mmol) in di-
chloromethane (50.0 mL) and the resulting mixture was stirred for 1 h at rt. After that, the 
reaction mixture was diluted with dichloromethane (~200 mL) and washed with sat. aq. 
NaHCO3 (2 x 50 mL) and water (2 x 50 mL). The organic phase was separated, dried 
over MgSO4, and concentrated in vacuo. The residue was purified by column chromatog-
raphy on silica gel (ethyl acetate-hexane gradient elution) to afford 2.46 as white foam 
(2.1 g, 97%).  Analytical data for 2.46: Rf = 0.25 (ethyl acetate/hexanes, 1/1, v/v); []D
30
 -
62.5 (c = 1, CHCl3); 
1H NMR: δ, 2.25 (t, 1H, OH), 2.69 (s, 1H, OH), 3.44-3.55 (m, 3H, 
H-5, CH2CH=), 3.63 (m, 1H, J3.4 = 9.2 Hz, H-3), 3.68 (dd, 1H, J4,5 = 2.2 Hz, H-4), 3.72-
3.82 (m, 2H, H-2, 6a), 3.86-3.94 (m, 1H, H-6b), 4.91 (dd, 2H, 
2
J = 11.5 Hz, CH2Ph), 4.97 
(dd, 2H, 
2
J = 10.9 Hz, CH2Ph), 5.04-5.12 (m, 2H, CH=CH2), 5.16 (d, 1H, J1,2 = 7.7 Hz, 
H-1), 5.98-6.08 (m, 1H, CH=CH2), 7.04-7.40 (m, 14H, aromatic) ppm; 
13
C NMR (75 
MHz): δ, 34.2, 62.5, 70.3, 75.3, 75.4, 75.5, 81.9, 84.2, 101.1, 114.8, 116.2, 122.9, 127.6, 
128.0, 128.1 (x2), 128.1 (x2), 128.2, 128.6 (x2), 128.8 (x2), 129.6, 130.4, 136.8, 138.2, 
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138.5, 154.7 ppm; HR-FAB MS [M+Na]
+
 calcd for C29H32NaO6 499.2097, found 
499.2088. 
 
2-Allylphenyl 2,3-di-O-benzyl-6-O-tert-butyldimethylsilyl-β-D-glucopyranoside 
(2.47).  tert-Butyldimethylsilyl chloride (1.18 g, 7.87 mmol) was added to a solution of 
2.46 (2.1 g, 3.93 mmol) in dry pyridine (10.0 mL) and the resulting mixture was stirred 
for 16 h at rt. After that the reaction mixture was diluted with dichloromethane (~200 
mL) and washed with sat. aq. NaHCO3 (50 mL), water (2 x 50 mL), 1N HCl (50 mL), 
and water (2 x 50 mL). The organic phase was separated, dried over MgSO4, and concen-
trated in vacuo. The residue was purified by column chromatography on silica gel (ethyl 
acetate-hexane gradient elution) to afford 2.47 as a colorless syrup (2.3 g, 90%).  Analyt-
ical data for 2.47: Rf = 0.60 (ethyl acetate/hexanes, 3/7, v/v); []D
30
 -41.7 (c = 1, CHCl3); 
1H NMR: δ, 0.07 (d, 6H, Si(CH3)2), 0.92 (s, 9H, C(CH3)3), 2.87 (br. s, 1H, OH), 3.41-
3.53 (m, 3H, H-5, CH2CH=), 3.59-3.78 (m, 3H, H-2, 3, 4), 3.81-3.93 (m, 2H, H-6a, 6b), 
4.91 (dd, 2H, 
2
J = 11.4 Hz, CH2Ph), 4.96 (dd, 2H, 
2
J = 10.9 Hz, CH2Ph), 5.03-5.10 (m, 
3H, H-1, CH=CH2), 5.93-6.04 (m, 1H, CH=CH2), 7.02-7.41 (m, 14H, aromatic) ppm; 
13
C 
NMR (75 MHz): δ, -5.3, -5.3, 18.4, 26.0 (x3), 34.3, 64.3, 72.5, 75.0, 75.3, 75.6, 81.8, 
84.5, 101.3, 115.4, 116.0, 122.7, 127.6, 127.9, 128.0, 128.1 (x2), 128.2 (x2), 128.6 (x2), 
128.7 (x2), 129.7, 130.1, 136.9, 138.3, 138.7, 155.0  ppm; HR-FAB MS [M+Na]
+
 calcd 
for C35H46NaO6Si 613.2961, found 613.2969. 
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2-Allylphenyl 2,3-di-O-benzyl-4-O-p-methoxybenzyl-β-D-glucopyranoside (2.15).  p-
Methoxybenzyl chloride (0.72 mL, 5.32 mmol) was added to a solution of 2.47 (2.3 g, 
3.55 mmol) in DMF (10.0 mL). The resulting mixture was cooled to 0 
o
C and NaH (60% 
in mineral oil, 0.43 g, 10.6 mmol) was added portionwise. The reaction mixture was al-
lowed to gradually warm to rt and stirred for additional 4 h at rt. After that, the reaction 
was quenched with ice water (50 mL). The organic phase was extracted with ethyl ace-
tate/diethyl ether (1/1, v/v, 3 x 60 mL). The combined organic extract was dried over 
MgSO4 and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to afford 2-allylphenyl 2,3-di-O-
benzyl-6-O-tert-butyldimethylsilyl-4-O-p-methoxybenzyl-β-D-glucopyranoside (2.25 g, 
83%) as a colorless syrup. The latter compound (1.32 g, 1.72 mmol) was dissolved in 
THF (10 mL), 1 M soln. of TBAF in THF (3.4 mL, 3.44 mmol) was added and the result-
ing mixture was stirred under argon for 1 h at rt. After that, the reaction mixture was di-
luted in dichloromethane (~150 mL), washed with water (30 mL), sat. aq. NaHCO3 (30 
mL), and water (2 x 30 mL). The organic phase was separated, dried over MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to afford the title compound (870 mg, 77%) as a 
white amorphous solid. Analytical data for 2.15: Rf = 0.20 (ethyl acetate/hexanes, 1/4, 
v/v); []D
30
 -25.0
o
 (c = 1, CHCl3); 
1H NMR: δ, 3.58 (2.54 (br. s, 1H, OH), 3.58-3.63 (m, 
3H, H-5, CH2CH=), 3.74-3.82 (m, 2H, H-3, 6a), 3.88 (s, 3H, OCH3), 3.86-3.92 (m, 2H, 
H-2, 4), 3.99 (m, 1H, H-6b), 4.86 (dd, 2H, 
2
J = 10.6 Hz, CH2Ph), 4.99-5.24 (m, 6H, H-1, 
2 x CH2Ph, CH=CH2), 7.04-7.60 (m, 18H, aromatic) ppm; 
13C NMR(75 MHz): δ, 18.9, 
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55.2, 61.8, 74.7, 75.1, 75.4, 75.7, 82.0, 84.6, 101.2, 113.9, 115.2, 122.8, 125.5, 126.4, 
126.9, 127.6, 127.7 (x3), 127.9 (x2), 128.0 (x2), 128.2, 128.3 (x2), 128.4 (x2), 129.8 (x2), 
130.1, 138.2, 138.6, 153.6, 159.4 ppm; HR-FAB MS [M+Na]
+
 calcd for C37H40NaO7 
619.2672, found 619.2660. 
 
2.4.9 Synthesis of Trisaccharide 2.19. 
Ethyl 2,3,4-tri-O-benzyl-6-O-(α,α,α-p-hydroxyphenyldimethyltolyl succinate)-1-thio-
β-D-glucopyranoside (2.13). A solution of DCC (301 mg, 1.46 mmol) and DMAP (17 
mg, 0.15 mmol) in dry dichloromethane (2.0 mL) was added dropwise (5 min) to a solu-
tion of 2.21 (434 mg, 0.73 mmol) and BPA (301 mg, 2.19 mmol) in dry dichloromethane 
(4.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. After that, the 
reaction mixture was diluted with dichloromethane (~30 mL) and washed with water (3 x 
10 mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate/toluene, 
1/1, v/v) to afford 2.13 in 66% yield ( 387 mg, 0.482 mmol) was obtained as a colorless 
syrup. Analytical data for 2.13: Rf = 0.48 (ethyl acetate/ hexanes, 2/3, v/v); []D
26
 12.5 (c 
= 1, CHCl3); 
1H NMR: δ, 1.39 (t, 3H, CH2CH3), 1.69 (s, 6H, C(CH3)2), 2.77-2.93 (m, 6H, 
CH2CH3, COCH2CH2CO), 3.55 (dd, 1H, J2,3 = 9.2 Hz, H-2), 3.60-3.70 (m, 2H, H-4, 5), 
3.81 (dd, 1H, J3,4 = 8.4 Hz, H-3), 4.35 (dd, 1H, J5,6a = 4.0 Hz, J6a,6b = 12.0 Hz, H-6a), 
4.49 (dd, 1H, J5,6b = 1.2 Hz, H-6b), 4.57 (d, 1H, J1,2 = 9.8 Hz, H-1), 4.81 (dd, 2H, 
2
J = 
10.9 Hz, CH2Ph), 4.93 (dd, 2H, 
2
J = 10.2 Hz, CH2Ph), 5.00 (dd, 2H, 
2
J = 11.0 Hz, 
CH2Ph), 6.75-7.48 (m, 23H, aromatic) ppm; 
13C NMR(75 MHz): δ, 15.2, 25.2, 29.0, 29.3, 
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31.1, 42.1, 63.8, 75.1, 75.6, 75.8, 81.7, 85.3, 86.6, 114.8, 114.9, 120.8, 120.9, 127.8 (x3), 
127.9 (x2), 128.0, 128.0, 128.2 (x2), 128.4 (x2), 128.5 (x2), 128.5 (x2), 128.6 (x2), 137.6, 
137.9, 138.3, 142.2, 142.9, 148.0, 148.3, 148.5, 148.7, 153.7, 153.9, 171.1, 172.1 ppm; 
HR-FAB MS [M+Na]
+
 calcd for C48H52NaO9S 827.3230, found 827.3236.  
 
Tethered compound 2.16.  A solution of 1-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide (EDC, 0.54 g, 2.82 mmol) and DMAP (46 mg, 0.38 mmol) in dichloromethane 
(10 mL) was added dropwise (5 mins) to a stirring solution of 2.13 (1.5 g, 1.88 mmol) 
and trimellitic anhydride (0.40 g, 2.07 mmol) in dichloromethane (40.0 mL) at 0 
o
C. The 
resulting mixture was kept at 0 
o
C for 30 min, then allowed to gradually warm to rt, and 
stirred for additional 1 h at rt. After that, the reaction mixture was concentrated and dried 
in vacuo. The crude residue containing compound 14 was dissolved in dichloromethane 
(60 mL), compound 15 (485 mg, 0.74 mmol) and triethylamine (0.52 mL, 3.71 mmol) 
were added, and the resulting mixture was kept at rt for 1 h. After that, the reaction mix-
ture was diluted in dichloromethane (~200 mL), washed with water (50 mL), 1 N HCl (2 
x 50 mL), and water (2 x 50 mL). The organic phase was separated, dried over MgSO4, 
and concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (methanol/dichloromethane graduate elution) to afford compound 2.16 in 95% yield 
(mixture of regioisomers) as a white amorphous solid. Analytical data for 2.16: Rf = 0.58 
(methanol/dichloromethane, 1/9, v/v); 
1H NMR: δ, 1.26 (t, 3H, CH2CH3), 1.63 (s, 6H, 
C(CH3)2), 1.68 (dd, 2H, CH2CH=), 2.66-2.71, 2.75-2.80 (2m, 4H, COCH2CH2CO), 3.39 
(dd, 1H, J2’,3’ = 9.5 Hz, H-2’), 3.45-3.52 (m, 2H, H-4’, 5’), 3.60 (m, 1H, H-3), 3.63-3.70 
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(m, 2H, H-3’, 5), 3.65 (s, 3H, OCH3), 3.73-3.80 (m, 2H, H-2, 4), 4.21 (dd, 1H, J5’,6a’ = 4.3 
Hz, J6a’,6b’ = 11.7 Hz, H-6a’), 4.32- 4.44 (m, 3H, H-1’, 6a, 6b’), 4.51-4.59 (m, 3H, H-6b, 
CH2Ph), 4.65-5.02 (m, 11H, H-1, 5 x CH2Ph), 6.03-6.14 (m, 1H, CH=CH2), 6.74-7.61 
(m, 37H, CH=CH2, aromatic), 7.63 (d, 1H, aromatic), 8.25 (dd, 1H, aromatic), 8.56 (s, 
1H, aromatic) ppm; 
13
C NMR (75 MHz): δ, 15.3, 18.9, 25.4, 29.1, 29.4, 31.1, 42.7, 55.3, 
63.8, 64.8, 73.0, 74.8, 75.2, 75.7, 75.9, 76.2, 77.0, 81.8, 82.0, 84.8, 85.3, 86.7, 101.6, 
114.1 (x2), 116.1, 121.0 (x2), 121.1 (x2), 123.2, 125.5, 126.4, 127.2, 127.9 (x4), 127.9 
(x3), 128.0 (x3), 128.1, 128.2 (x4), 128.3 (x2), 128.5 (x5), 128.6 (x9), 128.7 (x3), 129.5, 
129.7 (x2), 130.1 (x2), 130.9, 131.4, 132.2, 133.4, 137.0, 137.8, 137.9, 138.2, 138.4, 
138.5, 148.0, 148.6 (x2), 148.7, 153.7, 159.5, 163.6, 166.8, 169.3, 171.2, 172.0 ppm; HR-
FAB MS [M+Na]
+
 calcd for C94H93Na2O20S 1619.5776, found 1619.5770.  
 
Methyl 2,3-di-O-benzyl-6-O-(α,α,α-p-hydroxyphenyldimethyltolyl succinate)-4-O-p-
methoxybenzyl-α-D-glucopyranoside (2.17).  Succinic anhydride (716 mg, 6.07 mmol) 
was added to a solution of methyl 2,3-di-O-benzyl-4-O-p-methoxybenzyl-α-D-
glucopyranoside
28
 (1.0 g, 2.02 mmol) in dry pyridine (10 mL) and the resulting mixture 
was stirred under argon for 16 h at rt. After that, the reaction mixture was concentrated 
under reduced pressure. The residue was dissolved in dichloromethane (~100 mL) and 
washed with water (3 x 20 mL). The organic phase was separated, dried over MgSO4, and 
concentrated in vacuo.  The residue was dissolved in dichloromethane (10 mL) and 
cooled to 0 
o
C.  BPA (923 mg, 4.04 mmol) was added followed by the addition of a solu-
tion of DCC (834 mg, 4.04 mmol) and DMAP (49 mg, 0.40 mmol) in dry dichloro-
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methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate/toluene, 1/1, v/v) to afford compound 2.17
28
 in 65% yield (over 2 steps) as 
a colorless syrup. Analytical data for 2.17: Rf = 0.50 (ethyl acetate/hexanes, 1/1, v/v); 
[]D
25
 17.8 (c = 1, CHCl3); 
1H NMR: δ, 1.67 (s, 6H, C(CH3)2), 2.75-2.88, 2.90-2.95 (2m, 
4H, COCH2CH2CO), 3.41 (s, 3H, OCH3), 3.57 (dd, 1H, J4,5 = 9.1 Hz, H-4), 3.63 (dd, 1H, 
J2,3 = 9.6 Hz, H-2), 3.82 (s, 3H, OCH3), 3.89 (m, 1H, H-5), 4.10 (dd, 1H, J3,4 = 9.2 Hz, H-
3), 4.39 (m, 2H, H-6a, 6b), 4.65 (d, 1H, J1,2 = 3.5 Hz, H-1), 4.74 (dd, 2H, 
2
J = 10.6 Hz, 
CH2Ph), 4.78 (dd, 2H, 
2
J = 12.1 Hz, CH2Ph), 5.01 (dd, 2H, 
2
J = 10.9 Hz, CH2Ph), 6.75-
7.45 (m, 22H, aromatic) ppm; 
13C NMR (75 MHz): δ, 28.9, 29.2, 31.0, 42.0, 55.2, 60.7, 
63.4, 68.6, 73.4, 74.7, 75.8, 79.8, 82.0, 98.0, 113.9 (x2), 114.9 (x2) 120.7 (x2), 127.7 
(x3), 127.8 (x3), 128.0 (x4), 128.1 (x2), 128.5 (x5), 129.9 (x2), 137.9, 138.6, 142.0, 
148.3, 148.7, 154.0, 159.3, 171.2, 172.1 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C48H52NaO11 827.3407, found 827.3408.  
 
Tethered compound 2.18.  A solution of EDC (10.2 mg, 0.053 mmol) and DMAP (0.7 
mg, 0.005 mmol) in dichloromethane (1.0 mL) was added dropwise (5 min) to a solution 
of 2.16 (only p-substituted regioisomer was used, 43 mg, 0.027 mmol) and 2.17 (19.5 
mg, 0.024 mmol) in dichloromethane (1.0 mL) and the resulting mixture was stirred un-
der argon for 6 h at rt. After that, the reaction mixture was diluted with dichloromethane 
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(~40 mL) and washed with water (10 mL), sat. aq. NaHCO3 (10 mL), and water (2 x 10 
mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate - hexane 
gradient elution) to afford compound 2.18 in 82% as a colorless syrup. Analytical data for 
2.18: Rf = 0.48 (ethyl acetate/hexanes, 3/7, v/v), []D
32
 10.1 (c = 1, CHCl3); 
1
H NMR 
(500 MHz): δ, 1.33 (t, 3H, CH2CH3), 1.63 (s, 6H, C(CH3)2), 1.70 (s, 6H, C(CH3)2), 1.77 
(dd, 2H, CH2CH=), 2.70-2.90 (m, 10H, CH2CH3, 2 x COCH2CH2CO), 3.37 (s, 3H, 
OCH3), 3.46 (dd, 2H, H-2”, 4), 3.50-3.55 (m, 3H, H-2, 4”, 5”), 3.65 (dd, 1H, J4’,5’ = 8.6 
Hz, H-4’), 3.72 (dd, 1H, J3”,4” = 8.6 Hz, H-3”), 3.73-3.84 (m, 5H, H-2’, 3’, 3”, 5, 5’), 3.75 
(s, 3H, OCH3), 3.78 (s, 3H, OCH3), 4.00 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.27-4.30 (m, 2H, 
H-6a, 6a”),  4.34 (dd, 1H, J5,6b = 4.4 Hz, J6a,6b = 11.6 Hz, H-6b), 4.41-4.67 (m, 9H, H-1, 
1”, 6a’, 6b’, 6b”, 2 x CH2Ph), 4.74-5.09 (m, 15H, H-1’, 7 x CH2Ph), 6.14-6.21 (m, 1H, 
CH=CH2), 6.78 (dd, 2H, CH=CH2), 6.80-7.40 (m, 63H, aromatic), 7.70 (d, 1H, aromatic), 
8.34 (dd, 1H, aromatic), 8.71 (s, 1H, aromatic) ppm; 
13
C NMR (75 MHz): δ, 15.3, 19.0, 
21.7, 25.4, 29.1, 29.2, 29.4, 31.2, 42.7, 42.8, 55.4, 55.5, 63.5, 63.9, 68.8, 73.0, 73.6, 74.9, 
75.3, 75.8, 76.0, 77.7, 80.0, 81.9, 82.1, 82.3, 84.9, 85.4, 86.8, 89.5, 98.2, 101.5, 114.1 
(x4), 121.0 (x2), 121.1 (x4), 125.5, 125.6, 126.5, 127.2, 127.9, 128.0 (x11), 128.1 (x3), 
128.2 (x14), 128.3 (x8), 128.4 (x4), 128.5 (x5), 128.6 (x7), 128.7 (x16), 129.2 (x4), 
130.0, 130.1, 130.2, 136.5, 137.8, 138.0, 138.1, 138.2, 138.5 (x2), 138.8, 142.0, 142.3, 
142.6, 148.4, 148.6, 148.7, 154.3, 159.7, 164.1, 165.8, 166.8, 171.5, 172.0 ppm; HR-FAB 
MS [M+Na]
+
 calcd for C142H144NaO30S 2383.9631, found 2383.9620.  
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Methyl O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(14)-O-(2,3-di-O-benzyl-α-D-
glucopyranosyl)-(14)-2,3-di-O-benzyl-α-D-glucopyranoside (2.19).  A mixture of 
2.18 (20 mg, 0.008 mmol) in 1,2-dichloroethane (1.0 mL) and freshly activated molecular 
sieves (3 Å, 60 mg) was stirred under argon for 2 h at rt. The mixture was cooled to 0 
o
C, 
MeOTf (5.3 µL, 0.042 mmol) was added and the resulting mixture was stirred for 16 h at 
0 
o
C. Then, NIS (3.8 mg, 0.017 mmol) and TfOH (0.2 µL, 0.002 mmol) were added and 
the resulting mixture was stirred under argon for 6 h at 0 
o
C. After that, the solid was fil-
tered-off and rinsed successively with dichloromethane. The combined filtrate (~40 mL) 
was washed with 10% aq. Na2S2O3 (10 mL), sat. aq. NaHCO3 (10 mL), and water (2 x 10 
mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was dissolved in dry methanol (2.0 mL), a 1 M solution of NaOMe in metha-
nol (0.1 mL) was added, and the resulting mixture was kept for 1 h at rt. After that, the 
reaction mixture was neutralized with Dowex (H
+
), the resin was filtered off and rinsed 
successively with methanol. Combined filtrate was concentrated and dried. The residue 
was purified by size exclusion column chromatography on Sephadex LH-20 (metha-
nol/dichloromethane, 1/1, v/v elution) to afford the title compound (5.6 mg, 58%) as a 
clear film. Analytical data for 2.19: Rf = 0.24 (ethyl acetate/hexanes, 1/1, v/v), []D
19
 
43.9
o
 (c = 1, CHCl3); 
1H NMR (500 MHz): δ, 2.24, 2.33, 2.56 (3 br. s, 3H, 3 x OH), 3.38 
(dd, 1H, J4’,5’ = 9.4 Hz, H-4’), 3.40 (s, 3H, OCH3), 3.44 (dd, 1H, J2’,3’ = 9.8 Hz, H-2’), 
3.51 (dd, 1H, J2”,3” = 9.3 Hz, H-2”), 3.56 (dd, 1H, J2,3 = 9.5 Hz, H-2), 3.60 (m, 1H, H-5”), 
3.72 (m, 1H, H-5’), 3.77-3.87 (m, 6H, H-4”, 5, 6a’, 6b’, 6a”, 6b”), 3.89-4.01 (m, 4H, H-
3’, 4, 6a, 6b), 4.03 (dd, 1H, J3”,4” = 9.6 Hz, H-3”), 4.13 (dd, 1H, J3,4 = 9.1 Hz, H-3), 4.42-
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4.45 (m, 3H, CH2Ph), 4.54-4.60 (m, 4H, 2 x CH2Ph), 4.68-4.90 (m, 7H, J1,2 = 3.5 Hz, H-
1, 3 x CH2Ph), 5.06 (d, 1H, CH2Ph), 5.59 (d, 1H, J1’,2’ = 3.8 Hz, H-1’), 5.74 (d, 1H, J1”,2” 
= 3.8 Hz, H-1”), 7.05-7.30 (m, 35H, aromatic) ppm; 13C NMR (150 MHz): δ, 55.5, 61.5, 
62.2, 62.5, 70.2, 71.7, 71.8, 72.5, 73.1, 73.2, 73.4, 73.6, 74.2, 74.6, 75.3, 75.8, 78.3, 79.2, 
79.6, 80.4, 81.5, 81.9, 82.1, 96.7, 97.2, 98.1, 126.6 (x2), 126.7 (x2), 127.3, 127.4, 127.7 
(x2), 127.8 (x3), 127.9 (x2), 128.0 (x3), 128.2, 128.3 (x4), 128.4 (x2), 128.5 (x8), 128.6 
(x2), 128.7 (x4), 137.8, 138.0, 138.2 (x2), 138.8, 139.0, 139.1 ppm; HR-FAB MS 
[M+Na]
+
 calcd for C68H76NaO16 1171.5031, found 1171.5022.  
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
 
 
Chapter 3 Templated Oligosaccharide Synthesis: Driv-
ing Forces and Mechanistic Aspects 
  

3.1 Introduction 
An issue of controlling the stereoselectivity of glycosylations has been approached in a 
variety of modes.
1,2
 Amongst these, intramolecular approaches occupy an important niche 
amongst other methods available.
3-6
  The underlayment of the concept is that two glyco-
sylation components, glycosyl donor and acceptor, are tethered together using a suitable 
linker. The purpose of this tethering is to achieve an efficient facial selectivity due to ste-
ric or geometric constrains and forces. Our preliminary study dedicated to varying the 
linkers resulted in the development of a new concept that we named templated oligosac-
charide synthesis. A range of disaccharides were obtained in good yields and with high 
stereoselectivity (Chapter 2).
7
 We also demonstrated a possibility of extending the tem-
plate to the synthesis of a trisaccharide, which was also obtained with complete α-
stereoselectivity for both glycosylation steps.
7
 Described herein is a continuation of this 
study with the focus on dedicated mechanistic studies to reveal the driving forces of the 
templated synthesis and further improve the yields and stereoselectivities. 
 
3.2 Results and Discussion 
The preliminary results indicate that the rigidity of the template is essential for the stere-
oselection. The first series of conjugates 3.1-3.37 were designed to deliver the glycosyl 
acceptor from the bottom face (linker L1 is shorter than L2, succinoyl vs. glutaryl, re-
spectively). The results of this study are summarized in Table 3.1. When per-benzylated 
donor tethered with 3-OH acceptor 3.1 was activated with NIS/TfOH followed by the es-
ter bond cleavage under Zemplen conditions (NaOMe) and standard acetylation 
(Ac2O/pyridine), disaccharide 3.4
7 was isolated in 60% yield (entry 1, Table 3.1). The 

most encouraging outcome of this test reaction is that glycoside 3.4 was obtained with 
complete α-selectivity and no traces of the β-linked diastereomer could be detected. In 
spite of this promising result, it also became apparent that NIS/TfOH is too powerful an 
activator for this system as reflected by a modest yield of disaccharide 3.4 and relatively 
high rate of hydrolysis of the leaving group, as judged by the presence of the hemiacetal 
(1-OH derivative). Therefore, subsequent reactions have been conducted using MeOTf, a 
milder activator for thioglycosides.8 Thus, when the activation was performed in the 
presence of MeOTf at 0 oC, (13)-linked disaccharide 3.4 was isolated in a higher 73% 
yield (entry 2) and retains complete α-selectivity.  The better results led us to conclude 
that the donor and acceptor were not held in close proximity to each other, but the linkers 
are playing a direct role in approach of the acceptor toward the forming oxacarbenium 
ion.  When the promoter is stronger increased intermolecular reaction with H2O acting as 
the nucleophile is the predominating mechanism.  With the use of MeOTf, the system has 
an opportunity for the donor acceptor pair to rearrange to form the α-linked macrocycle.   
With optimized reaction conditions, the protocol was applied to glycosylation of tethered 
4-OH acceptor 3.2, disaccharide 3.57 was obtained in 81% yield and complete α-
selectivity (entry 3). Glycosylation of tethered 6-OH acceptor 3.3 provided disaccharide 
3.67 in 63% yield. Again, the preference was given to the formation of α-linked product, 
although the presence of the other diastereomer was also evident (α/β = 9.2/1, entry 4). It 
is possible that the compromised stereoselectivity in this case is related to the fact that 
primary 6-hydroxyl is more flexible and can reach out both from the bottom and from the 
top face of the activated donor (oxacarbenium ion intermediate).9 A second possibility is 
that the primary 6-hydroxyl is a less hindered nucleophile compared to the secondary ac-

ceptors.  This might increase the number of approach vectors towards the oxacarbenium 
ion.   
Table 3.1 A template is designed to deliver the nucleophile from the α-face (L2 is 
longer than L1). 
 
entry acceptor promoter
a
 Time 
Product 
(yield, α/β ratio) 
1 
 
3.1 
NIS/TfOH 5 min 3.4 (60%, α-only) 
2 
 
3.1 
MeOTf 18 h 3.4(73%, α-only) 
3 
 
3.2 
MeOTf 18 h 3.5 (81%, α-only) 
4 
 
3.3 
MeOTf 20 h 3.6 (63%, 9.2/1) 
a
 – performed in 1,2-dichloroethane in the presence of molecular sieves 4 Å at rt (NIS/TfOH) or 
3 Å at 0 °C (MeOTf) 
 
Having achieved promising stereoselectivity with the L2 longer than L1 model, we were 
curious to investigate the stereoselectivity of glycosylations with spacers of the equal 
length (L1 = L2). For this purpose we obtained a template with succinoyl linkers for both 
the glycosyl donor and acceptor attachment (3.7-3.9). As summarized in Table 3.2, 

complete α-stereoselectivity was still maintained in all reactions involving glycosylations 
of secondary glycosyl acceptors 3.7 and 3.87 (entries 1-4). Herein, we also tested the use 
of dimethyl(thiomethyl)sulfonium triflate (DMTST),10 another popular promoter for 
glycosidation of thioglycosides11 (entry 2). Nevertheless, most consistent results and best 
yields have been achieved with MeOTf (entries 3-5). Once again, glycosylation of the 
primary glycosyl acceptor 3.9 provided only moderate stereoselectivity (α/β = 6.3/1, 
entry 5).  
With good reaction yields and excellent α-stereoselectivity achieved in most template-
mediated glycosylations, we also investigated a template wherein the glycosyl acceptor 
would be expected to be delivered from the top (β-) face. For this purpose, the glycosyl 
donor was attached via a longer linker L1 (glutaryl) than that of the glycosyl acceptor 
(L2, succinoyl). compounds 3.10, 3.117 and 3.12. In this case, however, practically no 
selectivity was achieved. Results summarized in Table 3.3 clearly show that the synthesis 
of β-linked derivatives could not be accomplished using the longer linker L1. In all gly-
cosylations attempted, α-linked disaccharides 3.4-3.6 were still formed as major products 
albeit with rather poor selectivity (entries 1-5).  
Overall, we have determined that the rigidity of BPA backbone structure creates a suita-
ble environment for generating glycosidic linkages with superior stereoselectivity com-
pared to that previously seen with peptide-based templates.
12-14
 Complete stereoselectivi-
ty was achieved in the synthesis of disaccharides derived from secondary glycosyl accep-
tors, whereas the (16)-linked disaccharide was produced with lower selectivity (up to 
α/β = 9/1).  
 

 
Table 3.2 Template with identical linkers (L1 = L2 = succinoyl) still provides excel-
lent α-stereoselectivity. 
 
entry acceptor Conditions Time 
product 
(yield, α/β ratio) 
1 
 
3.7 
NIS/TfOH, MS4Å 
CH2Cl2, -78 
o
C 
4 h 3.4 (71%, α-only) 
2 
 
3.7 
DMTST, MS 3Å 
1,2-DCE, -30 
o
C 
8 h 3.4 (68%, α-only) 
3 
 
3.7 
MeOTf, MS 3Å, 
1,2-DCE, 0 
o
C 
16 h 3.4 (79%, α-only) 
4 
 
3.8 
MeOTf, MS 3Å, 
1,2-DCE, 0 
o
C 
18 h 3.5 (76%, α-only) 
5 
 
3.9 
MeOTf, MS 3Å, 
1,2-DCE, 0 
o
C 
20 h 3.6 (78%, 6.3/1) 
 
  

Table 3.3  Template is designed to deliver the nucleophile from the β-face (L1 is 
longer than L2). 
 
entry acceptor promoter
[a]
 time 
product 
(yield, α/β ratio) 
1 
 
3.10 
NIS/TfOH 5 min 3.4 (70%, 1.2/1) 
2 
 
3.10 
MeOTf 15 h 3.4 (83%, 3.0/1) 
3 
 
3.11 
NIS/TfOH
[b]
 4 h 3.5 (69%, 2.1/1) 
4 
 
3.11 
MeOTf 20 h 3.5 (71%, 2.8/1) 
5 
 
3.12 
MeOTf 24 h 3.6 (71%, 7.9/1) 
a
 – performed in 1,2-dichloroethane in the presence of molecular sieves 4 Å at rt (NIS/TfOH) or 
3 Å at 0 °C (MeOTf); 
b
 - performed in CH2Cl2 at -78 
o
C  

It is possible that the compromised stereoselectivity is related to the ability of the more 
flexible primary hydroxyl to reach out to both face of the activated donor (oxacarbenium 
ion intermediate). It became evident that the length of linkers may also have an effect on 
stereoselectivity, but the fact that the linkers of the same length still allowed for excellent 
α-stereoselectivity should help to reduce the number of options and focus our subsequent 
study on the properties of the linker rather than its length. Hence, we began looking at the 
mechanistic aspects of the templated oligosaccharide synthesis so as to gain practical in-
sights into the development of more effective linkers and further improve yields and ste-
reoselectivity.    
It occurred to us that using flexible succinoyl or glutaryl linkers may not be optimal for 
the effective positioning of the two coupling counterparts in a close proximity to ensure 
the effectiveness of this approach. This was investigated by setting up a simple test exper-
iment wherein two glycosyl acceptors, tethered compound 3.17 and “free floating” accep-
tor 3.13,15 were set to compete with the tethered donor. As illustrated in Scheme 2A, this 
simple competition experiment resulted in the preferential formation of the cross-
coupling product 3.15 (51% yield, α/β = 3.0/1) rather than the tethered disaccharide 3.14. 
The latter was obtained in a lower yield of 20% albeit complete α-selectivity. In our opin-
ion, this result serves as an indication that using a flexible spacer attachment is perhaps 
not the most ideal approach for the overall concept of the molecular clamping.  
  

Scheme 3.1 Competitive glycosylation of tethered glucosides 3.1 and 3.16 vs. “free-
floating” acceptor 3.13 
 
 
  

The fact that the acceptor moiety is distanced from the anomeric center of the glycosyl 
donor is perhaps the major reason for relatively modest yields and relaxed stereoselectivi-
ty with primary hydroxyls.7 Hence, a further search was focused on more rigid spacer 
systems. Certainly, geometrical constraints should lead to the enhanced diastereocontrol 
by maintaining the reacting centers at proper orientation. The flexible linkers allow gly-
cosylation of hydroxyl at remote locations from the tethering point. This distanced our 
templated approach from the traditional molecular clamping concept wherein glycosyla-
tion was mainly possible at the adjacent position due to the high rigidity of the donor-
acceptor pairs. Therefore, both the alignment and reactivity of tethered glycosyl do-
nor/acceptor pairs would be important factors to consider in more rigid systems.  
Bearing these considerations in mind, we investigated a more rigid phthaloyl linker with 
the following two anticipations. First, the enhanced rigidity would provide a more 
stringent acceptor delivery mode and, hence, help to improve the stereoselectivity 
outcome for primary glycosyl acceptors. Second, the free rotation around a number of 
linkages in such BPA-phthaloyl template-linker combinations would still offer enough 
flexibility to glycosylate the hydroxyl at remote positions. To investigate these, we ob-
tained the tethered compound 3.16, which was subjected to the competition experiment 
with the free floating acceptor 3.13. As illustrated in Scheme 2B, this experiment resulted 
in the preferential formation of the tethered disaccharide 3.17, which was isolated in 52% 
yield and with exclusive α-selectivity. The cross-coupling product 3.18 was also formed, 
but in a lower yield (30%) in comparison to that recorded for the experiment with the 
flexible linkers (51%).  

In our opinion, this result serves as a clear proof that a more rigid spacer attachment al-
lows for bringing the reaction components, glycosyl donor and acceptor, in close proxim-
ity while still maintaining complete α-selectivity and sufficient flexibility to glycosylate 
the remote hydroxyls. Being encouraged by this preliminary result, we conducted the in-
dividual experiment with the per-benzylated donor tethered with the 3-OH acceptor 3.16. 
When compound 3.16 was activated with MeOTf followed by the ester bond cleavage 
under Zemplen conditions (MeONa) and standard acetylation (Ac2O/pyridine), disaccha-
ride 3.4 was isolated in 71% yield and with complete stereoselectivity (entry 1, Table 
3.1). No traces of the β-linked diastereomer could be detected.  
When essentially the same protocol was applied to glycosylation of the tethered 4-OH 
acceptor 3.19,
7
 disaccharide 3.5 was obtained in 90% yield and with complete α-
selectivity (entry 2). In our previous study, we deemed NIS/TfOH too powerful an activa-
tor for the templated synthesis using flexible linkers.
7
 Also here, NIS/TfOH-promoted 
synthesis of disaccharide 3.5 was rather swift (2 h at -78 
o
C), but the increased rate was 
translated into the decreased yield of 75% (entry 3). Therefore, many subsequent reac-
tions have been conducted using MeOTf, a milder activator for thioglycosides.
8
 MeOTf-
promoted synthesis of the (16)-linked disaccharide 3.6 from the tethered donor-
acceptor 3.20
7
 also resulted in an excellent yield of 89% (entry 4). Even more important-
ly, complete α-selectivity in glycosylation of the primary alcohol was now obtained using 
this tethering approach. 
Having achieved excellent yields and complete stereoselectivities it all syntheses of α-
linked disaccharides, we were curious to see whether essentially the same approach could 
be used for the synthesis of β-linked disaccharides. For this purpose we obtained the ben-

zoylated glycosyl donor that was tethered with the 3-OH acceptor 3.21.
7
 MeOTf-
promoted glycosylation was rather sluggish (40 h) perhaps due to the disarmed nature of 
per-benzoylated donor or due to the hindrance caused by the acyloxonium ion used here-
in.
16
  
Table 3.4 Investigation of the phthaloyl linker in the BPA-templated glycosylations. 
 
entry donor-acceptor Conditions time 
product 
(yield, α/β ratio) 
1 
 
3.16, R = Bn 
MeOTf, MS 3Å,  
1,2-DCE, 0 
o
C 
16 h 3.4(71%, α-only) 
2 
 
3.19, R = Bn 
MeOTf, MS 3Å,  
1,2-DCE, 0 
o
C 
22 h 3.5 (90%, α-only) 
3 3.19 
NIS/TfOH, MS 
4Å,  
CH2Cl2, -78 
o
C 
2 h 3.5 (75%, α-only) 
4 
 
3.20, R = Bn 
MeOTf, MS 3Å,  
1,2-DCE, 0 
o
C 
18 h 3.6 (89%, α-only) 
5 
 
3.21, R = Bz 
MeOTf, MS 3Å,  
1,2-DCE, 0 
o
C 
40 h 3.22 (84%, β-only) 
6 3.21 
NIS/TfOH, MS 
4Å,  
1,2-DCE, 0 
o
C 
10 min 3.22 (75%, β-only) 
7 3.19 
MeOTf, MS 3Å,  
MeCN, 0 
o
C  rt 
24 h 3.5 (69%, α-only) 

Nevertheless, the reaction smoothly progressed and disaccharide 3.22
7
 was obtained in 
84% yield and with complete β-stereoselectivity (entry 5). The rate of this coupling could 
be significantly enhanced in the presence of NIS/TfOH (10 min), but the isolated yield of 
disaccharide 3.22 was reduced to 75% (entry 6). Again, the β-linked product was formed 
exclusively. Interestingly, when the benzylated donor tethered to 4-OH acceptor 3.19 was 
glycosylated in MeCN, a reaction solvent that is known to enhance β-selectivity,17 only 
the α-linked disaccharide 3.5 was obtained (68%, entry 7). This result implies that the 
effect of the intramolecular tethering on the stereoselectivity of glycosylation is stronger 
than that of the reaction solvent.  
In general, the effect of the steric bulkiness of a substituent at C-6 is known to be benefi-
cial for the formation of α-D-glucosides.18  This effect is attributed to shielding (steric or 
electronic) of the top face of the ring and hence favoring the nucleophilic attack from the 
opposite, bottom face. We wondered whether the steric bulkiness of the tethered glycosyl 
donors may contribute to the high α-stereoselectivity achieved in these reactions. This 
turned our attention to investigating whether it is the rigidity of the tethered structure ra-
ther than the effect of steric bulkiness at C-6 that is driving these glycosylations toward 
the α-linked products. To delineate between these two possible effects, glycosyl donor 
3.23 and acceptor 3.24 (Scheme 3), both bearing bulky phenylphthaloyl substituents at C-
6 were obtained.  Glycosylation of donor 3.23 with acceptor 3.24 was performed using 
MeOTf as a promoter in 1,2-dichloroethane. The resulting disaccharide 3.25 was isolated 
in 84% yield, but the stereoselectivity was low (α/β = 2.8/1).  In comparison to the intra-
molecular glycosylation of tethered donor-acceptor pairs, we can conclude that the steric 

bulkiness of the protecting group at C-6 in this case did not influence the stereoselectivity 
as much as tethering of the two components did.  
Interestingly, the influence of acetonitrile as the reaction solvent was more notable in this 
case. Disaccharide 3.25 was obtained in 88% yield with a slightly reversed stereoselectiv-
ity (α/β = 1/1.2, Scheme 3). In our opinion this may also serve as an indication that the 
steric bulkiness at C-6 has a minor contribution into the stereoselectivity achieved in 
tethered systems that were not influenced at all by the effect of acetonitrile. 
Scheme 3.2 Investigation of the effect of steric bulkiness at C-6 on stereoselectivity. 
 

Previously, Kusumoto and co-workers achieved excellent α-stereoselectivity using glyco-
syl donors equipped with a 6-O-phthaloyl linker attached to a bulky p-phenylbenzyl 
group.19 To investigate whether a phthaloyl linker connected to Bisphenol A can have any 
effect on stereoselectivity of glycosylation we obtained conjugate 3.26 equipped with a 
TBDMS-protected Bisphenol A phthaloyl protecting group at C-6.  Couplings of conju-
gate 3.26 with glycosyl acceptors 3.2720 and 3.2821 were practically non-stereoselective, 
and the respective disaccharides 3.29 and 3.30 were obtained in average yields and poor 
stereoselectivities (Scheme 3.2). This result indicates that rigid Bisphenol A template by 
itself has no stereodirecting impact on templated glycosylations. 
Recently, Manabe, Ito and their co-workers proposed an endocyclic pathway as a reaction 
mechanism for the β- to α-anomerization observed in glycosides carrying cyclic protect-
ing groups.22 This anomerization pathway takes place due to the inner strain caused by 
the fused ring and requires the presence of a weak Lewis acid as the promoter. We were 
curious to investigate whether our tethered disaccharides can also undergo endocyclic 
cleavage/anomerization. In principle, that would also explain high α-stereoselectivity ob-
served in all templated reactions. For the purpose of investigating the post-
glycosylational isomerization we obtained a β-linked macrocyclic compound 3.31 
(Scheme 3.3) and examined its anomerization. These reactions were first attempted in the 
presence of boron trifluoride etherate (BF3-OEt2) as a Lewis acid.
22 No anomerization 
occurred over 3 days at room temperature; in fact, the starting material 3.31 could be re-
covered quantitatively. In addition, in order to mimic our actual glycosylation reaction 
conditions, we also investigated a MeOTf-mediated anomerization of compound 3.31. 
However, no anomerization took place under these reaction conditions, ruling out this 

possible explanation for the excellent α-stereoselectivity achieved in templated glycosyla-
tions. 
Scheme 3.3 Investigation of a possibility of the endocyclic cleavage leading to 
anomerization 
 
Upon seeing the effects of linker rigidity on the selectivity of glycosylation we turned 
towards modifying the template rigidity.  Two template molecules, Bisphenol P and an-
thraquinone, were chosen.  In the case of anthraquinone, the placement of the hydroxyls 
on anthraquinone seems ideal, both acceptor and donor are facing each other and they 
should be in close proximity with each other.  The reduced selectivities may be due to the 
decreased angle between the di-hydroxyls.  The narrower template structure may have a 
harder time to bring the bulky benzylated sugars together in the right conformation in or-
der to obtain the desired conformer.  In the case of Bisphenol P, the extra aromatic func-
tionality adds flexibility and increases the distance between donor and acceptor.  Also, the 
favored conformation of bisphenol P is the placement of the two hydroxyls opposite of 
each other.  While the increased flexibility does reduce stereo-selectivity, it is not as dra-
matic as in the case of anthraquinone.  It seems that our initial results with BPA are still 
the best, it gives the reacting sugars enough room and also directs the sugars in the same 
side of the template.   

Scheme 3.4 Investigation of other related templates. 
 
3.3 Conclusions 
Overall, based on the results of the mechanistic studies described herein, it is easy to see 
why peptide linkers showed reduced selectivity.  The rigidity and conformation of the 
template plays a very important role on the stereoselective outcome of the reaction.  It 
seems that the rigid Bisphenol A template and phthaloyl linkers fit both the criteria of ri-
gidity and spatial conformational studies in this chapter that permit highly stereoselective 
glycoside bond formation. Efficient intramolecular glycosylation with glycosyl donors 
equipped with a non-participating benzyl group at C-2 led to the exclusive formation α-
linked disaccharides. Complete α-selectivity was obtained even with primary glycosyl 
acceptors that gave lowers stereoselectivity in our previous studies with flexible linkers. 
Extended studies revealed that it indeed is the tethering that offers the stereodirecting ef-
fect in α-glycosylations rather than steric bulkiness of C-6 substituents. We also demon-
strated that β-linked glycosides can be efficiently formed with the aid of a participatory 
effect of the neighboring ester group.   

3.4 Experimental 
3.4.1 General Remarks 
The reactions were performed using commercial reagents (Aldrich and Acros) and sol-
vents used for reactions purified in accordance with standard procedures.  Column chro-
matography was performed on silica gel 60 (EM Science, 70-230 mesh), reactions were 
monitored by TLC on Kieselgel 60 F254 (EM Science). The compounds were detected by 
examination under UV light and by charring with 10% sulfuric acid in methanol. Sol-
vents were removed under reduced pressure at <40 
o
C. Methylene chloride and 1,2-
dichloromethane (DCE) were distilled from CaH2 directly prior to application. Molecular 
sieves (3 Å), used for reactions, were crushed and activated in vacuo at 390 °C for 8 h in 
the first instance and then for 2-3 h at 390 °C directly prior to application. Optical rota-
tions were measured at ‘Jasco P-1020’ polarimeter. 1H NMR spectra were recorded at 
300, 500 or 600 MHz, 
13
C NMR spectra were recorded at 75, 125 or 150 MHz. The 
1
H 
NMR chemical shifts are referenced to the signal of the residual CHCl3 (δH = 7.27 ppm) 
for solutions in CDCl3. The 
13
C NMR chemical shifts are referenced to the central signal 
of CDCl3 (δC = 77.23 ppm) for solutions in CDCl3. HRMS determinations were made 
with the use of JEOL MStation (JMS-700) Mass Spectrometer.  
 
3.4.2 Procedures for linker introduction 
3.4.2-1 Introduction of the Succinoyl Linker: Preparation of Building Blocks 3.34, 
3.36, 3.38 and 3.40. 
Typical succinoyl linker introduction. Succinic anhydride (402 mg, 4.02 mmol) was 
added to a solution of a partially protected derivative (1.34 mmol) in dry pyridine (5.0 

mL) and the resulting mixture was stirred under argon for 16 h at rt. After that, the reac-
tion mixture was concentrated under reduced pressure. The residue was dissolved in di-
chloromethane (~100 mL) and washed with water (3 x 20 mL). The organic phase was 
separated, dried over MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford 
the respective succinoylated compounds. 
 
Ethyl 2,3,4-tri-O-benzyl-6-O-(3-hydroxycarbonylpropanoyl)-1-thio-β-D-
glucopyranoside (3.35). The title compound was obtained from ethyl 2,3,4-tri-O-benzyl-
1-thio-β-D-glucopyranoside (3.34)23 as described previously7 and its analytical data for 
were the same as reported previously.
24
 
 
Methyl 2,3-di-O-benzyl-6-O-(3-hydroxycarbonylpropanoyl)-α-D-glucopyranoside 
(3.37).  The title compound was obtained from methyl 2,3-di-O-benzyl-α-D-

glucopyranoside (3.36)
25
 as described previously
7
 and its analytical data for were the 
same as reported previously.
26
 
 
Methyl 2,4-di-O-benzyl-6-O-(3-hydroxycarbonylpropanoyl)-α-D-glucopyranoside 
(3.39).  Succinic anhydride (402 mg, 4.02 mmol) was added to a solution of methyl 2,4-
di-O-benzyl-α-D-glucopyranoside (3.38,20 500 mg, 1.14 mmol) in dry pyridine (5.0 mL) 
and the resulting mixture was stirred under argon for 16 h at rt. After that, the reaction 
mixture was concentrated under reduced pressure. The residue was dissolved in di-
chloromethane (~100 mL) and washed with water (3 x 20 mL). The organic phase was 
separated, dried over MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford 
compound 3.39 in 84% yield (585 mg, 1.24 mmol) as a colorless syrup. Analytical data 
for 3.39 were the same as reported previously.
26
 
 
Methyl 2,3-di-O-benzyl-4-O-(3-hydroxycarbonylpropanoyl)-6-O-triphenylmethyl-α-
D-glucopyranoside (3.41).  Succinic anhydride (350 mg, 3.50 mmol) was added to a so-
lution of methyl 2,3-di-O-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside (3.40,27 539 
mg, 0.88 mmol) in dry pyridine (3.0 mL) and the resulting mixture was stirred under ar-
gon for 16 h at rt. After that, the reaction mixture was concentrated under reduced pres-
sure. The residue was dissolved in dichloromethane (~100 mL) and washed with water (3 
x 20 mL). The organic phase was separated, dried over MgSO4, and concentrated in vac-
uo. The residue was purified by column chromatography on silica gel (ethyl acetate - 
hexane gradient elution) to afford compound 3.41 in 60% yield (375 mg, 0.52 mmol) as a 

white amorphous solid. Analytical data for 3.41: Rf = 0.40 (ethyl acetate/toluene, 2/3, 
v/v); []D
25
 +6.5 (c = 1, CHCl3); 
1H NMR: δ, 2.04-2.13, 2.20-2.36 (2m, 6H, 
CH2CH2COOH), 3.04 (dd, 1H, J5,6a = 2.0 Hz, J6a,6b = 10.1 Hz, H-6a), 3.10 (dd, 1H, J5,6b = 
6.0 Hz, H-6b), 3.47 (s, 3H, OCH3), 3.60 (dd, 1H, J2,3 = 9.5 Hz, H-2), 3.81 (m, 1H, H-5), 
3.90 (dd, 1H, J3,4 = 9.4 Hz, H-3), 4.73 (dd, 2H, 
2
J = 11.3 Hz, CH2Ph), 4.62-4.76 (m, 3H, 
J1,2 = 3.5 Hz, H-1, CH2Ph), 4.95 (dd, 1H, J4,5 = 9.6 Hz, H-4), 7.14-7.42 (m, 25H, aro-
matic), 8.53 (d, 1H, J = 4.4 Hz, COOH) ppm; 
13C NMR (75 MHz): δ, 28.8, 28.9, 55.2, 
62.6, 69.1, 70.8, 73.5, 75.4, 79.4, 79.8, 86.6, 98.0, 124.3, 127.0 (x 2), 127.7, 127.8 (x 5), 
128.0, 128.1 (x 4), 128.4 (x 2), 128.5 (x 3), 128.8 (x 5), 137.6, 138.1, 138.5, 143.7 (x 2), 
147.9, 170.8, 176.3 ppm; HR-FAB MS [M+Na]
+
 calcd for C44H44NaO9 739.2883, found 
739.2882. 
 
3.4.2-2 Introduction of the Glutaryl Linker: Preparation of Building Blocks 3.42-3.45 
Typical glutaryl linker introduction. Glutaric anhydride (459 mg, 4.02 mmol) was added 
to a solution of a partially protected derivative (1.34 mmol) in dry pyridine (5.0 mL) and 
the resulting mixture was stirring under argon for 16 h at rt. After that, the reaction mix-
ture was concentrated under reduced pressure. The residue was dissolved in dichloro-
methane (~100 mL) and washed with water (3 x 20 mL). The organic phase was separat-
ed, dried over MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate – hexane gradient elution) to afford the re-
spective glutarated compounds. 
. 

 
Ethyl 2,3,4-tri-O-benzyl-6-O-(4-hydroxycarbonylbutanoyl)-1-thio-β-D-
glucopyranoside (3.42).  The title compound was obtained from 3.34 as described previ-
ously
7
 and its analytical data for were the same as reported previously.
7
  
 
Methyl 2,3-di-O-benzyl-6-O-(4-hydroxycarbonylbutanoyl)-α-D-glucopyranoside 
(3.43).  The title compound was obtained from 3.36 as described previously
7
 and its ana-
lytical data for were the same as reported previously.
7
  
 
Methyl 2,4-di-O-benzyl-6-O-(4-hydroxycarbonylbutanoyl)-α-D-glucopyranoside 
(3.44).  The title compound was obtained from 3.38 as described previously
7
 and its ana-
lytical data for were the same as reported previously.
7
  
 

Methyl 2,3-di-O-benzyl-4-O-(4-hydroxycarbonylbutanoyl)-6-O-triphenylmethyl-α-
D-glucopyranoside (3.45).  The title compound was obtained from 3.40 as described 
previously
7
 and its analytical data for were the same as reported previously.
7
  
 
3.4.2-3 Introduction of the phthaloyl linker Preparation of Building Blocks 3.46-3.49 
and 3.51.   
Typical phthaloyl linker introduction. 4-N,N-Dimethylaminopyridine (DMAP, 82 mg, 
0.67 mmol) and phthalic anhydride (794 mg, 5.36 mmol) were added to a solution of a 
partially protected derivative (1.34 mmol) in dry pyridine (5.0 mL) and the resulting mix-
ture was stirred under argon for 24 h at 50 
o
C. After that, the volatiles were removed un-
der reduced pressure, the residue was dissolved in dichloromethane (~100 mL) and 
washed with water (3 x 20 mL). The organic phase was separated, dried over MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate/hexane, 1/1, v/v) to afford respective compounds.  
 

Ethyl 2,3,4-tri-O-benzyl-6-O-(2-hydroxycarbonylbenzoyl)-1-thio-β-D-
glucopyranoside (3.46).  The title compound was obtained from 3.34 as described previ-
ously
7
 and its analytical data for were the same as reported previously.
7
  
 
Methyl 2,3-di-O-benzyl-6-O-(2-hydroxycarbonylbenzoyl)-α-D-glucopyranoside 
(3.47). The title compound was obtained from 3.36 as described previously
7
 and its ana-
lytical data for were the same as reported previously.
7
  
 
Methyl 2,4-di-O-benzyl-6-O-(2-hydroxycarbonylbenzoyl)-α-D-glucopyranoside 
(3.48).  The title compound was obtained from 3.38 as described previously
7
 and its ana-
lytical data for were the same as reported previously.
7
  
 
Methyl 2,3-di-O-benzyl-4-O-(2-hydroxycarbonylbenzoyl)-6-O-triphenylmethyl-α-D-
glucopyranoside (3.49).  The title compound was obtained from 3.40 as described previ-
ously
7
 and its analytical data for were the same as reported previously.
7
  
 
Ethyl 2,3,4-tri-O-benzoyl-6-O-(2-hydroxycarbonylbenzoyl)-1-thio-β-D-
glucopyranoside (3.51).  The title compound was obtained from 3.50
28
 as described pre-
viously
7
 and its analytical data for were the same as reported previously.
7
 
 

3.4.3 General procedure for coupling reactions 
3.4.3-1 Coupling of linker to 4,4’-Bisphenol A. Preparation of Building Blocks 3.52-
3.59. 
A solution of N,N’-dicyclohexylcarbodiimide (DCC, 0.27 mmol) in dry dichloromethane 
(1.0 mL) was added dropwise to a solution of a linker-containing sugar derivative (0.11 
mmol) and 2,2-bis(4-hydroxyphenyl)propane (BPA, 0.22 mmol) in dry dichloromethane 
(1.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. After that, the 
reaction mixture was diluted with dichloromethane (~30 mL) and washed with water (3 x 
10 mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate/toluene, 
1/1, v/v) to afford the respected BPA-containing compounds. 
 

Methyl 2,3-di-O-benzyl-6-O-(α,α,α-p-hydroxyphenyldimethyltolyl succinate)-α-D-
glucopyranoside (3.52).  The title compound was obtained from 3.37 as described previ-
ously
7
 and its analytical data for were the same as reported previously.
7
 
 
Methyl 2,4-di-O-benzyl-6-O-(α,α,α-p-hydroxyphenyldimethyltolyl succinate)-α-D-
glucopyranoside (3.53).  A solution of N,N’-dicyclohexylcarbodiimide (DCC, 108 mg, 
0.522 mmol) in dry dichloromethane (1.0 mL) was added dropwise (over 5 min) to a so-
lution of 3.39 (124 mg, 0.261 mmol) and 2,2-bis(4-hydroxyphenyl)propane (BPA, 90 mg, 
0.392 mmol) in dry dichloromethane (3.0 mL) at 0 
o
C. The resulting mixture was allowed 
to warm to rt over 2 h. After that, the reaction mixture was diluted with dichloromethane 
(~30 mL) and washed with water (3 x 10 mL). The organic phase was separated, dried 
over MgSO4, and concentrated in vacuo. The residue was purified by column chromatog-
raphy on silica gel (ethyl acetate/toluene, 1/1, v/v) to afford the title compound in 74% 
yield (58.7 mg, 0.086 mmol) as a colorless syrup. Analytical data for 3.53: Rf = 0.53 
(ethyl acetate/toluene, 2/3, v/v); []D
24
 +20.0 (c = 0.8, CHCl3); 
1H NMR: δ, 1.53 (s, 6H, 
C(CH3)2), 2.60-2.67, 2.73-2.80 (2m, 4H, COCH2CH2CO), 3.22 (s, 3H, OCH3), 3.29 (dd, 
1H, J2,3 = 9.6 Hz, H-2), 3.33 (dd, 1H, J4,5 = 9.7 Hz, H-4), 3.71 (m, 1H, H-5), 4.02 (dd, 
1H, J3,4 = 9.1 Hz, H-3), 4.25 (m, 2H, H-6a, 6b), 4.51 (d, 1H, J1,2 = 3.5 Hz, H-1), 4.58 (m, 
2H, CH2Ph), 4.68 (dd, 2H, 
2
J = 11.2 Hz, CH2Ph), 6.64-7.28 (m, 18H, aromatic) ppm; 
13
C 
NMR (75 MHz): δ, 25.0, 25.7, 29.2, 29.5, 29.6, 29.9, 31.2, 33.9, 42.3, 49.6, 55.4, 63.7, 
68.4, 73.3, 73.8, 74.7, 79.8, 97.5, 115.0, 120.9, 121.0, 127.9, 128.0 (x2), 128.1, 128.3 
(x3), 128.4 (x2), 128.6, 128.8, 138.3, 142.7, 148.2, 148.5, 148.7, 153.7, 171.1, 172.0 
ppm; HR-FAB MS [M+Na]
+
 calcd for C40H44NaO10 707.2832, found 707.2838. 

 
Methyl 2,3-di-O-benzyl-4-O-(α,α,α-p-hydroxyphenyldimethyltolyl succinate)-6-O-
triphenylmethyl-α-D-glucopyranoside (3.54). A solution of N,N’-
dicyclohexylcarbodiimide (DCC, 230 mg, 1.12 mmol) in dry dichloromethane (3.0 mL) 
was added dropwise (over 5 min) to a solution of 3.41 (400 mg, 0.558 mmol) and 2,2-
bis(4-hydroxyphenyl)propane (BPA, 230 mg, 0.837 mmol) in dry dichloromethane (6.0 
mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. After that, the re-
action mixture was diluted with dichloromethane (~30 mL) and washed with water (3 x 
10 mL). The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate/toluene, 
1/1, v/v) to afford the title compound in 59% yield (307 mg, 0.33 mmol) as a colorless 
syrup. Analytical data for 3.54: Rf = 0.65 (ethyl acetate/toluene, 1/4, v/v); []D
24
 +6.7 (c 
= 1, CHCl3); 
1H NMR: δ, 1.65 (s, 6H, C(CH3)2), 2.18-2.36, 2.45-2.50 (2m, 4H, 
COCH2CH2CO), 3.08 (m, 2H, H-6a, 6b), 3.49 (s, 3H, OCH3), 3.61 (dd, 1H, J2,3 = 9.6 Hz, 
H-2), 3.82 (m, 1H, H-5), 3.89 (dd, 1H, J3,4 = 9.5 Hz, H-3), 4.68 (d, 1H, J1,2 = 3.6 Hz, H-
1), 4.73 (dd, 2H, 
2
J = 11.5 Hz, CH2Ph), 4.75 (dd, 2H, 
2
J = 12.1 Hz, CH2Ph), 4.95 (dd, 1H, 
J4,5 = 9.5 Hz, H-4), 6.73-7.42 (m, 33H, aromatic) ppm; 
13C NMR (75 MHz): δ, 29.1, 
29.3, 31.2 (x2), 42.3, 55.4, 62.8, 69.2, 71.0, 73.7, 75.6, 79.6, 80.0, 86.7, 98.2, 115.0 (x3), 
120.9 (x3), 127.2 (x3), 127.8, 127.9 (x5), 128.2 (x3), 128.3 (x3), 128.4, 128.5 (x3), 128.7 
(x3), 128.9 (x4), 129.2, 138.2, 138.7, 142.9, 143.9 (x3), 148.5, 148.7, 153.6, 170.7, 170.8 
ppm; HR-FAB MS [M+Na]
+
 calcd for C59H58NaO10 949.3928, found 949.3929.  

Methyl 2,3-di-O-benzyl-6-O-(α,α,α-p-hydroxyphenyldimethyltolyl glutarate)-α-D-
glucopyranoside (3.55).  The title compound was obtained from 3.43 as described previ-
ously
7
 and its analytical data for were the same as reported previously.
7
 
 
Methyl 2,4-di-O-benzyl-6-O-(α,α,α-p-hydroxyphenyldimethyltolyl glutarate)-α-D-
glucopyranoside (3.56).  The title compound was obtained from 3.44 as described previ-
ously
7
 and its analytical data for were the same as reported previously.
7
 
 
Methyl 2,3-di-O-benzyl-4-O-(α,α,α-p-hydroxyphenyldimethyltolyl glutarate)-6-O-
triphenylmethyl-α-D-glucopyranoside (3.57).  The title compound was obtained from 
3.45 as described previously
7
 and its analytical data for were the same as reported previ-
ously.
7
 
 
Methyl 2,3-di-O-benzyl-6-O-(α,α,α-(4-hydroxyphenyl)dimethyltolyl phthalate)-α-D-
glucopyranoside (3.58).  The title compound was obtained from 3.47 as described previ-
ously
7
 and its analytical data for were the same as reported previously.
7
 
 
Methyl 2,4-di-O-benzyl-6-O-(α,α,α-(4-hydroxyphenyl)dimethyltolyl phthalate)-α-D-
glucopyranoside (3.59).  The title compound was obtained from 3.48 as described previ-
ously
7
 and its analytical data for were the same as reported previously.
7
 
 
Methyl 2,3-di-O-benzyl-4-O-(α,α,α-(4-hydroxyphenyl)dimethyltolyl phthalate)-6-O-
triphenylmethyl-α-D-glucopyranoside (3.60). The title compound was obtained from 

3.49 as described previously
7
 and its analytical data for were the same as reported previ-
ously.
7
 
 
2.4.3-2 Synthesis of tethered donor-acceptor pairs. 3.1-3.3, 3.7-3.12, 3.16, 3.19-3.21 
Typical linker sugar conjugation. A solution of N,N’-dicyclohexylcarbodiimide (0.22 
mmol) and 4-dimethylaminopyridine (0.033 mmol) in dry dichloromethane (1.0 mL) was 
added dropwise to a stirring solution of a BPA-containing conjugate (0.11 mmol) and a 
linker-containing counterpart (0.13 mmol) in dry dichloromethane (2.0 mL) at 0oC. The 
resulting mixture was allowed to warm to rt over 2 h. After that, the reaction mixture was 
diluted with dichloromethane (~30 mL) and washed with water (3 x 10 mL). The organic 
phase was separated, dried over MgSO4, and concentrated in vacuo. The residue was pu-
rified by column chromatography on silica gel (ethyl acetate - toluene gradient elution) to 
afford the respective tethered compounds. To yield tethered 6-OH compounds 3.3, 3.9, 
3.12 and 3.20, the respective crude mixtures were dissolved in dichloromethane (2.0 mL), 
10% soln. of trifluoroacetic acid in wet dichloromethane (1.5 mL) was added dropwise 
and the resulting mixture was stirred for 1 h at rt. After that, the reaction mixture was di-
luted with dichloromethane (~30 mL), washed with water (~10 mL), sat. aq. NaHCO3 (2 
x 10 mL) and water (~10 mL). Organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to afford tethered compound 3.3, 3.9, 3.12 or 
3.20. 
 

Tethered compound 3.1.  The title compound was obtained from 3.33 and 3.55 as de-
scribed previously
7
 and its analytical data were the same as reported previously.
7
 
 
Tethered compound 3.2.  The title compound was obtained from 3.33 and 3.54 as de-
scribed previously
7
 and its analytical data were the same as reported previously.
7
 
 
Tethered compound 3.3.  The title compound was obtained from 3.33 and 3.56 as de-
scribed previously
7
 and its analytical data were the same as reported previously.
7
 
 
Tethered compound 3.7.  A solution of DCC (29 mg, 0.14 mmol) and DMAP (2.6 mg, 
0.021 mmol) in dry dichloromethane (1.0 mL) was added dropwise (5 min) to a stirring 
solution of 3.52 (48 mg, 0.071 mmol) and 3.34 (50 mg, 0.085 mmol) in dry dichloro-
methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - toluene gradient elution) to afford tethered compound 3.7 in 76% yield 
(67 mg, 0.054 mmol) as a colorless syrup. Analytical data for 3.7: Rf = 0.53 (ethyl ace-
tate/hexane, 1/1, v/v); []D
24
 +5.6
o
 (c = 1, CHCl3); 
1H NMR: δ, 1.26 (t, 3H, J = 7.4 Hz, 
SCH2CH3), 1.58 (s, 6H, C(CH3)2), 2.63-2.71 (m, 6H, SCH2CH3, COCH2CH2CO), 2.76-
2.82 (m, 4H, COCH2CH2CO), 3.26 (s, 3H, OCH3), 3.28-3.42 (m, 3H, H-2, 2’, 4), 3.42-
3.52 (m, 2H, H-4’, 5’), 3.65 (dd, 1H, J3’,4’ = 8.7 Hz, H-3’), 3.74 (m, 1H, H-5), 4.04 (dd, 
1H, J3,4 = 9.2 Hz, H-3), 4.17-4.35 (m, 4H, H-6a, 6b, 6a’, 6b’), 4.42 (d, 1H, J1’,2’ = 9.8 Hz, 

H-1’), 4.50-4.62 (m, 5H, H-1, 2 x CH2Ph), 4.66-4.92 (m, 6H, 3 x CH2Ph), 6.91-7.34 (m, 
33H, aromatic) ppm; 
13C NMR (75 MHz): δ, 15.3, 25.4, 29.2, 29.4 (x2), 31.1 (x2), 42.7 
(x2), 55.4 (x2), 63.7, 63.9, 68.4, 73.3, 73.8, 74.7, 75.3, 75.7, 76.0, 77.1, 77.8, 79.8, 81.9, 
85.4, 86.8, 97.6, 121.0 (x4), 127.9 (x5), 128.0 (x6), 128.1 (x2), 128.3 (x4), 128.4 (x3), 
128.5 (x2), 128.6 (x5), 128.7 (x2), 128.8 (x2), 137.9, 138.1, 138.3, 138.5, 148.1 (x2), 
148.7, 171.0 (x2), 172.0 (x2) ppm; HR-FAB MS [M+Na]
+
 calcd for C73H80NaO11S 
1283.5014, found 1283.5012. 
 
Tethered compound 3.8.  The title compound was obtained from 3.34 and 3.51 as de-
scribed previously
7
 and its analytical data were the same as reported previously.
7
 
 
Tethered compound 3.9.  A solution of DCC (35 mg, 0.17 mmol) and DMAP (3 mg, 
0.026 mmol) in dry dichloromethane (2.0 mL) was added dropwise (5 min) to a stirring 
solution of 3.34 (61 mg, 0.103 mmol) and 3.53 (68 mg, 0.074 mmol) in dry dichloro-
methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The crude mixture was dissolved in dichloromethane (2.0 mL), 10% 
soln. of trifluoroacetic acid in wet dichloromethane (1.5 mL) was added dropwise (1 min) 
and the resulting mixture was stirred for 1 h at rt. After that, the reaction mixture was di-
luted with dichloromethane (~30 mL), washed with water (~10 mL), sat. aq. NaHCO3 (2 
x 10 mL) and water (~10 mL). Organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 

(ethyl acetate - hexane gradient elution) to afford tethered compound 3.9 in 69% yield 
(65 mg, 0.051 mmol, over 2 steps) as a colorless syrup. Analytical data for 3.9: Rf = 0.33 
(ethyl acetate/toluene, 3/7, v/v); []D
24
 +3.8
o
 (c = 0.2, CHCl3); 
1H NMR: δ, 1.30 (t, 3H, J 
= 7.4 Hz, SCH2CH3), 1.64 (s, 6H, C(CH3)2), 2.66-2.78 (m, 6H, SCH2CH3, 
COCH2CH2CO), 2.78-2.90 (m, 4H, COCH2CH2CO), 3.37 (s, 3H, OCH3), 3.43 (dd, 1H, 
J2’,3’ = 9.5 Hz, H-2’), 3.47-3.62 (m, 6H, H-2, 4’, 5, 5’, 6a’, 6b’), 3.67 (dd, 1H, J3’,4’ = 8.7 
Hz, H-3’), 4.00 (dd, 1H, J3,4 = 9.4 Hz, H-3), 4.25 (dd, 1H, J5,6a = 4.6 Hz, J6a,6b = 11.9 Hz, 
H-6a), 4.38 (dd, 1H, H-6b), 4.47 (d, 1H, J1’,2’ = 9.8 Hz, H-1’), 4.55-4.74 (m, 5H, H-1, 2 x 
CH2Ph), 4.77-4.96 (m, 7H, H-4, 3 x CH2Ph), 6.95-7.35 (m, 33H, aromatic) ppm; 
13
C 
NMR(75 MHz): δ, 15.3, 25.4, 29.1, 29.2, 29.4, 31.1, 42.7, 55.6, 61.2, 63.9, 71.2, 73.7, 
75.3, 75.6, 75.7, 76.0, 77.1, 77.4, 77.7, 79.1, 79.7, 81.9, 85.4, 86.8, 98.5, 121.0 (x2), 
121.1 (x2), 127.8, 127.9 (x3), 128.0 (x6), 128.1, 128.2 (x2), 128.3 (x2), 128.4 (x2), 128.5 
(x2), 128.6 (x4), 128.7 (x7), 137.8, 138.1, 138.5, 138.9, 148.0, 148.2, 148.6, 148.7, 171.0 
(x2), 172.0, 172.7 ppm; HR-FAB MS [M+Na]
+
 calcd for C73H80NaO11S 1283.5014, 
found 1283.5010. 
 
Tethered compound 3.10.  A solution of DCC (55 mg, 0.27 mmol) and DMAP (4.9 mg, 
0.004 mmol) in dry dichloromethane (2.0 mL) was added dropwise (5 min) to a stirring 
solution of 3.52 (108 mg, 0.132 mmol) and 3.41 (78 mg, 0.075 mmol) in dry dichloro-
methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 

(ethyl acetate - toluene gradient elution) to afford tethered compound 3.10 in 80% yield 
(170.1 mg, 0.171 mmol) as a colorless syrup. Analytical data for 3.10:  Rf = 0.55 (ethyl 
acetate/toluene, 3/7, v/v); []D
24
 +29.2
o
 (c = 2, CHCl3); 
1H NMR: δ, 1.26 (t, 3H, J = 7.4 
Hz, SCH2CH3), 1.58 (s, 6H, C(CH3)2), 1.99 (m, 2H, COCH2CH2CH2CO), 2.39, 2.57 
(2dd, 4H, COCH2CH2CH2CO), 2.65-2.82 (m, 6H, SCH2CH3, COCH2CH2CO), 3.26 (s, 
3H, OCH3), 3.27-3.32 (m, 2H, H-2, 4), 3.35 (dd, 1H, J2’,3’ = 10.1 Hz, H-2’), 3.52-3.56 (m, 
2H, H-4’, 5’), 3.72 (dd, 1H, J3’,4’ = 8.5 Hz, H-3’), 3.80 (m, 1H, H-5), 4.04 (dd, 1H, J3,4 = 
9.3 Hz, H-3), 4.13 (dd, 1H, J5’,6a’ = 4.5 Hz, J6a’,6b’ = 12.0 Hz, H-6a’), 4.22-4.38 (m, 3H, 
H-6a, 6b, 6b’), 4.42 (d, 1H, J1’,2’ = 9.8 Hz, H-1’), 4.51-4.65 (m, 5H, H-1, 2 x CH2Ph), 
4.68-4.88 (m, 6H, 3 x CH2Ph), 6.95-7.31 (m, 33H, aromatic) ppm; 
13
C NMR (75 MHz): 
δ, 15.4, 20.3, 25.2, 29.2, 29.5, 31.2, 33.3, 33.6, 42.7 (x2), 55.5, 63.6, 63.7, 68.5, 73.3, 
73.4, 74.8, 75.4, 75.8, 76.0, 77.2, 77.3, 77.9, 79.8, 82.0, 85.4, 86.9, 97.6, 121.2 (x3), 
128.0 (x3), 128.1 (x2), 128.2 (x2), 128.3 (x2), 128.4 (x3), 128.5 (x6), 128.6 (x2), 128.7 
(x3), 128.8 (x2), 128.9 (x5), 130.2 (x2), 137.9, 138.1, 138.4, 138.6, 148.1, 148.2, 148.8, 
171.1, 171.7, 172.1, 172.7 ppm; HR-FAB MS [M+Na]
+
 calcd for C74H82NaO11S 
1297.5170, found 1297.5175. 
 
Tethered compound 3.11.  The title compound was obtained from 3.34 and 3.51 as de-
scribed previously
7
 and its analytical data were the same as reported previously.
7
 
 
Tethered compound 3.12.  A solution of DCC (36 mg, 0.176 mmol) and DMAP (3.2 
mg, 0.026 mmol) in dry dichloromethane (5.0 mL) was added dropwise (5 min) to a stir-
ring solution of 3.41 (63.2mg, 0.11 mmol) and 3.53 (81 mg, 0.09 mmol) in dry dichloro-

methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The crude mixture was dissolved in dichloromethane (2.0 mL), 10% 
soln. of trifluoroacetic acid in wet dichloromethane (1.5 mL) was added dropwise (1 min) 
and the resulting mixture was stirred for 1 h at rt. After that, the reaction mixture was di-
luted with dichloromethane (~30 mL), washed with water (~10 mL), sat. aq. NaHCO3 (2 
x 10 mL) and water (~10 mL). Organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - hexane gradient elution) to afford tethered compound 3.12 in 66% yield 
(87.3 mg, 0.132 mmol, over 2 steps) as a colorless syrup. Analytical data for 3.12:  Rf = 
0.33 (ethyl acetate/toluene, 3/7, v/v); []D
24
 +11.2
o
 (c = 2, CHCl3); 
1
H-n.m.r: δ, 1.34 (t, 
3H, J = 7.4 Hz, SCH2CH3), 1.68 (s, 6H, C(CH3)2), 2.07 (m, 2H, COCH2CH2CH2CO), 
2.45-2.51 (m, 4H, COCH2CH2CH2CO), 2.63-2.68 (m, 4H, COCH2CH2CO), 2.68-2.80 
(m, 2H, SCH2CH3), 3.40 (s, 3H, OCH3), 3.47 (dd, 1H, J2’,3’ = 9.2 Hz, H-2’), 3.52-3.66 
(m, 6H, H-2, 4’, 5, 5’, 6a’, 6b’), 3.73 (dd, 1H, J3’,4’ = 8.7 Hz, H-3’), 4.03 (dd, 1H, J3,4 = 
9.5 Hz, H-3), 4.22 (dd, 1H, J5,6a = 4.5 Hz, J6a,6b = 11.9 Hz, H-6a), 4.44 (dd, 1H, H-6b), 
4.50 (d, 1H, J1’,2’ = 9.8 Hz, H-1’), 4.60-4.76 (m, 5H, H-1, 2 x CH2Ph), 4.77-5.00 (m, 7H, 
H-4, 3 x CH2Ph), 6.96-7.02 (m, 4H, aromatic), 7.21-7.41 (m, 29H, aromatic) ppm; 
13
C 
NMR(75 MHz): δ, 15.3, 20.2, 25.3, 29.0, 29.2, 31.1, 33.2, 33.4, 42.6, 55.6, 61.1, 63.5, 
69.6, 71.1, 73.7, 75.3, 75.6, 75.7, 75.9, 77.0, 77.4, 77.8, 79.0, 79.6, 81.8, 85.3, 86.7, 98.4, 
120.9 (x2), 121.1 (x2), 127.8, 127.9 (x3), 128.0 (x6), 128.1, 128.2 (x4), 128.4 (x2), 128.5 
(x4), 128.6 (x3), 128.7 (x4), 137.7, 138.0 (x2), 138.4, 138.8, 148.0, 148.1, 148.5, 148.6, 

171.0, 171.7, 172.7 (x2) ppm; HR-FAB MS [M+Na]
+
 calcd for C74H82NaO11S 
1297.5170, found 1297.5160. 
 
Tethered compound 3.16.  A solution of DCC (73 mg, 0.35 mmol) and DMAP (6.4 mg, 
0.021 mmol) in dry dichloromethane (1.0 mL) was added dropwise (5 min) to a stirring 
solution of 3.58 (130 mg, 0.177 mmol) and 3.45 (136 mg, 0.213 mmol) in dry dichloro-
methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - toluene gradient elution) to afford tethered compound 3.16 in 81% yield 
(183 mg, 0.136 mmol) as a colorless syrup. Analytical data for 3.16:  Rf = 0.63 (ethyl 
acetate/ toluene, 3/7, v/v); []D
25
 +35.0
o
 (c = 0.5, CHCl3); 
1H NMR: δ, 1.16 (t, 3H, J = 
7.4 Hz, SCH2CH3), 1.57 (s, 6H, C(CH3)2), 2.61 (m, 2H, SCH2CH3), 3.20 (s, 3H, OCH3), 
3.27 (dd, 1H, J2,3 = 9.6 Hz, H-2), 3.37 (m, 2H, J2’,3’= 8.5 Hz, J4,5 = 9.8 Hz, H-2’, 4), 3.46-
3.57 (m, 2H, H-4’, 5’), 3.63 (dd, 1H, J3’,4’= 8.3 Hz, H-3’), 3.79 (m, 1H, J5,6a = 3.0 Hz, H-
5), 4.02 (dd, 1H, J3,4 = 9.1 Hz, H-3), 4.33-4.57 (m, 10H, J1,2 = 3.4 Hz, H-1, 1’, 6a, 6b, 6a’, 
6b’, 2 x CH2Ph), 4.61-4.88 (m, 6H, 3 x CH2Ph), 7.06-7.79 (m, 41H, aromatic) ppm; 
13
C 
NMR (75 MHz): δ, 15.3, 25.1, 31.2, 42.7, 55.4, 64.5, 65.7, 68.4, 73.2, 73.8, 74.7, 75.3, 
75.7, 76.0, 77.0, 77.4, 77.9, 79.7, 81.8, 85.2, 86.7, 97.4, 121.1 (x4), 127.9 (x4), 128.0 
(x3), 128.1 (x5), 128.2 (x3), 128.3 (x5), 128.5 (x3), 128.6 (x6), 128.7 (x5), 128.8 (x2), 
129.3 (x2), 129.4, 131.5, 131.6, 131.7, 131.9, 132.1, 132.2, 137.7, 138.0 (x2), 138.1, 

148.2, 148.9, 166.4, 166.5, 166.8, 167.0 ppm;  HR-FAB MS [M+Na]
+
 calcd for 
C81H80NaO17S 1379.5013, found 1379.5010. 
 
Tethered compound 3.19.  The title compound was obtained from 3.45 and 3.57 as de-
scribed previously
7
 and its analytical data were the same as reported previously.
7
 
 
Tethered compound 3.20.  The title compound was obtained from 3.45 and 3.59 as de-
scribed previously
7
 and its analytical data were the same as reported previously.
7
 
 
Tethered compound 3.21.  The title compound was obtained from 3.49 and 3.58 as de-
scribed previously
7
 and its analytical data were the same as reported previously.
7
 
 
3.4.3. Glycosylation Reaction, Synthesis of Disaccharides 3.4-3.6 and 3.22. 
Typical NIS/TfOH-promoted glycosylation. A mixture of a donor-acceptor conjugate 
(0.032 mmol) and freshly activated molecular sieves (4 Å, 120 mg) in 1,2-dichloroethane 
(1.0 mL) was stirred under argon for 16 h at rt. The mixture was cooled to -78 oC, NIS 
(0.07 mmol) and TfOH (0.007 mmol) were added, and the resulting mixture was stirred 
at -78 oC until the disappearance of the starting material, as indicated by TLC. After that, 
the solid was filtered off through a pad of Celite and rinsed successively with dichloro-
methane. The combined filtrate (~30 mL) was washed with 20% aq. Na2S2O3 (~10 mL) 
and water (3 x 10 mL). The organic phase was separated, dried over MgSO4, concentrat-
ed in vacuo and dried. The residue was dissolved in dry methanol (1.0 mL), 1N soln. of 
NaOMe in MeOH (0.5 mL) was added and the resulting mixture was stirred for 2-16 h at 

rt. After that, the reaction mixture was neutralized with Dowex (H+), the resin was fil-
tered off and washed successively with MeOH. The combined filtrate was concentrated in 
vacuo. The residue was dissolved in pyridine (1.0 mL), acetic anhydride (0.2 mL) was 
added dropwise, and the resulting mixture was stirred for 16 h at rt. After that, the reac-
tion was quenched with methanol (~2.0 mL) and the volatiles were evaporated in vacuo. 
The residue was co-evaporated with toluene and the residue was purified by column 
chromatography on silica gel (ethyl acetate - hexane gradient elution) to afford the re-
spective disaccharide. 
 
Typical MeOTf promoted glycosylation.  A mixture of a donor-acceptor conjugate (0.020 
mmol) and freshly activated molecular sieves (3 Å, 100 mg) in 1,2-dichloroethane (0.5 
mL) was stirred under argon for 16 h at rt. The mixture was cooled to 0 oC, MeOTf (0.06 
mmol) was added, and the reaction mixture was stirred at 0 oC until the disappearance of 
the starting material, as indicated by TLC. After that, the solid was filtered off through a 
pad of Celite and rinsed successively with dichloromethane. The combined filtrate (~30 
mL) was washed with sat aq. NaHCO3 (~10 mL) and water (3 x 10 mL). The organic 
phase was separated, dried over MgSO4, concentrated in vacuo and dried. The residue 
was dissolved in dry methanol (1.0 mL), 1N soln. of NaOMe in MeOH (0.5 mL) was 
added and the resulting mixture was stirred for 2-16 h at rt. After that, the reaction mix-
ture was neutralized with Dowex (H+); the resin was filtered off and washed successively 
with MeOH. The combined filtrate was concentrated in vacuo. The residue was dissolved 
in pyridine (1.0 mL), acetic anhydride (0.2 mL) was added dropwise, and the resulting 
mixture was stirred for 16 h at rt. After that, the reaction was quenched with methanol 

(~2.0 mL) and the volatiles were evaporated in vacuo. The residue was co-evaporated 
with toluene and the residue was purified by column chromatography on silica gel (ethyl 
acetate - hexane gradient elution) to afford the respective disaccharide. 
 
Typical DMTST promoted glycosylation.  A mixture of a donor-acceptor conjugate 
(0.023 mmol) and freshly activated molecular sieves (3 Å, 90 mg) in 1,2-dichloroethane 
(0.5 mL) was stirred under argon for 16 h at rt. The mixture was cooled to -30 oC, 
DMTST (0.07 mmol) was added and the resulting mixture was stirred at -30 oC until the 
disappearance of the starting material, as indicated by TLC. After that, the solid was fil-
tered off through a pad of Celite and rinsed successively with dichloromethane. The 
combined filtrate (~30 mL) was washed with sat aq. NaHCO3 (~10 mL) and water (3 x 
10 mL). The organic phase was separated, dried over MgSO4, concentrated in vacuo and 
dried. The residue was dissolved in dry methanol (1.0 mL), 1N soln. of NaOMe in MeOH 
(0.5 mL) was added and the resulting mixture was stirred for 2-16 h at rt. After that, the 
reaction mixture was neutralized with Dowex (H+); the resin was filtered off and washed 
successively with MeOH. The combined filtrate was concentrated in vacuo. The residue 
was dissolved in pyridine (1.0 mL), acetic anhydride (0.2 mL) was added dropwise, and 
the resulting mixture was stirred for 16 h at rt. After that, the reaction was quenched with 
methanol (~2.0 mL) and the volatiles were evaporated in vacuo. The residue was co-
evaporated with toluene and the residue was purified by column chromatography on sili-
ca gel (ethyl acetate - hexane gradient elution) to afford the respective disaccharide.  
 

Methyl 3-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-6-O-acetyl-2,4-di-O-
benzyl-α-D-glucopyranoside (3.4).  The title compound was obtained from various pre-
cursors (see Tables 1-4) and its analytical data were the same as reported previously.
7
 
 
Methyl 4-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-6-O-acetyl-2,3-di-O-
benzyl-α-D-glucopyranoside (3.5).  The title compound was obtained from various pre-
cursors (see Tables 1-4) and its analytical data were the same as reported previously.
7
 
 
Methyl 6-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-4-O-acetyl-2,3-di-O-
benzyl-α-D-glucopyranoside (3.6).  The title compound was obtained from various pre-
cursors (see Tables 1-4) and its analytical data were the same as reported previously.
7
  
 
Methyl 6-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-6-O-acetyl-2,4-di-O-benzyl-
α-D-glucopyranoside (3.22). The title compound was obtained from precursor 3.21 and 
its analytical data were the same as reported previously.
7
  
 
3.4.4 Competition experiments 
A mixture of the tethered compound 3.1 or 3.16 (0.019 mmol), acceptor 3.13
15
 (0.016 
mmol), and freshly activated molecular sieves (3 Å, 100 mg) in 1,2-dichloroethane (0.5 
mL) was stirred under argon for 1 h at rt. The mixture was cooled to 0 
o
C, MeOTf (0.06 
mmol) was added and the resulting mixture was stirred for 18 h at 0 
o
C. After that, the 
solid was filtered off through a pad of Celite and washed successively with dichloro-
methane. The combined filtrate (~30 mL) was washed with sat. aq. NaHCO3 (~10 mL) 

and water (3 x 10 mL). The organic phase was separated, dried with MgSO4, and concen-
trated in vacuo. The residue was purified by column chromatography on silica gel (ethyl 
acetate/toluene, 1/5, v/v) to afford respective compounds. 
 
Methyl 2,4,6-tri-O-benzyl-α-D-glucopyranoside (3.13) was synthesized according to 
the reported procedure and its analytical data was essentially the same as reported previ-
ously.
29
 
 
Macrocyclic disaccharide 3.14 was obtained from compound 3.1 in 20% yield (α only) 
as a clear film. Analytical data for 3.14: Rf = 0.63 (ethyl acetate/toluene, 3/7, v/v); []D
24
 
+15.6
o
 (c = 1, CHCl3); 
1H NMR: δ, 1.59 (s, 6H, C(CH3)2), 2.60-2.88 (m, 8H, 2 x 
COCH2CH2CO), 3.27 (s, 3H, OCH3), 3.42-3.58 (m, 4H, H-2, 2’, 4’, 5’), 3.84-3.90 (m, 
2H, H-4, 5), 3.97 (dd, 1H, J3’,4’ = 9.3 Hz, H-3’), 4.22-4.36 (m, 4H, H-3, 6a, 6a’, 6b’), 
4.49-4.87 (m, 10H, H-1, 6b, 4 x CH2Ph), 4.88 (dd, 2H, 
2
J = 10.9 Hz, CH2Ph), 5.42 (d, 
1H, J1’,2’ = 3.6 Hz, H-1’), 6.84-7.34 (m, 33H, aromatic) ppm; 
13C NMR (75 MHz): δ, 
29.5, 29.6, 29.7, 29.7, 29.9, 31.0, 42.6 (x 2), 55.2, 68.5, 71.6, 73.2, 73.3, 74.9, 75.7, 77.3 
(x 2), 77.4 (x 2), 78.3, 79.6, 79.8, 82.3, 96.4, 97.3, 121.0 (x 2), 121.3 (x 2), 127.7 (x 5), 
128.0 (x 6), 128.1 (x 3), 128.2 (x 3), 128.4 (x 2), 128.5 (x 4), 128.6 (x 2), 128.7 (x 2), 
128.8 (x 2), 137.5, 137.8, 138.1, 138.6, 138.9, 148.0, 148.2, 148.6, 148.9, 170.8 (x 2), 
171.9, 172.0 ppm; HR-FAB MS [M+Na]
+
 calcd for C71H74NaO17 1221.4824, found 
1221.4866.  
 

Compound 3.15 was isolated as a colorless foam from the completion reaction between 
compound 3.1 and 3.13 in 52% yield (α:β = 3.0:1). Selected analytical data for α-3.15: Rf 
= 0.49 (ethyl acetate/toluene, 1/5, v/v); 
1H NMR: δ, 1.25 (s, 6H, 2 x CH3), 2.35-2.84 (m, 
8H, 2 x -CH2CH2-), 3.29-3.31 (m, 6H, 2 x OCH3), 3.32-3.44 (m, 4H, H-2, 2”, 4, 4”), 
3.47-3.81 (m, 5H, H-2’, 3’, 4’, 5’, 5”), 4.02- 4.12 (m, 4H, H-3, 3”, 5, 6a’), 4.20-4.48 (m, 
6H, H-6a, 6b, 3’, 6b’, 6a”, 6b”), 4.51-4.74 (m, 13H, H-1’, 1”, 5½ CH2Ph), 4.81-4.93 (m, 
5H, 2½ CH2Ph), 5.54 (d, 1H, J1,2 = 3.4 Hz, H-1), 6.92-7.36 (m, 48H, aromatic) ppm;  
13
C 
NMR (150 MHz): δ, 31.6, 31.8, 33.6, 45.1, 57.7, 57.9, 66.0, 66.1, 70.8, 71.1, 71.4, 72.2, 
75.6, 75.8, 76.0, 76.2 (x 2), 76.3, 77.2, 77.5, 78.2, 78.9, 79.6, 80.5, 81.0, 81.2, 82.1, 82.2, 
84.9, 99.7, 100.0, 100.1, 123.4 (x 2), 123.5 (x 2), 129.3 (x 2), 129.9, 130.1, 130.2, 130.3 
(x 2), 130.4 (x 8), 130.5 (x 4), 130.6 (x 2), 130.7 (x 3), 130.8, 130.9 (x 4), 131.0 (x 8), 
131.1 (x 8), 131.2 (x 2), 131.4 (x 2), 140.3, 140.4, 140.5, 140.7, 140.9, 141.0, 141.2, 
150.4, 150.6, 151.1, 151.2, 173.5, 173.6, 174.5 ppm, HR-FAB MS [M+Na]
+
 calcd for 
C99H106NaO23 1662.7125, found 1685.7776.   
 
Macrocyclic disaccharide 3.17 was obtained as a clear film from compound 3.16 in 
52% yield (α-only). Analytical data for 3.17: Rf = 0.63 (ethyl acetate/toluene, 3/7, v/v); 
[]D
24
 +65.8
o
 (c = 1, CHCl3); 
1H NMR: δ, 1.62, 1.72 (2s, 6H, C(CH3)2), 3.31 (s, 3H, 
OCH3), 3.53 (dd, 1H, J2,3 = 9.1 Hz, H-2), 3.55-3.62 (m, 2H, H-2, 4), 3.68 (dd, 1H, J3’,4’ = 
9.7 Hz, H-4’), 4.02-4.14 (m, 3H, H-5, 3’, 6a), 4.28 (dd, 1H, H-3), 4.29 (dd, 1H, 2J = 10.7 
Hz, ½ CH2Ph), 4.42 (dd, 2H, 
2
J = 10.2 Hz, CH2Ph), 4.51 (m, 7H, H-5’,6a’, 6b’, CH2Ph), 
4.87-5.01 (m, 4H, H-6b, 1½ CH2Ph), 5.52 (d, 1H, J1,2 = 3.5, H-1), 7.05-8.00 (m, 41H, ar-
omatic) ppm; 
13C NMR (75 MHz): δ, 31.5, 31.6, 42.9, 55.4, 64.3, 65.6, 67.1, 28.6, 72.2, 

72.5, 73.2, 73.4, 75.2, 75.7, 77.4, 78.2, 79.7, 79.8,82.2, 96.3, 96.9, 120.5 (x2), 121.4 (x2), 
127.8 (x2), 127.9 (x4), 128.0 (x6), 128.3 (x3), 128.4 (x2), 128.5 (x3), 128. 6 (x4), 128.7 
(x2), 129.0, 129.2, 129.5, 129.9, 130.2, 131.1, 131.2, 131.5, 131.6, 131.9 (x2), 132.1, 
133.1, 137.2, 137.4, 137.9, 138.6, 138.8, 147.9, 148.3, 148.9, 149.0, 166.1, 166.3, 167.6, 
167.7 ppm; HR-FAB MS [M+Na]
+
 calcd for C71H74NaO17 1317.4824, found 1317.4828.  
 
Compound 3.18 was isolated as a colorless syrup from the completion reaction between 
3.16 and 3.13 in 30% yield (α/β = 1.6/1). Selected analytical data for α-3.18: Rf = 0.38 
(ethyl acetate/toluene, 1/5, v/v); 
1
H NMR (500 MHz): δ, 1.57 (s, 6H, C(CH3)2), 3.35 (s, 
3H, OCH3), 3.44 (dd, 1H, J2’,3’ = 9.8 Hz, H-2’), 3.50 (dd, 1H, H-4’), 3.80 (dd, 1H, H-3’), 
3.95 (m, 1H, H-5’), 5.58 (d, 1H, J1’,2’ = 3.5 Hz, H-1’) ppm; 
13C NMR (125 MHz): δ, 96.6, 
96.8, 97.3 ppm; HR-FAB MS [M+Na]
+
 calcd for C105H102NaO22 1737.6760, found 
1737.6740. 
 
3.4.5 Investigation of the effect of the steric bulkiness at C-6. 
Ethyl 2,3,4-tri-O-benzyl-6-O-(o-phenyloxycarbonyl)benzoyl-1-thio-β-D-
glucopyranoside (3.23). A solution of N,N’-dicyclohexylcarbodiimide (34 mg, 0.17 
mmol) in dry CH2Cl2 (1.0 mL) was added dropwise to a solution of 3.45 (64 mg, 0.10 
mmol) and phenol (7.8 mg, 0.083 mmol) in dry CH2Cl2 (1.0 mL) at 0 
o
C. The resulting 
mixture was stirred for 2 h, and during this time the temperature was allowed to gradually 
increase to rt. After that, the reaction mixture was diluted with CH2Cl2 (~30 mL) and 
washed with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 

(ethyl acetate/hexanes, 1/1, v/v) to afford the title compound in 68% yield (40 mg, 0.057 
mmol) as a white amorphous solid. Analytical data for 3.23: Rf = 0.87 (ethyl ace-
tate/toluene, 3/7, v/v); []D
29
 +8.6
o
 (c = 1, CHCl3); 
1H NMR: δ, 1.25 (t, 3H, J = 7.5 Hz, 
SCH2CH3), 2.73 (m, 2H, SCH2CH3), 3.44 (dd, 1H, J2,3 = 8.9 Hz, H-2), 3.54-3.62 (m, 2H, 
H-4, 5), 3.71 (dd, 1H, J3,4 = 8.6 Hz, H-3), 4.45 (dd, 1H, J6a,6b = 5.19), 4.47 (d, 1H, J1,2 = 
8.9, H-1), 4.56-4.93 (m, 7H, H-6b, 3 x CH2Ph), 7.21-7.90 (24H, aromatic); 
13
C NMR (75 
MHz): δ, 15.3, 25.2, 64.7, 75.3, 75.7, 76.0, 77.1, 77.9, 81.8, 85.2, 86.7, 121.7 (x 2), 
126.2, 128.0 (x 2), 128.1 (x 2), 128.3 (x 2), 128.5 (x 2), 128.6 (x 2), 128. 7 (x 5), 129.4 (x 
2), 129.7 (x 2), 131.6, 131.7, 131.8, 132.2, 137.7, 138.0, 138.4, 151.0, 166.9 ppm; HR-
FAB MS [M+Na]
+
 calcd for for C43H42O8SNa 741.2498, found 741.2499. 
 
Methyl 2,3-di-O-benzyl-6-O-(o-phenyloxycarbonyl)benzoyl-α-D-glucopyranoside 
(3.24). The title compound was prepared from 3.46 as described for the synthesis of 3.23 
in 83% as a colorless syrup. Analytical data for 3.24: Rf = 0.52 (ethyl acetate/hexane, 1/1, 
v/v); []D
29
 +48.1
o
 (c = 1, CHCl3); 
1H NMR: δ, 3.18 (s, 3H, OCH3), 3.23 (dd, 1H, J2,3 = 
9.5 Hz, H-2), 3.34 (dd, 1H, J3,4 = 8.8 Hz, J4,5 = 9.8 Hz, H-4), 3.36 (m, 1H, H-5), 3.99 (dd, 
1H, H-3), 4.44 (m, 3H, J1,2 = 3.5 Hz, H-1, 6a, 6b), 4.52 (m, 3H, 1½ CH2Ph), 4.76 (d, 1H, 
2
J = 11.1 Hz, ½ CH2Ph), 7.11-7.79 (m, 19H, aromatic) ppm; 
13C NMR (75 MHz): δ, 
55.3, 64.4, 68.3, 73.1, 73.7, 74.6, 77.3, 79.6, 97.3, 121.6 (x 2), 126.1, 127.9, 128.1 (x 2), 
128.2 (x 3), 128.5 (x 2), 128.7 (x 2), 129.2, 129.3, 129.5 (x 2), 131.5 (x 2), 131.8, 132.0, 
137.9, 138.1, 150.9, 166.2, 166.9 ppm; HR-FAB MS [M+Na]
+
 calcd for C35H34O9Na 
621.2101, found 621.2093. 
 

Methyl O-(2,3,4-tri-O-benzyl-6-O-(o-phenyloxycarbonyl)benzoyl-D-glucopyranosyl)-
(14)-2,3-di-O-benzyl-6-O-(o-phenyloxycarbonyl)benzoyl-α-D-glucopyranoside 
(3.25). A mixture of 3.23 (21.2 mg, 0.030 mmol), 24 (16.2 mg, 0.027 mmol) and freshly 
activated molecular sieves (3 Å, 120 mg) in 1,2-dichloroethane (10 mL) was stirred under 
argon for 16 h at rt.  The mixture was cooled to 0 
oC, MeOTf (10.1 μL, 0.09 mmol) was 
added and the resulting mixture was stirred under argon for 16 h at 0 
o
C. After that, the 
solid was filtered off through a pad of Celite and rinsed successively with dichlorole-
thane. The combined filtrate (~30 mL) was washed with sat. aq. NaHCO3 (10 mL) and 
water (3 x 10 mL). The organic phase was separated, dried with MgSO4, and concentrat-
ed in vacuo. The residue was purified by column chromatography on silica gel (ethyl ace-
tate - hexane gradient elution) to afford the title compound (28.4 mg, 84%, α/β = 2.5/1). 
Selected analytical data for α-3.25: Rf = 0.28 (ethyl acetate/ hexane, 3/7, v/v); 
1
H NMR: 
δ, 3.25 (s, 3H, OCH3), 3.40–3.60 (m, 5H, J2,3 = 9.2 Hz, H-2, 2’, 4, 4’, 5’), 3.93 (m, 1H, 
H-5), 4.04 (dd, 1H, H-3), 4.21-4.65 (m, 12H, H-1’, 3’, 6a, 6b, 6a’, 6b’, 3 x CH2Ph), 4.77-
4.98 (m, 4H, 2 x CH2Ph), 7.04-7.86 (m, 43H, aromatic) ppm; 
13C NMR (75 MHz): δ, 
30.0, 55.0, 68.1, 68.9, 73.4, 75.1, 75.7, 77.3, 78.1, 78.7, 78.9, 79.8, 82.3, 97.2, 97.3, 
126.0, 126.1, 127.2, 127.5, 127.6, 127.7, 128.9, 128.0, 128.1, 128.3 (x2), 128.4, 128.5 
(x2), 129.1, 129.2, 129.5, 131.4, 131.6, 131.8, 131.9, 132.0, 137.6, 137.3, 137.4, 138.2, 
138.5, 150.9, 166.2, 166.3, 166.4, 166.9 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C76H70NaO17 1277.4511, found 1277.4504. 
 
Ethyl 2,3,4-tri-O-benzyl-1-thio-6-O-(α,α,α-(4-t-butyldimethylsilyloxyphenyl) dime-
thyltolyl phthalate)-α-D-glucopyranoside (3.26). A solution of N,N’-

dicyclohexylcarbodiimide (154 mg, 0.74 mmol) and 4-dimethylaminopyridine (9.0 mg, 
0.074 mmol) in dry CH2Cl2 (8.0 mL) was added dropwise to a solution of 3.45 (200 mg, 
0.37 mmol) and α,α,α-(4-t-butyldimethylsilyloxyphenyl)dimethyl-p-cresol30 (383 mg, 
1.12 mmol) in dry CH2Cl2 (8.0 mL) at 0 
o
C. The resulting mixture was stirred for 2 h, and 
during this time the temperature was allowed to gradually increase to rt. After that, the 
reaction mixture was diluted with CH2Cl2 (~30 mL) and washed with water (3 x 10 mL). 
The organic phase was separated, dried over MgSO4, and concentrated in vacuo. The res-
idue was purified by column chromatography on silica gel (ethyl acetate/hexanes, 1/1, 
v/v) to afford the title compound in 72% yield (256 mg, 0.278 mmol) as a white amor-
phous solid. Analytical data for 3.26: Rf = 0.62 (ethyl acetate/hexane, 2/3, v/v); []D
22
 
+5.04
o
 (c = 1, CHCl3); 
1H NMR: δ, 0.00 (s, 6H, Si(CH3)2), 0.79 (s, 9H, SiC(CH3)3), 1.07 
(t, 3H, SCH2CH3), 1.39, 1.45 (2s, 6H, C(CH3)2), 2.53 (m, 2H, SCH2CH3), 3.26 (dd, 1H, 
J2,3 = 9.5 Hz, H-2), 3.35-3.45 (m, 2H, H-4, 5), 3.52 (dd, 1H, J3,4 = 8.5 Hz, H-3), 4.23-4.30 
(m, 2H, H-1, 6a), 4.42 (dd, 1H, J5,6b = 1.5 Hz, H-6b), 4.52 (dd, 2H, 
2
J = 10.8 Hz, CH2Ph), 
4.64 (dd, 2H, 
2
J = 10.2 Hz, CH2Ph), 4.71 (dd, 2H, 
2
J = 10.9 Hz, CH2Ph), 6.54-7.67 (m, 
27H, aromatic) ppm; 
13C NMR (75 MHz): δ, -4.33, 1.08, 15.1, 18.2, 25.0, 25.7 (x3), 31.0, 
31.1, 42.2, 64.6, 75.2, 75.6, 75.9, 76.9, 77.8, 81.7, 85.1, 86.6, 119.4, 120.8, 127.8 (x4), 
127.9 (x2), 128.0 (x2), 128.2 (x2), 128.4 (x2), 128.5 (x5), 129.2, 129.3, 131.4, 131.5, 
131.7, 132.1, 137.6, 137.9, 138.3, 143.0, 148.6, 148.8, 153.5, 166.4, 166.8 ppm; HR-FAB 
MS [M+Na]
+
 calcd for C58H66NaO9SSi 989.4095, found 989.4092. 
 

Methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.27) was synthesized according to 
the reported procedure and its analytical data was essentially the same as reported previ-
ously.
29
 
 
Methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside (3.28) was synthesized according to 
the reported procedure and its analytical data was essentially the same as reported previ-
ously.
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Methyl O-[2,3,4-tri-O-benzyl-6-O-(α,α,α-(4-t-butyldimethylsilyloxyphenyl) dimethyl-
tolyl phthalate)-D-glucopyranosyl]-(16)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
(3.29).  A mixture of 3.26 (35 mg, 0.036 mmol), and 3.27 (25 mg, 0.054 mmol) and 
freshly activated molecular sieves (3 Å, 100 mg) in 1,2-dichloroethane (1.0 mL) was 
stirred under argon for 16 h at rt. The mixture was cooled to 0 
o
C, MeOTf (17.9 mg, 
0.108 mmol) was added, and the reaction mixture was stirred at 0 
o
C until the disappear-
ance of the starting material, as indicated by TLC. After that, the solid was filtered off 
through a pad of Celite and rinsed successively with dichloromethane. The combined fil-
trate (~30 mL) was washed with sat aq. NaHCO3 (~10 mL) and water (3 x 10 mL). The 
organic phase was separated, dried over MgSO4, concentrated in vacuo and dried. The 
residue was dissolved in dry methanol (1.0 mL), 1N soln. of NaOMe in MeOH (0.5 mL) 
was added and the resulting mixture was stirred for 2-16 h at rt. After that, the reaction 
mixture was neutralized with Dowex (H
+
), the resin was filtered off and washed succes-
sively with MeOH. The combined filtrate was concentrated in vacuo. The residue was 
dissolved in pyridine (1.0 mL), acetic anhydride (0.2 mL) was added dropwise, and the 

resulting mixture was stirred for 16 h at rt. After that, the reaction was quenched with 
methanol (~2.0 mL) and the volatiles were evaporated in vacuo. The residue was co-
evaporated with toluene and the residue was purified by column chromatography on sili-
ca gel (ethyl acetate - hexane gradient elution) to afford the title compound in 57% yield 
(28 mg, 0.020 mmol, α/β = 1.7/1) as a white amorphous solid. Selected analytical data for 
α-3.29: Rf = 0.54 (ethyl acetate/hexane, 3/10, v/v); 
1H NMR: δ, 3.15 (s, 3H, OCH3), 3.20 
(dd, 1H, J2,3 = 9.6 Hz, H-2), 3.27-3.52 (m, 4H, H-2, 2’, 4, 4’), 3.71-3.83 (m, 2H, H-3, 3’), 
4.35 (d, 1H, J1,2 = 3.6 Hz, H-1), 4.72 (d, 1H, H-1’) ppm; 
13C NMR (75 MHz): δ, 96.9, 
97.9 ppm; HR-FAB MS [M+Na]
+
 calcd for C84H92NaO15Si 1391.6103, found 1391.6108. 
 
Methyl O-[2,3,4-tri-O-benzyl-6-O-(α,α,α-(4-t-butyldimethylsilyloxyphenyl) dimethyl-
tolyl phthalate)-D-glucopyranosyl]-(14)-2,3,6-tri-O-benzyl-α-D-glucopyranoside 
(3.30).  The title compound was prepared as described for the synthesis of 3.29 from 3.26 
(35 mg, 0.035 mmol) and 3.28 (25 mg, 0.072 mmol) in 61% yield (26.7 mg, 0.021 mmol) 
as a white amorphous solid. Selected analytical data for α-3.30: Rf = 0.55 (ethyl ace-
tate/hexane, 3/10, v/v); 
1H NMR: δ, 3.18 (s, 3H, OCH3), 3.23-3.43 (m, 4H, H-2, 2’, 4, 4’), 
3.62-3.73 (m, 2H, H-5, 6a), 3.74-3.80 (dd, 1H, H-3’), 3.85-3.91 (m, 2H, H-3, 6b), 4.42 (d, 
1H, H-1), 5.40 (d, 1H, J1’2’ = 3.6 Hz, H-1’) ppm; 
13
C NMR (150 MHz): δ, 96.6, 97.9 
ppm; HR-FAB MS [M+Na]
+
 calcd for C84H92NaO15Si 1391.6103, found 1391.6110. 
 

3.4.6 Synthesis of compound 3.31 for investigating a possibility of anomerization. 
 
Methyl 2,4-di-O-benzyl-6-O-triphenylmethyl-α-D-glucopyranoside (3.61).  The title 
compound was prepared as previously reported.
31
 Analytical data for 3.61: Rf = 0.67 
(ethyl acetate/toluene, 1/1, v/v); []D
27
 +26.5 (c = 1, CHCl3); 
1H NMR: δ, 2.50 (d, 1H, J = 
2.2 Hz, OH), 3.24 (dd, 1H, J5,6a = 3.2 Hz, J6a,6b = 10.1 Hz, H-6a), 3.47 (s, 3H, OCH3), 
3.51-3.70 (m, 3H, J2,3 = 11.0, J4,5 = 10.0 Hz, H-2, 4, 6b), 3.83 (m, 1H, H-5), 4.10 (ddd, 
1H, H-3), 4.39 (d, 1H, 
2
J = 10.9 Hz, ½ CH2Ph), 4.72 (d, 1H, 
2
J = 9.6 Hz, ½ CH2Ph), 4.80 
(s, 2H, CH2Ph), 4.83 (d, 1H, J1,2 = 3.5 Hz, H-1), 7.01-7.54 (m, 25H, aromatic); 
13
C NMR 
(75 MHz): δ, 55.0, 62.9, 69.9, 73.1, 73.8, 74.6, 78.1, 79.9, 97.4, 127.0, 127.7, 127.9, 
128.1 (x 9), 128.3 (x 4), 128.7 (x 3), 128.9 (x 3), 138.2 (x 6), 138.2, 144.0 (x 3) ppm; 
HR-FAB MS [M+Na]
+
 calcd for C40H40O6Na 639.2722, found 639.2717. 
 
Methyl O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-(13)-2,4-di-O-benzyl-6-O-
triphenylmethyl-α-D-glucopyranoside (3.62).  A mixture of ethyl 2,3,4,6-tetra-O-
acetyl-1-thio-β-D-glucopyranoside32 (3.60, 124 mg, 0.316 mmol), 3.61 (162 mg, 0.263 
mmol), and freshly activated molecular sieves (3 Å, 360 mg) in 1,2-dichloroethane (4.0 

mL) was stirred under argon for 2 h at rt. MeOTf (71 μL, 0.631 mmol) was added and the 
resulting mixture was stirred for 4 h at rt. After that, the solid was filtered off through a 
pad of Celite and rinsed successively with dichloromethane. The combined filtrate (~50 
mL) was washed with water (10 mL), sat. aq. NaHCO3 (10 mL), and water (2 x 10 mL). 
The organic phase was separated, dried with MgSO4, and concentrated in vacuo. The res-
idue was purified by silica gel column chromatography (ethyl acetate-hexanes gradient 
elution) to afford the title compound (160 mg, 64%) as a white amorphous solid. Analyti-
cal data for 3.62: Rf = 0.63 (ethyl acetate/ hexane, 3/10, v/v); []D
27
 +9.5 (c = 1, CHCl3); 
1H NMR: δ, 2.00, 2.07 (x2), 2.16 (4s, 12H, 4 x COCH3), 3.18 (dd, 1H, J5,6a = 4.4 Hz, 
J6a,6b = 9.9 Hz, H-6a), 3.45-3.52 (m, 5H, H-6b, 4, OCH3), 3.60 (dd, 1H, J2,3 = 9.63 Hz, H-
2), 3.67 (dd, 1H, H-5’), 3.85 (dd, 1H, J5,6b = 4.3 Hz, H-5), 4.37 (dd, 1H, J5’,6a’ = 2.0 Hz, 
J6a’,6b’ = 12.4 Hz, H-6a’), 4.24-4.36 (m, 3H, H-3, 6b’, ½ CH2Ph), 4.60 (d, J=11.4 Hz, ½ 
CH2Ph), 4.72 (d, 1H, J1,2 = 3.6 Hz, H-1), 4.82-4.92 (m, 2H, CH2Ph), 5.09-5.28 (m, 4H, 
J4’,5’ = 10.3 Hz, H-1’, 2’, 3’, 4’), 7.00-7.48 (m, 25H, aromatic) ppm; 
13
C NMR (75 MHz): 
δ, 20.7 (x3), 21.0, 54.9, 62.0, 63.1, 68.4, 69.9, 71.7, 72.2, 73.3, 73.7, 74.6, 76.3, 79.2, 
81.2, 86.4, 97.1, 100.4, 127.0 (x3), 127.5, 127.8 (x4), 128.1 (x3), 128.3 (x6), 128.4, 128.8 
(x7), 137.8, 138.2, 144.0 (x3), 169.5, 169.6, 170.3, 170.8 ppm; HR-FAB MS [M+Na]
+
 
calcd for C54H58O15 946.3776, found 969.3673. 
 
Methyl O-(2,3,4-tri-O-benzyl-β-D-glucopyranosyl)-(13)-2,4-di-O-benzyl-α-D-
glucopyranoside (3.63).  A solution of NaOMe in methanol (1M, ~1.0 mL) was added 
dropwise to a solution of 3.62 (150 mg, 0.22 mmol) in methanol (3.0 mL) till pH ~ 9 and 
the resulting mixture was kept for 1 h at rt.  After that, Dowex (H+) was added till pH ~ 

7, the resin was filtered off and washed successively with methanol.  The combined fil-
trate (~30 mL) was concentrated in vacuo and dried. The residue (117 mg, 0.218 mmol) 
was dissolved in pyridine (5.0 mL), triphenylmethyl chloride (243 mg, 0.872 mmol) was 
added, and the resulting mixture was stirred for 24 h at rt. After that, the volatiles were 
removed under the reduced pressure and the residue was co-evaporated with toluene and 
dried. The residual solid (210 mg, 206 mmol) was dissolved in dry DMF (3.0 mL) and 
benzyl bromide (0.1 mL, 0.93 mmol). The resulting solution was added dropwise over a 
period of 15 min to a stirring mixture of NaH (60 % in mineral oil, 50 mg, 1.23 mmol) in 
DMF (3.0 mL) at 0 ˚C. The reaction mixture was then allowed to warm to rt and stirred 
for 16 h at rt. After that, the reaction mixture was poured on crushed ice and stirred until 
cessation of H2 evolution. The mixture was then extracted with ethyl acetate/diethyl ether 
(3 x 15 mL, 1/1, v/v) and the combined organic phase was washed with water (3 x 10 
mL). The organic phase was separated, dried with MgSO4, and concentrated in vacuo. 
The residue (229 mg, 0.205 mmol) was dissolved in CH2Cl2 (10 mL), trifluoroacetic acid 
(0.3 mL) and water (100 μL) were added, and the resulting mixture was stirred for 1 h at 
rt. After that, the reaction mixture was diluted with CH2Cl2 (~25 mL) and washed with 
water (10 mL), sat. aq. NaHCO3 (2 x 10 mL), and water (3 x 10 mL). The organic phase 
was separated, dried with MgSO4, and concentrated in vacuo. The residue was purified 
by column chromatography on silica gel (ethyl acetate - hexane gradient elution) to ob-
tain the title compound in 78% overall yield (0.138 mg, 0.171 mmol) as a colorless syrup. 
Analytical data for 3.63: Rf = 0.48 (ethyl acetate/toluene, 1/1, v/v); []D
22
 +37.2 (c = 1, 
CHCl3); 
1H NMR: δ, 1.57 (br. s, 2H, OH), 3.19-3.23 (m, 4H, H-6a, OCH3), 3.34-3.71 (m, 
10H, H-2, 2’, 3’, 4, 4’, 5, 5’, 6a’, 6b, 6b’) 4.24 (dd, 1H, J3-4 = 9.1, H-3), 4.29 (d, 1H, 
2
J = 

11.7, ½ CH2Ph), 4.36 (d, 1H, J1,2 = 3.6 Hz, H-1), 4.51-6.50 (m, 3H, 1½ CH2Ph), 4.75-
4.65 (m, 7H, H-1’, 3 x CH2Ph), 7.13-7.36 (m, 25H, aromatic) ppm; 
13
C NMR (75 MHz): 
δ, 55.2, 61.7, 61.9, 70.3, 73.8, 74.7, 74.8, 75.1, 75.2, 75.7, 75.9, 77.8, 78.0, 81.1, 83.3, 
84.8, 97.9, 102.5, 127.7 (x2), 127.9, 128.0, 128.1 (x2), 128.4 (x5), 128.5, 128.6 (x2), 
129.1, 138.0, 138.1, 138.4, 138.6, 138.8 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C48H54NaO11 829.3564, found 829.3535. 
 
Methyl O-[2,3,4-tri-O-benzyl-6-O-(o-hydroxycarbonyl)benzoyl-β-D-glucopyranosyl]-
(13)-2,4-di-O-benzyl-6-O-(o-hydroxycarbonyl)benzoyl-α-D-glucopyranoside 
(3.64).  The title compound was prepared from 3.63 (55 mg, 0.068 mmol), phthalic anhy-
dride (2 x 61 mg, 2 x 0.818 mmol) and 4-(N,N-dimethylamino)pyridine (2 x 4.2 mg, 
0.068 mmol) in accordance with the general procedure for introducing the phthaloyl link-
er in 85% as a colorless syrup. Analytical data for 3.64: Rf = 0.25 (metha-
nol/dichloromethane, 1/9, v/v); []D
26
 +2.76
o
 (c = 1, CH3Cl); 
1H NMR: δ, 3.21 (s, 3H, 
OCH3), 3.31-3.42 (m, 4H, H-2, 2’, 4, 4’), 3.63-3.66 (m, 2H, H-3, 5’), 4.21-4.57 (m, 10H, 
H-1, 3, 5’, 6a, 6b, 6a’, 6b’, 2 x CH2Ph), 4.67-4.98 (m, 7H, H-1’, 3 x CH2Ph) 7.10-7.90 
(m, 33H, aromatic); 
13C NMR (75 MHz): δ, 55.3, 65.2, 66.0 (x2), 67.6, 72.8, 73.7, 75.1, 
75.3, 75.8, 76.0, 78.8, 79.3, 81.2, 83.0, 84.9, 97.3, 102.3, 127.7, 127.8, 127.9 (x4), 128.0, 
128.1 (x4), 128.4 (x6), 128.5 (x6), 128.7 (x3), 128.8, 129.0 (x2), 129.2, 129.6 (x3), 130.5, 
130.6, 131.3, 131.6, 132.1, 132.2, 133.8, 135.9, 137.6, 137.9, 138.3, 138.6 ppm; HR-FAB 
MS [M+Na]
+
 calcd for C64H62NaO17 1125.3885, found 1125.3926. 
 

Macrocyclic disaccharide 3.31 was prepared in accordance with the general procedure 
for the introduction of BPA linker form 3.64 (0.46 mg, 0.042 mmol) in 75% yield (41 
mg, 0.032 mmol) as a colorless syrup. Analytical data for 3.31: Rf = 0.26 (ethyl ace-
tate/dichloromethane, 1/9, v/v); []D
26
 +18.2
o
 (c = 1, CHCl3); 
1H NMR: δ, 1.25 (s, 6H, 
C(CH3)2), 3.30 (s, 3H, OCH3), 3.43-3.49 (m, 2H, H-2, 4), 3.52 (dd, 1H, J2’,3’ = 8.5 Hz, H-
2’), 3.63 (br. s, 2H, H-4, 5), 3.73 (dd, 1H, J2,3= 7.5 Hz, H-3), 3.90 (m, 1H, H-5’),  4.35 (d, 
1H, 
2
J = 11.6 Hz, ½ CH2Ph), 4.41 (dd, 1H, J2’,3’ = 9.2 Hz, H-3’), 4.44-4.66 (m, 8H, H-1, 
6a, 6b, 6a’, 6b’, 1½ CH2Ph), 4.87 (m, 2H, CH2Ph), 4.93 (d, 1H, 
2
J = 11.8 Hz, ½ CH2Ph), 
4.99-5.09 (m, 2H, CH2Ph), 5.14 (d, 1H, J1’,2’ = 7.7 Hz, H-1’), 7.02-7.36 (m, 41H, aro-
matic) ppm; 
13C NMR (125 MHz): δ, 32.4, 45.0 (x2), 57.9, 67.4, 68.3, 70.9, 75.1, 76.3, 
77.8, 77.9, 78.2, 78.6, 80.7, 83.8, 85.7, 87.5, 100.1, 105.3, 110.0, 130.3 (x3), 130.4 (x2), 
130.5 (x8), 130.7(x3), 130.9 (x10), 131.0 (x19), 131.1 (x9), 131.7 (x2), 140.5, 141.2, 
156.3, 156.4ppm; HR-FAB MS [M+Na]
+
 calcd for C79H74NaO17 1317.4824, found 
1294.4827. 
 
An attempt to anomerize 3.31 in the presence of BF3-Et2O.  A mixture of 3.31 (5.5 
mg, 4.24 μmol) and freshly activated molecular sieves (3 Å, 20 mg) in 1,2-dichloroethane 
(0.5 mL) was stirred under argon for 2 h at rt. The mixture was cooled to -30 
o
C, BF3-
Et2O (1 μL, 7.7 μmol) was added, and the reaction mixture was stirred at -30 
o
C for 7 h. 
After that, the reaction mixture was allowed to gradually warm to rt and stirred for addi-
tional 72 h. The solid was filtered off through a pad of Celite and rinsed successively 
with dichloromethane. The combined filtrate (~30 mL) was washed with sat aq. NaHCO3 
(~10 mL) and water (3 x 10 mL). The organic phase was separated, dried over MgSO4, 

concentrated in vacuo and dried. The residue was purified by column chromatography on 
silica gel (ethyl acetate - hexane gradient elution) to afford 3.31 quantitatively. 
 
An attempt to anomerize 3.31 in the presence of MeOTf was performed as described 
in the typical procedure for MeOTf-promoted glycosylation (Method B). No anomeriza-
tion was detected. 
 
3.4.7 Investigation of Other Templates 
Methyl 2,3-di-O-benzyl-6-O-(α,α, bis(4-hydroxyphenyl)-1,4-diisopropylbenzene suc-
cinate)-α-D-glucopyranoside) 3.65. A solution of N,N’-dicyclohexylcarbodiimide 
(DCC, 164 mg, 0.80 mmol) in dry dichloromethane (2.0 mL) was added dropwise (over 5 
min) to a solution of 3.36 (126 mg, 0.27 mmol) and 2,2-bis(4-hydroxyphenyl)-1,4-
diisopropylbenzene (138 mg, 0.40 mmol) in dry dichloromethane (4.0 mL) at 0 
o
C. The 
resulting mixture was allowed to warm to rt over 4 h. After that, the reaction mixture was 
diluted with dichloromethane (~30 mL) and washed with water (3 x 10 mL). The organic 
phase was separated, dried over MgSO4, and concentrated in vacuo. The residue was pu-
rified by column chromatography on silica gel (ethyl acetate/toluene, 1/1, v/v) to afford 
the title compound in 79% yield (168 mg, 0.21 mmol) as a colorless syrup. Analytical 
data for 3.65: Rf = 0.53 (ethyl acetate/toluene, 2/3, v/v); []D
24
  +21.9 (c = 0.8, CHCl3); 
1H NMR: δ, 1.68 (s, 12H, 2 x C(CH3)2), 2.11 (s, 1H, Ph-OH), 2.69-3.02 (m, 4H, 
COCH2CH2CO), 3.42 (s, 3H, OCH3), 3.49-3.58 (m, 2H, H-2, 4), 3.80-3.89 (m, 2H, H-3, 
5), 4.34 (d, 1H, J6a-6b = 12.04 Hz H-6a), 4.51 (dd, 1H, J6a-5 = 3.45 Hz, H-6b), 4.65-5.06 
(m, 5H, H-1, 2 x CH2Ph), 6.75-7.78 (m, 22H, aromatic) ppm; 
13C NMR (75 MHz): δ  

114.8 (x 2), 120.8 (x2), 126.3 (x2), 126.4 (x2), 127.9 (x2), 128.0 (x3), 128.1, 128.2 (x4), 
128.6 (x2), 128.7 (x2), 138.0, 138.6, 142.3, 147.3, 148.2, 148.4, 148.5, 153.6, 171.1, 
172.5 ppm; HR-FAB MS [M+Na]
+
 calcd for C49H54NaO10 825.3615, found 825.3614. 
 
Tethered compound 3.32.  A solution of DCC (38 mg, 0.186 mmol) and DMAP (2.6 
mg, 0.021 mmol) in dry dichloromethane (2.0 mL) was added dropwise (5 min) to a stir-
ring solution of 3.65 (50 mg, 0.062 mmol) and 3.34 (55 mg, 0.093 mmol) in dry di-
chloromethane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 
h. After that, the reaction mixture was diluted with dichloromethane (~30 mL) and 
washed with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - toluene gradient elution) to afford tethered compound 3.32 in 88% yield 
(76 mg, 0.055 mmol) as a colorless syrup. Analytical data for 3.32: Rf = 0.48 (ethyl ace-
tate/toluene, 3/7, v/v); [α]D
24 
= 2.96 (c = 1, CHCl3); 
1H NMR: δ, 1.48 (t, 3H, J = 7.4 Hz, 
SCH2CH3), 1.81 (s, 12H, C(CH3)2), 2.85-2.98 (m, 6H, SCH2CH3, COCH2CH2CO), 3.00-
3.06 (m, 4H, COCH2CH2CO), 3.55 (s, 3H, OCH3), 3.58-3.72 (m, 5H, H-2, 2’, 4, 4’, 5’), 
3.86-3.96 (m, 3H, H-3, 3’, 5), 4.40-4.43 (m, 2H, H-6a’, 6b’), 4.54-4.66 (m, 3H, H-1’, 6a, 
6b), 4.12 (d, 1H, J1,2 = 3.08 Hz, H-1), 4.74-5.19 (m, 10H, 5 x CH2Ph), 7.12-7.54 (m, 37H, 
aromatic) ppm; 
13
C NMR (75 MHz): δ 15.3, 25.3, 29.1, 29.3, 30.9, 42.4, 55.5, 63.7, 69.3, 
70.0, 73.4, 75.2, 75.7, 75.9, 77.0, 77.4, 79.6, 81.2, 81.8, 85.3, 86.7, 98.3, 120.8, 126.5 
(x4) , 127.9 (x6), 128.1 (x3), 128.2 (x3), 128.3 (x5), 128.5 (x3), 128.6 (x3), 128.6 (x8), 
128.8 (x3), 137.7, 137.9, 138.1, 138.4, 138.7, 147.6 (x2), 148.4 (x3), 171.1 (x2), 172.0, 
172.5 ppm; HR-FAB MS [M
+
Na]
+
 calcd for C82H90NaO17S 1401.5796, found 1401.5795 

 
Methyl 2,3-di-O-benzyl-6-O-(8-hydroxy-9,10-dioxo-9,10-dihydroanthracen-1-
yl)succinoyl-α-D-glucopyranoside) 3.66. A solution of N,N’-dicyclohexylcarbodiimide 
(DCC, 87 mg, 0.42 mmol) in dry dichloromethane (2.0 mL) was added dropwise (over 5 
min) to a solution of 3.36 (100 mg, 0.21 mmol) and 1,8-dihydroxyanthraquinone ( 76 mg, 
0.32 mmol) in dry dichloromethane (2.0 mL) at 0 
o
C. The resulting mixture was allowed 
to warm to rt over 4 h. After that, the reaction mixture was diluted with dichloromethane 
(~30 mL) and washed with water (3 x 10 mL). The organic phase was separated, dried 
over MgSO4, and concentrated in vacuo. The residue was purified by column chromatog-
raphy on silica gel (ethyl acetate/toluene, 1/1, v/v) to afford the title compound in 84% 
yield (124 mg, 0.17 mmol) as a colorless syrup. Analytical data for 3.66: Rf = 0.36 (ethyl 
acetate/hexanes, 1/1, v/v); []D
24
 = +1.78 (c = 1, CHCl3); 
1H NMR: δ 2.81 (t, 2H, J = 6.8 
Hz, COCH2CH2CO), 3.08 (t, 2H, J = 6.93 Hz, COCH2CH2CO), 3.32 (s, 3H, OCH3), 3.37 
(t, 1H, J4-5 =9.69 Hz, H-4), 3.42, (dd, 1H, J2-3 =9.63 Hz, H-2), 3.68 (m, 1H, H-5), 3.71 
(dd, 1H, J3-4 = 9.09, H-3), 4.24 (dd, 1H, J6a-6b = 12.09 Hz, J5-6a= 2.1 Hz, H-6a), 4.41(dd, 
1H, J5-6b= 4.74 Hz, H-6b) 4.39 (d, 1H, J1-2= 3.57 Hz, H-1), 4.54-4.92 (m, 4H, 2xCH2Ph), 
7.09-8.20 (m, 16H, aromatic)  ppm; 
13C NMR (75 MHz): δ 29.0, 29.4, 55.4, 63.7, 69.9, 
73.3, 75.6, 79.58, 81.2, 98.3, 116.6, 119.5, 124.6, 124.9, 125.4, 126.1, 128.0, 128.1 (x2), 
128.2, 128.3(x2), 128.6(x2), 128.7, 129.1, 130.3, 132.7, 135.3, 135.6, 136.8, 138.0, 
138.7, 150.4, 162.7, 170.9, 172.5, 181.8, 188.0 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C39H36NaO12 719.2104, found 719.2102. 
 

Tethered compound 3.33.  A solution of DCC (80 mg, 0.39 mmol) and DMAP (4.7 mg, 
0.04 mmol) in dry dichloromethane (2.0 mL) was added dropwise (5 min) to a stirring 
solution of 3.66 (135 mg, 0.19 mmol) and 3.34 (173 mg, 0.29 mmol) in dry dichloro-
methane (2.0 mL) at 0 
o
C. The resulting mixture was allowed to warm to rt over 2 h. Af-
ter that, the reaction mixture was diluted with dichloromethane (~30 mL) and washed 
with water (3 x 10 mL). The organic phase was separated, dried over MgSO4, and con-
centrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate - toluene gradient elution) to afford tethered compound 3.33 in 81% yield 
(218 mg, 0.158 mmol) as a clear yellow syrup. Analytical data for 3.33: Rf = 0.50 (ethyl 
acetate/toluene, 1/9, v/v); [α]D
23 
= 1.78 (c = 1, CHCl3); 
1H NMR: δ, 1.31 (t, 3H, J = 7.4 
Hz, SCH2CH3), 2.35-2.53 (m, 4H, COCH2CH2CO),  COCH2CH2CO), 3.73 (m, 2H, 
SCH2CH3), 2.71-2.87 (m, 4H, COCH2CH2CO), 3.37 (s, 3H, OCH3), 3.41 (dd, 1H, J2-3= 
8.9 Hz, H-2’), 3.50 (m, 2H, H-2, 4’), 3.56 (dd, 1H, J5-6a = 9.57 Hz, H-5), 3.68 (dd, 1H, J3’-
4’ = 8.64 Hz, H-3’), 3.85 (m,1H, H-5), 3.92 (dd, 1H, J3-4 = 9.42 Hz, H-4), 4.08-4.37 (m, 
4H, H-6a, 6b, 6a’, 6b’), 4.45 (d, 1H, J1’-2’ = 9.82 Hz, H-1’), 4.55 (d, 1H, J1,2 = 6.88 Hz, H-
1), 4.58-4.96 (m, 10H, 5 x CH2Ph), 5.00 (dd, 1H, J4-5=9.65 Hz, H-4), 7.16-7.81 (m, 31H, 
aromatic) ppm; 
13
C NMR (75 MHz): 15.3, 25.4, 28.9, 29.0 (x2), 29.5, 55.6, 62.8 (x2), 
63.8, 67.7, 70.1, 73.7, 75.2, 75.5, 75.7, 75.9, 77.7, 79.2, 79.7, 81.8, 85.7, 86.7, 98.3, 
116.7, 119.5, 124.7, 125.0, 126.1, 127.8, 127.9 (x2), 128.0, 128.1 (x4), 128.2 (x4), 128.3 
(x3), 128.4 (x2), 128.5 (x4), 128.6 (x4), 130.5, 132.8, 135.4, 135.7, 136.8, 137.8, 138.0 
(x2), 138.4, 138.6, 150.5, 162.7, 171.0, 171.2, 171.9 (x2), 181.9, 188.0 δ  ppm; HR-FAB 
MS [M
+
Na]
+
 calcd for C72H72NaO19S 1295.4286, found 1295.4285 
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Chapter 4 Glycosyl Donors with Switchable Stereoselec-
tivity 
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4.1 Introduction 
The application of the BPA template in intramolecular glycosylation reaction has been 
explored and successfully applied towards the synthesis of hard to obtain disaccharides 
and a trisaccharide in high yields and complete selectivity (Chapters 2 and 3).  Despite 
the excellent results, applying the concept to larger molecules becomes less attractive due 
to the extra steps required for the attachment of linkers and templates.  One idea is to de-
velop a system where the template can be added in the same step as the glycosylation. 
Towards that goal, we proposed to investigate whether temporary tethering of the reac-
tion components can be performed via metal coordination via picolinyl or picoloyl sub-
stituents (Scheme 4.1). Subsequently, we would need to investigate whether these teth-
ered structures could be used in accordance with the general concept of templated oligo-
saccharide synthesis.   
Scheme 4.1 Proposed metal linkage for intramolecular glycosylation. 
 
 
Previous studies showed that remote 6-O-picolinyl or 6-O-picoloyl substituents often 
provide high β-selectivity due to H-bond-mediated aglycone delivery (HAD).  In our 
studies developing metal templated intramolecular glycosylations we observed that palla-
dium binding to 6-O-picolinyl had a reversal effect of selectivity.  We conceptualized that 
if the nitrogen atom of the Pic or Pico moiety is temporarily blocked by coordination to 
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the metal center, and as a consequence, it would not engage in HAD during glycosylation 
and the stereoselectivity might be “switched”. The anticipated significance of this ap-
proach would be the use of a single glycosyl donor for the synthesis of either a 1,2-cis or 
1,2-trans linkage on demand, a trait that is rather uncommon in glycosylation.
1
  It should 
be noted that the role of metal complexation in chemical glycosylation remains practical-
ly unexplored because common oxygen-containing carbohydrates typically form unstable 
flexidentate complexes.
2,3
  Our previous study showed that targeted coordination can be 
achieved by the introduction of N-Lewis base substituents.  Thus, we demonstrated that 
multidentate metal coordination to the leaving group along with O-5, and/or a protecting 
group at O-6, has a strong effect on the stereoselectivity of chemical glycosylation (C, 
Figure 4.1). Specifically, we designed pyridine-based protecting groups for O-6 in that 
study.
4
  
Figure 4.1 The concept of switchable stereoselectivity. 
We hypothesized that combining the conventions of these two latter approaches would 
give us a convenient tool for achieving switchable stereoselectivity with use of the same 
glycosyl donor, non-complexed (A), leading to β-, and complexed (B) leading to α-
selectivity. Among the possibilities, the picolinyl group offers a suitable platform for 
providing nitrogen atoms that form stable metal complexes. The high stability of such 
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complexes during the glycosylation process would be key for providing the desired ef-
fects that might lead to enhanced stereocontrol. 
Previously we reported that a coupling of S-ethyl donor 4.1a
5
 with glycosyl acceptor 4.2
6
 
in the presence of dimethyl(thiomethyl)sulfonium triflate (DMTST)
7
 provided disaccha-
ride 4.3a in 93% yield (α/β = 1/2.4, entry 1, Table 4.1).5 The β-stereoselectivity could 
typically be further improved by performing essentially the same reaction at high dilution 
(5 mM concentration of the donor).
5
 The use of picoloylated donor 4.1b
5
 (β-only, entry 2) 
often gave a further enhancement of the β-stereoselectivity.5 Analogous S-phenyl glyco-
syl donors 4.4a and 4.4b, prepared specifically for this study, provided similar results 
surveyed in entries 3 and 4.  
Table 4.1 High β-stereoselectivity achieved with HAD. 
 
entry donor time, h product (yield/%, α/β ratio) 
1  
4.1a  
5 4.3a (93, 1/2.4) 
2  
4.1b 
1.5 4.3b (96, β only) 
3  
4.4a  
8 4.3a (79, 1/1.5) 
4  
4.4b  
8 4.3b (88, β only) 
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4.2. Results and Discussion 
We then turned our attention to investigation of glycosylations in the presence of PdBr2. 
For this, we developed a convenient three-step one-pot protocol involving sequential 
complexation, glycosylation, and decomplexation. Accordingly, donor 4.1a (1.3 equiv. 
with respect to the acceptor) was treated with PdBr2 (1.5 equiv. with respect to the donor) 
in the presence of glycosyl acceptor 4.2 and molecular sieves (4 Å) in CH2Cl2 for 3 h at 
rt. During this time, donor 4.1a was completely converted into its Pd-complex (4.5a). Af-
ter that, the reaction mixture was cooled to -30 °C, DMTST (2.0 equiv. with respect to 
the donor) was added, and the resulting mixture was allowed to warm to rt and stirred for 
6-8 h. At this stage, disaccharide 4.3a was still present as its PdBr2 complex. DMAP was 
added to conduct the decomplexation, which was typically completed in 30 min. As a re-
sult, disaccharide 4.3a was isolated in 97% with some α-selectivity (α/β = 2.1/1, entry 1, 
Table 4.1). Applying essentially the same reaction conditions to glycosylation of accep-
tors 4.6, 4.8, and 4.10,
8,9
 we obtained the corresponding disaccharides 4.7, 4.9, and 4.11 
in excellent yields of 85-96% and preferential α-selectivity (α/β = 4.5-13.6/1, entries 2-4). 
Glycosylation of glycosyl acceptor 4.2 with S-phenyl donors 4.4a or 4.4b provided a sim-
ilar outcome in terms of both yields and stereoselectivities (entries 5 and 6). 
In a commitment to further enhancing α-stereoselectivity, we screened various reaction 
conditions. While we have practically seen no effect of the reaction temperature, we de-
termined that a reduced amount of DMTST (1.3 equiv. with respect to the donor) helps 
improve stereoselectivity. This effect was particularly strong in case of glycosyl donor 
4.4a, which provided disaccharide 4.3a with excellent α-selectivity and in high yield (α/β 
157 
 
= 12.5/1, 89%, entry 7). The enhancement of stereoselectivity obtained with donor 4.4b 
was not so pronounced, but still noticeable (α/β = 6.3/1, 88%, entry 8). Encouraged by 
these results, we glycosylated a range of the secondary acceptors 4.6, 4.8, and 4.10 and 
obtained excellent results for the synthesis of the respective disaccharides 4.7, 4.9, and 
4.11 (entries 9-11). A particularly impressive result for the synthesis of the 16-linkage 
was obtained with benzoylated acceptor 4.12
10
 wherein the formation of disaccharide 
4.13 was accomplished in high yield and with complete α-selectivity (entry 12). For 
comparison, we also synthesized and tested 4,6-di-O-picolylated donor 4.4c. The three-
step one pot procedure was practically ineffective in this case, and the selectivity was 
poor (entry 13).  
Having achieved good levels of stereocontrol, we were curious to look into the structure 
of possible reaction intermediates. As mentioned, upon treatment of 4.1a with PdBr2, 
complex 4.5a forms entirely, but its ligation mode remained uncertain. The NMR analy-
sis of 4.5a showed the presence of two distinct structures in the ratio of 4/1. Interestingly, 
S,N-complex 4.5a-B (Scheme 4.2) is not formed herein, as evident from the lack of split-
ting of the SCH2 protons that would have occurred otherwise,
11
 similarly to that observed 
for the formation of complex 4.5b from 6-O-picoloylated donor 4.1b  
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Scheme 4.2 Anticipated pathways for enhancing α-stereoselectivity with complexed 
6-O-picolinyl donors. 
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Table 4.2 High α-stereoselectivity with PdBr2-complexed 6-O-Pic/Pico donors. 
 
entry Donor acceptor 
DMTST, 
equiv. 
product yield (%), α/β ratio 
1 
 
4.1a 
 
4.2 
2.6 
4.3a 
97, 2.1/1 
2 4.1a 
 
4.6 
2.6 
4.7 
96, 8.3/1 
3 4.1a 
 
4.8 
2.6 
4.9 
94, 4.5/1 
4 4.1a 
 
4.10 
2.6 
4.11 
85, 13.6/1 
5 
 
4.4a 
4.2 2.6 4.3a 97, 2.5/1 
6 
 
4.4b 
4.2 2.6 
4.3b 
84, 3.9/1 
7 4.4a 4.2 1.7 4.3a 89, 12.5/1 
8 4.4b 4.2 1.7 4.3b 88, 6.3/1 
9 4.4a 4.6 1.7 4.7 69, 8.1/1 
10 4.4a 4.8 1.7 4.9 94, 6.7/1 
11 4.4a 4.10 1.7 4.11 84, 22.5/1 
12 4.4a 
 
4.12 
1.7 
4.13 
89, α-only 
13 
 
4.4c 
4.2 1.7 
4.14 
73, 1/1.4 
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Although previously we detected the formation of bis-ligand dimeric complexes,
12
 we 
believe that N,N-complex 4.5a-D is not forming here for the reason outlined below. 
Hence, it is possible that 4.5a represents an interchangeable mixture of N,O-complexes 
4.5a-A and 4.5a-C, typical for unstable oxygen-containing flexidentate complexes of 
carbohydrates with palladium(II).
2,3
 The treatment of complex 4.5a with lutidine led to 
the formation of a relatively stable complex 4.5e, the structure of which was confirmed 
by spectral techniques. For comparison, complex 4.5c formed from dipicolylated donor 
4.4c did not undergo the ligand exchange with lutidine and required a stronger base 
(DMAP) to decomplex.  In our opinion, if 4.5a existed as bis-ligand structure 4.5a-D, it 
would also be expected to remain stable in the presence of lutidine. Similarly to that of 
other N,N-ligated intermediates, complex 4.5e provided very poor stereoselectivity in 
glycosylation. A similar structure determination experiment with S-phenyl donor 4.4a led 
to the formation of the respective complex 4.5d, which exists as a 2/1 mixture as evident 
from its NMR.  
To demonstrate the utility of the newly developed approach in the context of multistep 
oligosaccharide synthesis, we performed the synthesis of cis-trans patterned trisaccharide 
4.16 (Scheme 4.3). HAD glycosylation of acceptor 4.2 with donor 4.4b gave disaccharide 
4.3a. The picoloyl group of the latter was selectively removed with copper(II) acetate and 
the resulting acceptor 4.15 was reacted with donor 4.4a in the presence of PdBr2 and 
DMTST to afford trisaccharide 4.16 with complete stereoselectivity in both steps. 
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Scheme 4.3 The synthesis of cis-trans-patterned trisaccharide 4.16 
 
4.3 Conclusions 
In conclusion, we have shown that if the nitrogen atom of the 6-O-picolinyl or picoloyl 
moiety is temporarily blocked by coordination to a metal center (Pd), it cannot engage in 
HAD-mediated β-glycosylation, and hence the stereoselectivity of 6-O-Pic/Pico-assisted 
glycosylations can be “switched” to α-selectivity. The utility of this technique was 
demonstrated by the synthesis of a cis-trans linked trisaccharide via sequential trans-cis 
glycosylation. Say something about supposedly intended templated synthesis? Further 
application of metal directed glycosylation towards intramolecular applications is cur-
rently underway.   
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4.4 Experimental Section 
4.4.1 General Remarks 
Column chromatography was performed on silica gel 60 (70-230 mesh), reactions were 
monitored by TLC on Kieselgel 60 F254. The compounds were detected by examination 
under UV light and by charring with 10% sulfuric acid in methanol. Palladium (II) bro-
mide (99.9%, STREM Chemicals) was used without additional purification. Solvents 
were removed under reduced pressure at <40 °C. CH2Cl2 was distilled from CaH2 directly 
prior to application. Pyridine was dried by refluxing with CaH2 and then distilled and 
stored over molecular sieves (3 Å). Anhydrous DMF was used as it is. Molecular sieves 
(3 Å or 4 Å), used for reactions, were crushed and activated in vacuo at 390 °C during 8 h 
in the first instance and then for 2-3 h at 390 °C directly prior to application. Optical rota-
tions were measured at ‘Jasco P-1020’ polarimeter.  Unless noted otherwise, 1H NMR 
spectra were recorded in CDCl3 at 300, 500 or 600 MHz, 
13
C NMR spectra were recorded 
in CDCl3 at 75 or 125 MHz. 
 
4.4.2 Synthesis of glycosyl donors 
Ethyl 2,3,4-Tri-O-benzyl-6-O-picolinyl-1-thio-β-D-glucopyranoside (4.1a).  The title 
compound was synthesized as reported previously.
5
 
 
Ethyl 2,3,4-Tri-O-benzyl-6-O-picoloyl-1-thio- β -D-glucopyranoside (4.1b). The title 
compound was synthesized as reported previously.
5
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Phenyl 2,3,4-Tri-O-benzyl-6-O-picolinyl-1-thio- β -D-glucopyranoside (4.4a).  NaH 
(60% in mineral oil, 0.33 g, 8.30 mmol) and 2-(bromomethyl)pyridine hydrobromide 
(1.17 g, 4.61 mmol) were added to a solution of phenyl 2,3,4-tri-O-benzyl-1-thio-β-D-
glucopyranoside
13
 (1.00 g, 1.84 mmol) in DMF (5.0 mL) and the resulting mixture was 
stirred for 2.5 h at rt. The reaction mixture was then quenched with ice water (15 mL, 30 
min) and extracted with ethyl acetate / diethyl ether (1/1, v/v, 3 × 50 mL). The combined 
organic extract (~150 mL) was washed with cold water (3 × 15 mL). The organic phase 
was separated, dried with magnesium sulfate, filtered, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate - hexane gra-
dient elution) to give the title compound as a white amorphous solid in 85% yield (1.02 g, 
1.61 mmol). Analytical data for 4.4a: Rf = 0.31 (ethyl acetate/hexane, 2/3, v/v); [α]D
25
 -
2.9 (c = 1.00, CHCl3); 
1H NMR: δ, 3.58 (dd, 1H, J2,3 = 8.6 Hz, H-2), 3.76 (dd, 1H, J3,4 = 
9.5 Hz, H-3), 3.71-3.98 (m, 4H, H-4, 5, 6a, 6b), 4.75 (d, 1H, J1,2 = 8.9 Hz, H-1), 4.67-
4.82 (m, 4H, 2 x CH2Ph), 4.90-5.00 (m, 4H, 2 x CH2Ph), 7.24-7.73 (m, 23H, aromatic), 
8.61 (s, 1H, aromatic) ppm; 
13C NMR: δ, 69.5, 74.0, 75.0, 75.3, 75.8, 77.6, 78.8, 80.7, 
86.6, 87.3, 121.2, 122.3, 127.3, 127.6, 127.7, 127.8 (x 2), 127.9 (x 2), 128.1 (x 2), 128.3 
(x 2), 128.4 (x 2), 128.7 (x 2), 128.8 (x 2), 131.8 (x 2), 133.7, 136.5, 137.8, 137.9, 138.2, 
148.8, 158.6, 175.2 ppm; HR FAB MS [M+H]
+
 calcd for C39H40NO5S 634.2627, found 
634.2626. 
 
Phenyl 2,3,4-Tri-O-benzyl-6-O-picoloyl-1-thio-β-D-glucopyranoside (4.4b).  Picolinic 
acid (0.27 g, 2.21 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 0.56 g, 
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2.95 mmol), and 4-dimethylaminopyridine (DMAP, 45 mg, 0.37 mmol) were added to a 
solution of phenyl 2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside13 (1.0 g, 1.84 mmol) in 
CH2Cl2 (10 mL) and the resulting mixture was stirred under argon 15 min at rt. The solid 
was filtered off and rinsed successively with CH2Cl2. The combined filtrate (~100 mL) 
was washed with brine (2 x 10 mL). The organic phase was separated, dried with magne-
sium sulfate, and concentrated in vacuo. The residue was purified by column chromatog-
raphy on silica gel (ethyl acetate - hexane gradient elution) to give the title compound as 
a white amorphous solid in 96% yield (1.12 g, 1.77 mmol). Analytical data for 4.4b: Rf = 
0.56 (ethyl acetate/hexane, 2/3, v/v); [α]D
25
 9.3 (c = 1.00, CHCl3); 
1
H NMR: δ, 3.58 (dd, 
1H, J2,3 = 9.3 Hz, H-2), 3.68 (dd, 1H, J4,5 = 9.2 Hz, H-4), 3.80 (m, 1H, H-5), 3.85 (dd, 
1H, J3,4 = 8.8 Hz, H-3), 4.61 (dd, 1H, J5,6a = 5.7 Hz, J6a,6b = 11.8 Hz, H-6a), 4.68-4.82 (m, 
3H, CH2Ph, H-6b), 4.77 (d, 1H, J
 
1,2 = 9.8 Hz, H-1), 4.89-5.01  (m, 4H, 2 x CH2Ph), 7.13-
7.59 (m, 21H, aromatic), 7.86 (t, 1H, J = 7.3 Hz, aromatic), 8.06 (d, 1H, J = 7.8 Hz, aro-
matic), 8.84 (d, 1H, J = 3.7 Hz, aromatic) ppm; 
13
C NMR: δ, 64.8, 75.0, 75.4, 75.8, 76.8, 
77.5, 80.7, 86.6, 87.3, 125.1, 126.8, 127.3, 127.7 (x 2), 127.8 (x 2), 127.9 (x 3), 128.1 (x 
2), 128.3 (x 2), 132.0 (x 2), 133.2, 136.7, 137.4, 137.7, 138.0, 147.7, 149.9, 164.5 ppm; 
HR FAB MS [M+H]
+
 calcd for C39H38NO6S 648.2420, found 648.2399. 
 
Phenyl 2,3,-Di-O-benzyl-4,6-di-O-picolinyl-1-thio-β-D-glucopyranoside (4.4c).  NaH 
(60% in mineral oil, 0.64 g, 16.1 mmol) and 2-(bromomethyl)pyridine hydrobromide 
(1.97 g, 7.8 mmol) were added to a solution of phenyl 2,3-di-O-benzyl-1-thio-β-D-
glucopyranoside
14
 (1.05 g, 2.6 mmol) in DMF (3.0 mL) and the resulting mixture was 
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stirred for 4 h at rt. The reaction mixture was quenched with ice water (15 mL, 30 min) 
and extracted with ethyl acetate / diethyl ether (1/1, v/v, 3 × 30 mL). The combined or-
ganic extract (~90 mL) was washed with cold water (3 × 10 mL). The organic phase was 
separated, dried with magnesium sulfate, filtered, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate - hexane gradient elu-
tion) to give the title compound as a white amorphous solid in 83% yield (1.47 g, 2.2 
mmol). Analytical data for 4.4c: Rf = 0.49 (methanol/dichloromethane, 1/9, v/v); [α]D
26 
+26.6 (c = 1.0, CHCl3); 
1
H NMR: δ, 3.53-3.88 (m, 6H, H-2, 3, 4, 5, 6a, 6b), 4.65-5.04 
(m, 8H, 4 x CH2Ph), 4.73 (d, 1H, J1,2 = 9.9 Hz, H-1), 7.14-7.71 (m, 21H, aromatic), 8.55 
(s, 2H, aromatic) ppm; 
13
C NMR: δ, 69.7, 74.0, 75.4, 75.6, 75.8, 78.3, 78.8, 80.8, 86.5, 
87.4, 121.3, 121.5, 122.3, 122.4, 127.4, 127.7, 127.9, 128.0 (x 2), 128.2 (x 2), 128.4 (x 2), 
128.5 (x 3), 128.9 (x 2), 131.9 (x 2), 133.7, 136.7, 136.8, 138.0, 138.2, 148.7, 149.1, 
158.0, 158.4 ppm; HR FAB MS [M+H]
+
 calcd for C38H39N2O5S 635.2580, found 
635.2583. 
 
4.4.3 Synthesis of di- and trisaccharides 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-picolinyl-D-
glucopyranosyl)--D-glucopyranoside (4.3a).  Table 4.1, entry 1.  A mixture of a gly-
cosyl donor 4.4a (20.0 mg, 0.034 mmol), glycosyl acceptor 2 (12.2 mg, 0.026 mmol), and 
freshly activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (2.0 mL) was stirred under 
argon for 30 min at rt. The mixture was cooled to -30 °C, DMTST (17.6 mg, 0.68 mmol) 
was added, and the resulting mixture was allowed to warm to rt and stirred for 5 h. After 
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that, Et3N (~0.3 mL) was added and the resulting mixture was stirred for 30 min at rt. The 
mixture was diluted with CH2Cl2 (~10 mL), the solid was filtered off and was washed 
successively with CH2Cl2. The combined filtrate (~40 mL) was washed with 20% aq. 
NaHCO3 (10 mL) and water (3 x 10 mL). The organic phase was separated, dried with 
sodium sulfate, and concentrated in vacuo. The residue was purified by column chroma-
tography on silica gel (ethyl acetate - hexane gradient elution) to give the title compound 
in 93% yield (α/β = 1/ 2.4, 24.1 mg, 0.024 mmol).  Analytical data for -4.3a: Rf  = 0.3 
(ethyl acetate / hexane, 3/7, v/v); 
1
H NMR: , 3.28 (s, 3H, OCH3), 3.37 (dd, 1H, J2,3 = 9.6 
Hz, H-2), 3.46 (dd, 1H, J2’,3’ = 9.5 Hz, H-2’), 3.52-3.76 (m, 7H, H-4, 5, 5’, 6a, 6b, 6a’, 
6b’), 3.91 (m, 3H, H-3, 3’, 4’), 4.46-4.91 (m, 16H, H-1, 1’, 7 x CH2Ph), 7.10-8.02 (m, 
33H, aromatic), 8.42 (s, 1H, aromatic) ppm; 
13C NMR: δ, 55.1, 66.0, 69.5, 70.2, 70.3, 
72.3, 73.3, 74.9, 75.0, 75.5, 75.7, 76.5, 77.5, 77.7, 80.0, 80.1, 81.6, 82.1, 97.1, 97.9, 
121.6, 122.5, 127.5-128.4 (x 31), 138.1, 138.3 (x 2), 138.7, 142.1, 142.2, 142.3, 157.9 
ppm; HR FAB MS [M+Na]
+
 calcd for C61H65NNaO11 1010.4455, found 1010.4443. 
 
Table 4.1, entry 3.  A mixture of a glycosyl donor 4.1a (20.0 mg, 0.033 mmol), glycosyl 
acceptor 4.2 (11.3 mg, 0.024 mmol), and freshly activated molecular sieves (4 Å, 100 
mg) in CH2Cl2 (2.0 mL) was stirred under argon for 30 min at rt. The mixture was cooled 
to -30 °C, DMTST (16.3 mg, 0.063 mmol) was added, and the resulting mixture was al-
lowed to warm to rt and stirred for 8 h. After that, Et3N (~0.3 mL) was added and the re-
sulting mixture was stirred for 30 min at rt. The mixture was diluted with CH2Cl2 (~10 
mL), the solid was filtered off and was washed successively with CH2Cl2. The combined 
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filtrate (~40 mL) was washed with 20% aq. NaHCO3 (10 mL) and water (3 x 10 mL). 
The organic phase was separated, dried with sodium sulfate, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate - hexane 
gradient elution). To give the title compound as a white amorphous solid in 79% ((α/β = 
1/ 1.5, 19.0 mg, 0.019 mmol).   
 
Table 4.2, entry 1.  A mixture of a glycosyl donor 4.1a (30.0 mg, 0.051 mmol), glycosyl 
acceptor 4.2 (18.3 mg, 0.039 mmol), and freshly activated molecular sieves (4 Å, 150 
mg) in CH2Cl2 (3.0 mL) was stirred under argon for 30 min at rt. PdBr2 (20.4 mg, 0.077 
mmol) was added to reaction and stirred for 3 h at rt. The mixture was then cooled to -30 
°C, DMTST (26.5 mg, 0.102 mmol) was added, and the resulting mixture was allowed to 
warm to rt and stirred for 8 h. After that, DMAP (19.3 mg, 0.156 mmol) was added and 
the resulting mixture was stirred for 30 min at rt. The resulting pale yellow mixture was 
diluted with CH2Cl2 (~10 mL), the solid was filtered off and was washed successively 
with CH2Cl2. The combined filtrate (~40 mL) was washed with water (3 x 10 mL). The 
organic phase was separated, dried over sodium sulfate, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate - hexane gra-
dient elution) to give the title compound in 97% yield (α/β = 2.1/1, 37.7 mg, 0.038 
mmol).   
 
Table 4.2, entry 5.  A mixture of a glycosyl donor 4.4a (21.4 mg, 0.036 mmol), glycosyl 
acceptor 4.2 (13.1 mg, 0.028 mmol), and freshly activated molecular sieves (4 Å, 100 
168 
 
mg) in CH2Cl2 (2.0 mL) was stirred under argon for 30 min at rt. PdBr2 (14.6 mg, 0.055 
mmol) was added to reaction and stirred for 3 h at rt. The mixture was then cooled to -30 
°C, DMTST (18.9 mg, 0.073 mmol) was added, and the resulting mixture was allowed to 
warm to rt and stirred for 8 h. After that, DMAP (13.8 mg, 0.112 mmol) was added and 
the resulting mixture was stirred for 30 min at rt. The resulting pale yellow mixture was 
diluted with CH2Cl2 (~10 mL), the solid was filtered off and was washed successively 
with CH2Cl2. The combined filtrate (~40 mL) was washed with water (3 x 10 mL). The 
organic phase was separated, dried over sodium sulfate, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate - hexane gra-
dient elution) to give the title compound in 97% yield (α/β = 2.5/1, 26.9 mg, 0.027 
mmol). 
 
Table 4.2, entry 7.  A mixture of a glycosyl donor 4.4a (15.1 mg, 0.024 mmol), glycosyl 
acceptor 4.2 (8.5 mg, 0.018 mmol), and freshly activated molecular sieves (4 Å, 100 mg) 
in CH2Cl2 (2.0 mL) was stirred under argon for 30 min at rt. PdBr2 (9.5 mg, 0.036 mmol) 
was added to reaction and stirred for 3 h at rt. The mixture was then cooled to -30 °C, 
DMTST (8.0 mg, 0.031 mmol) was added, and the resulting mixture was allowed to 
warm to rt and stirred for 8 h. After that, DMAP (8.9 mg, 0.073 mmol) was added and the 
resulting mixture was stirred for 30 min at rt. The resulting pale yellow mixture was di-
luted with CH2Cl2 (~10 mL), the solid was filtered off and was washed successively with 
CH2Cl2. The combined filtrate (~40 mL) was washed with water (3 x 10 mL). The organ-
ic phase was separated, dried over sodium sulfate, and concentrated in vacuo. The residue 
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was purified by column chromatography on silica gel (ethyl acetate - hexane gradient elu-
tion) to give the title compound in 89% yield (α/β = 12.5/1, 16.1 mg, 0.016 mmol).   
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-picoloyl--D-glucopyranosyl) 
--D-glucopyranoside (-4.3b). Table 4.1, entry 2.  A mixture of a glycosyl donor 4.1b 
(20.0 mg, 0.033 mmol), glycosyl acceptor 4.2 (11.9 mg, 0.026 mmol), and freshly acti-
vated molecular sieves (4 Å, 100 mg) in CH2Cl2 (2.0 mL) was stirred under argon for 30 
min at rt. The mixture was cooled to -30 °C, DMTST (17.2 mg, 0.067 mmol) was added, 
and the resulting mixture was allowed to warm to rt and stirred for 1.5 h. After that, Et3N 
(~0.3 mL) was added and the resulting mixture was stirred for 30 min at rt. The mixture 
was diluted with CH2Cl2 (~10 mL), the solid was filtered off and was washed successive-
ly with CH2Cl2. The combined filtrate (~40 mL) was washed with 20% aq. NaHCO3 (10 
mL) and water (3 x 10 mL). The organic phase was separated, dried with sodium sulfate, 
and concentrated in vacuo. The residue was purified by column chromatography on silica 
gel (ethyl acetate - hexane gradient elution). To give the title compound as a white amor-
phous solid in 96 % (β only, 24.3 mg, 0.025 mmol). Analytical data for title compound 
were essentially the same as reported previously.
5
  
 
Table 4.1, entry 4.  A mixture of a glycosyl donor 4.4b (20.1 mg, 0.031 mmol), glycosyl 
acceptor 4.2 (11.1 mg, 0.024 mmol), and freshly activated molecular sieves (4 Å, 100 
mg) in CH2Cl2 (2.0 mL) was stirred under argon for 30 min at rt. The mixture was cooled 
to -30 °C, DMTST (14.3 mg, 0.062 mmol) was added, and the resulting mixture was al-
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lowed to warm to rt and stirred for 8 h. After that, Et3N (~0.3 mL) was added and the re-
sulting mixture was stirred for 30 min at rt. The mixture was diluted with CH2Cl2 (~10 
mL), the solid was filtered off and was washed successively with CH2Cl2. The combined 
filtrate (~40 mL) was washed with 20% aq. NaHCO3 (10 mL) and water (3 x 10 mL). 
The organic phase was separated, dried with sodium sulfate, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate - hexane 
gradient elution). To give the title compound as a white amorphous solid in 88% (β only, 
20.7 mg, 0.021 mmol).   
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-picoloyl--D-
glucopyranosyl)--D-glucopyranoside (-4.3b).  Table 4.2, entry 6.  A mixture of a 
glycosyl donor 4.4b (31.6 mg, 0.049 mmol), glycosyl acceptor 4.2 (17.4 mg, 0.037 
mmol), and freshly activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (2.0 mL) was 
stirred under argon for 30 min at rt. PdBr2 (19.5 mg, 0.073 mmol) was added to reaction 
and stirred for 3 h at rt. The mixture was then cooled to -30 °C, DMTST (25.1 mg, 0.097 
mmol) was added, and the resulting mixture was allowed to warm to rt and stirred for 8 h. 
After that, DMAP (18.3 mg, .149 mmol) was added and the resulting mixture was stirred 
for 30 min at rt. The resulting pale yellow mixture was diluted with CH2Cl2 (~10 mL), 
the solid was filtered off and was washed successively with CH2Cl2. The combined fil-
trate (~40 mL) was washed with water (3 x 10 mL). The organic phase was separated, 
dried over sodium sulfate, and concentrated in vacuo. The residue was purified by col-
umn chromatography on silica gel (ethyl acetate - hexane gradient elution) to give the 
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title compound in 84% yield (α/β = 3.9/1, 31.2 mg, 0.032 mmol).  Selected analytical da-
ta for -4.3b: 1H NMR: , 3.28 (s, 3H, OCH3), 3.31 (dd, 1H, J2’,3’ = 8.7 Hz, H-2’), 3.43-
3.78 (m, 6H, H-2, 4, 4’, 5’, 6a’, 6b’), 3.84-4.02 (m, 3H, H-3, 3’, 5), 4.42-5.00 (m, 14H, 
J1’,2’ = 3.5 Hz, H-1, 1’, 6 x CH2Ph), 7.00-7.95 (m, 33 H, aromatic), 8.66 (dd, 1H, 
2
J = 4.5 
Hz, aromatic) ppm; 
13
C NMR: , 96.8, 97.8 ppm; HR FAB MS [M+Na]+ calcd for 
C61H63NNaO12 1024.4248, found 1024.4276. 
 
Table 4.2, entry 8. A mixture of a glycosyl donor 4.4b (20.0 mg, 0.031 mmol), glycosyl 
acceptor 4.2 (11.1 mg, 0.024 mmol), and freshly activated molecular sieves (4 Å, 100 
mg) in CH2Cl2 (2.5 mL) was stirred under argon for 30 min at rt. PdBr2 (12.4mg, 0.046 
mmol) was added to reaction and stirred for 3 h at rt. The mixture was then cooled to -30 
°C, DMTST (11.6 mg, 0.095 mmol) was added, and the resulting mixture was allowed to 
warm to rt and stirred for 8 h. After that, DMAP (11.6 mg, .095 mmol) was added and the 
resulting mixture was stirred for 30 min at rt. The resulting pale yellow mixture was di-
luted with CH2Cl2 (~10 mL), the solid was filtered off and was washed successively with 
CH2Cl2. The combined filtrate (~40 mL) was washed with water (3 x 10 mL). The organ-
ic phase was separated, dried over sodium sulfate, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate - hexane gradient elu-
tion) to give the title compound in 88% yield (α/β = 6.3/1, 20.6 mg, 0.025 mmol).   
 
Methyl 2,3,6-Tri-O-benzyl-4-O-(2,3,4-tri-O-benzyl-6-O-picolinyl-/-D-
glucopyranosyl)--D-glucopyranoside (4.7).  Table 4.2, entry 2.  A mixture of a glyco-
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syl donor 4.1a (19.7 mg, 0.034 mmol), glycosyl acceptor 4.6 (12.0 mg, 0.026 mmol), and 
freshly activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (2 mL) was stirred under ar-
gon for 30 min at rt. PdBr2 (13.1 mg, 0.049 mmol) was added to reaction and stirred for 3 
h at rt. The mixture was then cooled to -30 °C, DMTST (17.4 mg, 0.067 mmol) was add-
ed, and the resulting mixture was allowed to warm to rt and stirred for 6 h. After that, 
DMAP (13 mg, .103 mmol) was added and the resulting mixture was stirred for 30 min at 
rt. The resulting pale yellow mixture was diluted with CH2Cl2 (~10 mL), the solid was 
filtered off and was washed successively with CH2Cl2. The combined filtrate (~40 mL) 
was washed with water (3 x 10 mL). The organic phase was separated, dried over sodium 
sulfate, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to give the title compound in 96% 
yield (α/β = 8.3 / 1, 24.5 mg, 0.025 mmol).  Analytical data for -4.7: Rf  = 0.31 (ethyl 
acetate / hexane, 3/7, v/v);  
1
H NMR: , 3.37 (s, 3H, OCH3), 3.47 (m, 1H, H-6a), 3.49 
(dd, 1H, J2’,3’ = 11.3 Hz, H-2’), 3.56 (m, 1H, H-6a), 3.58 (dd, 1H, J2,3 = 9.3 Hz, H-2), 
3.66 (m, 2H, H-6b, 6b’), 3.75 (m, 1H, H-5’), 3.82 (dd, 1H, J4’,5’ = 9.9 Hz, H-4’), 3.85 (m, 
1H, H-5), 3.93 (dd, 1H, J3’,4’ = 9.3 Hz, H-3’), 4.03 (dd, 1H, J4,5 = 9.1 Hz, H-4), 4.08 (dd, 
1H, J3,4 = 9.0 Hz, H-3), 4.50-5.04 ( m, 14H, 7 x CH2Ph), 4.61 (d, 1H, J1,2 = 3.8 Hz, H-1), 
5.69 (d, 1H, J1’,2’ = 3.5 Hz, H-1’), 7.10-8.02 (m, 33H, aromatic), 8.50 (s, 1H, aromatic) 
ppm; 
13
C NMR: , 55.1, 68.9, 69.2, 69.4, 70.8, 72.1, 73.2 (x 2), 73.3 (x 2), 74.3, 74.9, 
75.5, 77.5, 79.5, 80.1, 82.0 (x 2), 96.4, 97.7, 121.5, 122.8, 126.7-128.4 (x 31), 137.9 (x 
3), 138.0, 138.3, 138.6, 138.9, 151.5 ppm; HR FAB MS [M+Na]
+
 calcd for 
C61H65NNaO11 1010.4455, found 1010.4468. 
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Table 4.2, entry 9.  A mixture of a glycosyl donor 4.4a (30.0 mg, 0.048 mmol), glycosyl 
acceptor 4.6 (17.1 mg, 0.037 mmol), and freshly activated molecular sieves (4 Å, 100 
mg) in CH2Cl2 (3 mL) was stirred under argon for 30 min at rt. PdBr2 (19.1 mg, 0.072 
mmol) was added to reaction and stirred for 3 h at rt. The mixture was then cooled to -30 
°C, DMTST (16.2 mg, 0.066 mmol) was added, and the resulting mixture was allowed to 
warm to rt and stirred for 6 h. After that, DMAP (14mg, .121 mmol) was added and the 
resulting mixture was stirred for 30 min at rt. The resulting pale yellow mixture was di-
luted with CH2Cl2 (~10 mL), the solid was filtered off and was washed successively with 
CH2Cl2. The combined filtrate (~40 mL) was washed with water (3 x 10 mL). The organ-
ic phase was separated, dried over sodium sulfate, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate - hexane gradient elu-
tion) to give the title compound in 69% yield (α/β = 8.1 / 1, 25.2 mg, 0.025 mmol).   
 
Methyl 2,4,6-Tri-O-benzyl-3-O-(2,3,4-tri-O-benzyl-6-O-picolinyl-/D-
glucopyranosyl)--D-glucopyranoside (4.9).  Table 4.2, entry 3. A mixture of a glyco-
syl donor 4.1a (18.0 mg, 0.031 mmol), glycosyl acceptor 4.8
9
 (11.0 mg, 0.024 mmol), 
and freshly activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (2 mL) was stirred under 
argon for 30 min at rt. PdBr2 (12.3 mg, 0.046 mmol) was added to reaction and stirred for 
3 h at rt. The mixture was then cooled to -30 °C, DMTST (15.9 mg, 0.062 mmol) was 
added, and the resulting mixture was allowed to warm to rt and stirred for 8 h. After that, 
DMAP (11.6 mg, 0.094 mmol) was added and the resulting mixture was stirred for 30 
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min at rt. The resulting pale yellow mixture was diluted with CH2Cl2 (~10 mL), the solid 
was filtered off and was washed successively with CH2Cl2. The combined filtrate (~40 
mL) was washed with water (3 x 10 mL). The organic phase was separated, dried over 
sodium sulfate, and concentrated in vacuo. The residue was purified by column chroma-
tography on silica gel (ethyl acetate - hexane gradient elution) to give the title compound 
in 94% yield (α/β = 4.5 / 1, 22.1 mg, 0.022 mmol).  Analytical data for -4.9: Rf  = 0.31 
(ethyl acetate / hexane, 3/7, v/v); 
1
H NMR: δ, 3.27 (s, 3H, OCH3), 3.52-3.76 (m, 9H, H-2, 
2’, 4, 4’, 5, 6a, 6b, 6a’, 6b’), 4.04 (dd, 1H, J3,4 = 9.4 Hz, H-3), 4.21 (dd, 1H, J3’,4’ = 9.0 
Hz, H-3’), 4.32-4.41 (m, 3H, H-5’, CH2Ph), 4.45-4.65 (m, 8H, 4 x CH2Ph), 4.62 (d, 1H, 
J1,2 = 5.1 Hz, H-1), 4.80-4.90 (m, 4H, 2 x CH2Ph), 5.55 (d, 1H, J1’,2’ = 3.3 Hz, H-1’), 
6.95-7.59 (m, 33H, aromatic), 8.45 (s, 1H, aromatic) ppm; 
13
C NMR: , 55.0, 68.4, 69.3, 
69.4, 70.1, 73.1, 73.4 (x 2), 73.5 (x 2), 74.8, 75.5, 76.5, 78.0, 78.5, 78.6, 76.9, 82.3, 97.3, 
97.5, 121.6, 122.3, 126.7-128.7 (x 31), 137.7 (x 2), 137.9, 138.3, 138.6, 138.7, 148.1, 
158.1 ppm; HR FAB MS [M+Na]
+
 calcd for C61H65NNaO11 1010.4455, found 
1010.4476. 
 
Table 4.2, entry 10.  A mixture of a glycosyl donor 4.4a (30.0 mg, 0.048 mmol), glyco-
syl acceptor 4.8
9
 (17.3 mg, 0.037 mmol), and freshly activated molecular sieves (4 Å, 150 
mg) in CH2Cl2 (3 mL) was stirred under argon for 30 min at rt. PdBr2 (19.3 mg, 0.073 
mmol) was added to reaction and stirred for 3 h at rt. The mixture was then cooled to -30 
°C, DMTST (16.8 mg, 0.065 mmol) was added, and the resulting mixture was allowed to 
warm to rt and stirred for 8 h. After that, DMAP (18.2 mg, 0.149 mmol) was added and 
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the resulting mixture was stirred for 30 min at rt. The resulting pale yellow mixture was 
diluted with CH2Cl2 (~10 mL), the solid was filtered off and was washed successively 
with CH2Cl2. The combined filtrate (~40 mL) was washed with water (3 x 10 mL). The 
organic phase was separated, dried over sodium sulfate, and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel (ethyl acetate - hexane gra-
dient elution) to give the title compound in 94% yield (α/β = 6.7 / 1, 34.5 mg, 0.035 
mmol).   
 
Methyl 3,4,6-Tri-O-benzyl-2-O-(2,3,4-tri-O-benzyl-6-O-picolinyl-/D-
glucopyranosyl)--D-glucopyranoside (4.11).  Table 4.2, entry 4.  A mixture of a gly-
cosyl donor 4.1a (20.0 mg, 0.034 mmol), glycosyl acceptor 4.10
9
 (12.2 mg, 0.026 mmol), 
and freshly activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (2 mL) was stirred under 
argon for 30 min at rt. PdBr2 (13.6 mg, 0.051 mmol) was added to reaction and stirred for 
3 h at rt. The mixture was then cooled to -30 °C, DMTST (17.6 mg, 0.68 mmol) was add-
ed, and the resulting mixture was allowed to warm to rt and stirred for 8 h. After that, 
DMAP (12.8 mg, 0.105 mmol) was added and the resulting mixture was stirred for 30 
min at rt. The resulting pale yellow mixture was diluted with CH2Cl2 (~10 mL), the solid 
was filtered off and was washed successively with CH2Cl2. The combined filtrate (~40 
mL) was washed with water (3 x 10 mL). The organic phase was separated, dried over 
sodium sulfate, and concentrated in vacuo. The residue was purified by column chroma-
tography on silica gel (ethyl acetate - hexane gradient elution) to give the title compound 
in 85% yield (α/β = 13.6/1, 22.0 mg, 0.022 mmol).  
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Table 4.2, entry 11.  A mixture of a glycosyl donor 4.4a (32.6 mg, 0.051 mmol), glyco-
syl acceptor 4.10
9
 (18.4 mg, 0.040 mmol), and freshly activated molecular sieves (4 Å, 
100 mg) in CH2Cl2 (3 mL) was stirred under argon for 30 min at rt. PdBr2 (20.6 mg, 
0.077 mmol) was added to reaction and stirred for 3 h at rt. The mixture was then cooled 
to -30 °C, DMTST (17.4 mg, 0.67 mmol) was added, and the resulting mixture was al-
lowed to warm to rt and stirred for 8 h. After that, DMAP (19mg, 0.152 mmol) was add-
ed and the resulting mixture was stirred for 30 min at rt. The resulting pale yellow mix-
ture was diluted with CH2Cl2 (~10 mL), the solid was filtered off and was washed suc-
cessively with CH2Cl2. The combined filtrate (~40 mL) was washed with water (3 x 10 
mL). The organic phase was separated, dried over sodium sulfate, and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate - 
hexane gradient elution) to give the title compound in 84% yield (α/β = 22.5/1, 32.9 mg, 
0.034 mmol).  Analytical data for -4.11: Rf  = 0.28 (ethyl acetate / hexane, 3/7, v/v); 
1
H 
NMR: , 3.38 (s, 3H, OCH3), 3.45-3.76 (m, 8H, H-2’, 4’, 5, 5’, 6a, 6a’, 6b, 6b’), 3.78 (dd, 
1H, J2,3 = 9.3 Hz, H-2), 3.97-4.06 (m, 3H, H-3, 3’, 4), 4.39-4.94 (m, 14H, 7 x CH2Ph), 
4.77 (d, 1H, J1,2 = 3.1 Hz, H-1), 4.84 (d, 1H, J1’,2’ = 5.0 Hz, H-1’), 6.94-7.33 (m, 32H, ar-
omatic), 7.52 (s, 1H, aromatic), 8.42 (s, 1H, aromatic) ppm; 
13
C NMR: , 54.9, 68.5, 
69.4, 70.0, 70.1, 72.9, 73.5 (x 2), 74.7, 74.9, 75.0, 75.7, 76.1, 77.5, 77.9, 79.1, 80.6, 82.1, 
94.2, 96.4, 122.2, 123.0, 127.5-128.4 (x 31), 137.8, 138.1, 138.2, 138.3, 138.5, 138.6, 
148.1, 157.6 ppm; HR FAB MS [M+H]
+
 calcd for C61H66NO11  988.4636, found 
988.4669. 
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Methyl 2,3,4-Tri-O-benzoyl-6-O-(2,3,4-tri-O-benzyl-6-O-picolinyl--D-
glucopyranosyl)--D-glucopyranoside (4.13).  Table 2, entry 12.  A mixture of a glyco-
syl donor 4.4a (25.5 mg, 0.040 mmol), glycosyl acceptor 4.12 (15.7 mg, 0.031 mmol), 
and freshly activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (3 mL) was stirred under 
argon for 30 min at rt. PdBr2 (16.1 mg, 0.060 mmol) was added to reaction and stirred for 
3 h at rt. The mixture was then cooled to -30 °C, DMTST (13.6mg, 0.053 mmol) was 
added, and the resulting mixture was allowed to warm to rt and stirred for 6 h. After that, 
DMAP (15.2 mg, 0.124 mmol) was added and the resulting mixture was stirred for 30 
min at rt. The resulting pale yellow mixture was diluted with CH2Cl2 (~10 mL), the solid 
was filtered off and was washed successively with CH2Cl2. The combined filtrate (~40 
mL) was washed with water (3 x 10 mL). The organic phase was separated, dried over 
sodium sulfate, and concentrated in vacuo. The residue was purified by column chroma-
tography on silica gel (ethyl acetate - hexane gradient elution) to give the title compound 
in 89% yield (α-only, 27.2 mg, 0.028 mmol).  Analytical data for compound 4.13: Rf = 
0.30 (ethyl acetate / hexane, 3/7, v/v); []D
24
 51.7 (c = 1.00, CHCl3);  
1
H NMR: , 3.37 
(s, 3H, OCH3), 3.47 (dd, 1H, J2,3 = 9.4 Hz, H-2), 3.51-3.66 (m, 5H, H-5, 6a, 6b, 6a’, 6b’), 
3.76-3.82 (m, 2H, H-4, 5’), 3-92 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.25 (m, 1H, H-4’), 4.42-
4.58 ( m, 4H, 2 x CH2Ph ), 4.67 (d, 1H, J1,2 = 4.9 Hz, H-1), 4.69-4.87 (m, 3H, 1 ½ x 
CH2Ph), 5.14 (m, 1H, ½ CH2Ph), 5.15 (d, 1H, J1’,2’ = 4.8 Hz, H-1’), 5.45 (dd, 1H, J3’,4’ = 
9.9 Hz, H-3’), 6.06 (dd, 1H, J = 9.8, Hz, H-2’), 7.04-7.46 (m, 27H, aromatic), 7.78-7.92 
(m, 6H, aromatic), 8.42 (dd, 1H, 
2
J = 4.5 Hz, aromatic) ppm; 
13
C NMR: , 55.6, 66.6, 
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68.5, 69.2, 69.6, 70.2, 70.6, 72.2, 73.1, 74.1, 74.8, 75.6, 77.2, 80.0, 81.7, 96.7, 97.2, 
121.2, 122.2, 127.5-129.9 (x 31), 133.0, 133.4, 136.6, 138.4, 138.5, 138.8, 148.9, 158.4, 
165.2, 165.8 (x 2) ppm; HR FAB MS [M+Na]
+
 calcd for C61H59NNaO14 1052.3833, 
found 1052.3839. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3-di-O-benzyl-4,6-di-O-picoloyl-/D-
glucopyranosyl)--D-glucopyranoside (4.14).  A mixture of a glycosyl donor 4.4c (24.6 
mg, 0.042 mmol), glycosyl acceptor 4.2 (15.0 mg, 0.032 mmol), and freshly activated 
molecular sieves (4 Å, 100 mg) in CH2Cl2 (3 mL) was stirred under argon for 30 min at 
rt. PdBr2 (16.7 mg, 0.063 mmol) was added to reaction and stirred for 3 h at rt. The mix-
ture was then cooled to -30 °C, DMTST (14.2 mg, 0.055 mmol) was added, and the re-
sulting mixture was allowed to warm to rt and stirred for 8 h. After that, DMAP (15.8 
mg, 0.129 mmol) was added and the resulting mixture was stirred for 30 min at rt. The 
resulting pale yellow mixture was diluted with CH2Cl2 (~10 mL), the solid was filtered 
off and was washed successively with CH2Cl2. The combined filtrate (~40 mL) was 
washed with water (3 x 10 mL). The organic phase was separated, dried over sodium sul-
fate, and concentrated in vacuo. The residue was purified by column chromatography on 
silica gel (ethyl acetate - hexane gradient elution) to give the title compound was obtained 
as a white amorphous solid from glycosyl donor 4.1c and acceptor 4.2
9
 in 73% yield 
(α/β= 1 /1.4, 23.4 mg, 0.024 mmol).  Selected analytical data for compound 4.14; 1H 
NMR: , 4.41 (d, 1H, J1’,2’ = 7.8 Hz, H-1’), 5. 07 (d, 1H, J1’,2’ = 3.3 Hz, H-1’); 
13
C NMR: 
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, 96.0, 102.8 ppm; HR FAB MS [M+H]+ calcd for C60H65N2O11 989.4588, found 
989.4573. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl--D-glucopyranosyl)--D-
glucopyranoside (4.15).  Cu(OAc)2 (14.1 mg, 0.08mmol) was added to a solution of 
4.3b (60 mg, 0.06 mmol) in CH2Cl2 (7.5 mL) and MeOH (0.3 mL), and the resulting mix-
ture was stirred for 3 h at rt. The reaction mixture was then diluted with CH2Cl2 (~50 mL) 
and washed with water (2 x 5 mL). The organic phase was separated, dried over sodium 
sulfate, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexane gradient elution) to afford 4.15 as an amorphous solid 
in 89% yield (48 mg, 0.08mmol). Analytical data for 4.15: Rf  = 0.51 (ethyl acetate / hex-
ane, 3/7, v/v); []D
24
 19.8 (c = 1.00, CHCl3); 
1
H NMR: , 3.28-3.38 (m, 1H, H-5’), 3.30 
(s, 3H, OCH3), 3.46 (dd, 1H, J2’,3’ = 8.7 Hz, H-2’), 3.48-3.60 (m, 3H, H-2, 4, 4’), 3.61-
3.73 (m, 3H, H-3’, 6a, 6a’), 3.75-3.88 (m, 2H, H-5, 6b’), 3.99 (dd, 1H, J3, 4 = 9.2 Hz, H-
3), 4.09 (dd, 1H, J5, 6b = 1.3 Hz,  J6a, 6b = 10.6 Hz, H-6b), 4.37 (dd, 1H, J1’,2’ = 7.8 Hz, H-
1’), 4.49 (d, 1H, 2J = 11.2 Hz, ½ CH2Ph), 4.58- 5.02 (m, 12H, H-1, 5½ x CH2Ph), 7.10-
7.40 (m, 30 H, aromatic) ppm; 
13
C NMR: , 55.5, 62.3, 70.1, 73.6, 75.9, 77.8, 78.0, 80.0, 
82.2 (x 2), 84.8, 98.4, 104.0, 127.8-128.7 (x 36), 138.2, 138.3, 138.4, 138.5, 138.6, 139.0 
ppm; HR FAB MS [M+Na]
+
 calcd for C55H60NaO11 919.4033, found 919.4038. 
 
Methyl O-(2,3,4-tri-O-benzyl-6-O-picolinyl--D-glucopyranosyl)-(16)-O-(2,3,4-tri-
O-benzyl--D-glucopyranosyl)-(16)-2,3,4-tri-O-benzyl--D-glucopyranoside 
180 
 
(4.16).  A mixture of a glycosyl donor 4.4a (37.7 mg, 0.059 mmol), glycosyl acceptor 
4.15 (41.0 mg, 0.046 mmol), and freshly activated molecular sieves (4 Å, 200 mg) in 
CH2Cl2 (5 mL) was stirred under argon for 30 min at rt. PdBr2 (23.7 mg, 0.089 mmol) 
was added to reaction and stirred for 3 h at rt. The mixture was then cooled to -30 °C, 
DMTST (30.7 mg, 0.119 mmol) was added, and the resulting mixture was allowed to 
warm to rt and stirred for 6 h. After that, DMAP (22.3 mg, .183 mmol) was added and the 
resulting mixture was stirred for 30 min at rt. The resulting pale yellow mixture was di-
luted with CH2Cl2 (~20 mL), the solid was filtered off and was washed successively with 
CH2Cl2. The combined filtrate (~80 mL) was washed with water (3 x 20 mL). The organ-
ic phase was separated, dried over sodium sulfate, and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate - hexane gradient elu-
tion) to give the title compound in 77% yield (α only, 50.0 mg, 0.035 mmol).  Analytical 
data for compound 16:  Rf  = 0.36 (ethyl acetate / hexane, 3/7, v/v); []D
25
 33.2 (c = 1.00, 
CHCl3); 
1
H NMR: , 3.14 (s, 3H, OCH3), 3.26 (dd, 1H, J2’,3’ = 8.6 Hz, H-2’), 3.36 (m, 
1H, 6b”), 3.39 (dd, 1H, J2”,3” = 9.5 Hz, H-2”), 3.46 (m, 2H, H-6b, 6b’), 3.53 (dd, 1H, J2,3 
= 9.5 Hz, H-2), 3.58-3.79 (m, 9H, H-4, 4’, 4”, 5, 5’, 5”, 6a, 6a’, 6a”), 3.87-3.93 (m, 2H, 
H-3’, 3”), 4.04 (dd, 1H, J3,4= 9.8 Hz, H-3), 4.27 (d, 1H, J1,2 = 7.9 Hz, H-1’), 4.41 (m, 1H, 
½ CH2Ph), 4.46 (d, 1H, J1”,2” = 3.5 Hz, H-1”), 4.47-4.50 (m, 2H, CH2Ph), 4.53-4.62 (m, 
6H, 3 x CH2Ph), 4.66-4.71 (m, 5H, 2½ x CH2Ph), 4.79-4.81 (dd, 4H, 
2
J = 10.8 Hz, 2 x 
CH2Ph), 4.89 (dd, 2H, 
2
J = 10.8 Hz, CH2Ph), 4.98 (d, 1H, J1,2 = 3.2 Hz, H-1), 7.04-7.34 
(m, 47H, aromatic), 7.53 (td, 1H, J = 1.6, 7.6 Hz, aromatic), 8.54 (d, 1H, J = 4.5 Hz, ar-
omatic) ppm; 
13
C NMR: , 55.1, 65.7, 67.9, 69.4, 69.8, 70.2, 72.2, 73.3, 74.0, 74.8 (x 2), 
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74.9 (x 3), 75.5 (x 2), 76.5, 77.4, 77.5, 77.7, 79.8, 80.1, 81.6, 81.9, 82.1, 84.6, 97.2, 98.0, 
103.4, 121.2, 122.2, 127.4-128.4 (x 45), 136.1, 138.0, 138.2, 138.3 (x 2), 138.4 (x 2), 
138.5, 138.7, 138.8, 148.7, 158.3 ppm; HR FAB MS [M+Na]
+
 calcd for C88H93NNaO16 
1442.6392, found 1442.6394. 
 
4.4.4 Synthesis of glycosyl donor complexes with PdBr2 
Complex 4.5a.  A mixture of a glycosyl donor 4.1a (30.0 mg, 0.051 mmol) and freshly 
activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (3.0 mL) was stirred under argon for 
30 min at rt. PdBr2 (17.7 mg, 0.067 mmol) was added and the resulting mixture was 
stirred for 3 h at rt. The resulting dark brown mixture was diluted with CH2Cl2 (10 mL), 
the solid was filtered off, and the residue was washed successively with CH2Cl2. The fil-
trate (~40 mL) was then concentrated in vacuo to give the title complex as an amber yel-
low solid in 83% yield (36.5 mg, 0.043 mmol). Selected analytical data for 4.5a: Rf  = 
0.59 (ethyl acetate / hexane, 1/1, v/v); 
1
H NMR: , 3.99 (m, 2H, H-6a, 6b) 4.52 (d, 1H, 
J1,2 = 9.72 Hz, H-1), 4.70-5.00 (m, 6H, 3 x CH2Ph), 5.63-5.79 (m, 2H, CH2Ph), 7.24-7.98 
(m, 18H, aromatic), 8.89 (d, 1H, J = 5.4 Hz, aromatic) ppm; 
13
C NMR: , 15.2, 25.2,  
65.4, 70.6, 74.4, 75.3, 75.6, 75.9, 78.9, 81.8, 85.3, 86.7, 127.7 (x 2), 127.8 (x 2), 127.9 (x 
2), 128.1 (x 2), 128.4 (x 3), 128.5 (x 4), 128.6 (x 2), 138.0, 138.5 ppm; HR FAB MS [M-
Br]
+
 calcd for C35H39BrNO5PdS 770.0767, found 770.0770 
 
Complex 4.5b.  A mixture of a glycosyl donor 4.1b (30.0 mg, 0.050 mmol) and freshly 
activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (3.0 mL) was stirred under argon for 
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30 min at rt. PdBr2 (17.3 mg, 0.065 mmol) was added and the resulting mixture was 
stirred for 3 h at rt. The resulting dark brown mixture was diluted with CH2Cl2 (10 mL), 
the solid was filtered off, and the residue was washed successively with CH2Cl2. The fil-
trate (~40 mL) was then concentrated in vacuo to give the title complex as an amber yel-
low solid in 91% yield (38.9 mg, 0.045 mmol). Selected analytical data for 4.5b: Rf  = 
0.65 (acetone/ toluene, 1/4, v/v); 
1
H NMR: , 1.27 (t, 3H, J = 7.5 Hz, SCH2CH3), 2.90 
(m, 1H, SCH2
a
CH3), 3.24 (m, 1H, SCH2
b
CH3), 3.66-3.90 (m, 2H, H-2, 3), 4.05 (m, 1H, 
H-5), 4.20 (dd, 1H, J4,5 = 9.7 Hz, H-4), 4.42 (dd, 1H, J6a, 6b = 9.2 Hz, H-6a), 4.55-4.75 (m, 
4H, H-1, 6b, CH2Ph), 4.78-5.05 (m, 4H, 2 x CH2Ph), 7.00-8.20 (m, 18H, aromatic), 9.11 
(d, 1H, J = 5.2 Hz, aromatic) ppm; 
13
C NMR: , 13.5, 32.9, 64.0, 73.9, 75.3, 75.4, 75.6, 
76.3, 79.2, 84.2, 89.2, 128.0 (x 2), 128.1 (x 4), 128.2 (x 4), 128.6 (x 4), 128.7 (x 2), 
129.1, 137.3, 138.0, 138.2, 139.1, 150.6, 154.7, 163.7 ppm; HR FAB MS [M-Br]
+
 calcd 
for C35H37BrNO6PdS 784.0560, found 784.0247. 
 
Complex 4.5c.  A mixture of a glycosyl donor 4.4c (30.0 mg, 0.047 mmol) and freshly 
activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (3.0 mL) was stirred under argon for 
30 min at rt. PdBr2 (16.3 mg, 0.061 mmol) was added and the resulting mixture was 
stirred for 3 h at rt. The resulting dark brown mixture was diluted with CH2Cl2 (10 mL), 
the solid was filtered off, and the residue was washed successively with CH2Cl2. The fil-
trate (~40 mL) was then concentrated in vacuo to give the title complex as an bright yel-
low solid in 93% yield (39.7 mg, 0.044 mmol)  Analytical data for 4.5c: Rf  = 0.69 (meth-
anol/ CH2Cl2, 1/ 19, v/v); 
1
H NMR: , 3.35-3.60 (m, 3H, H-2, 3, 4),  4.26 (dd, 2H, 2J = 
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11.0 Hz, CH2Ph), 4.40-4.80 (m, 5H, H-5, 6a, 6b, CH2Ph), 4.90-5.15 (m, 3H, H-1, 
CH2Ph), 5.80 (dd, 2H, 
2
J = 13.0 Hz, CH2Ph), 6.70-7.70 (m, 21H, aromatic), 8.82 (d, 1H, 
J = 5.4 Hz, aromatic), 9.03 (m, 1H, J = 5.3 Hz, aromatic) ppm; 
13
C NMR: , 70.3, 74.4, 
74.5, 75.1, 75.4 (x 2), 79.7, 80.0, 85.2, 87.5, 124.1 (x 2), 126.4 (x 2), 126.6, 126.9, 127.0, 
127.6, 127.8, 128.1 (x 2), 128.3 (x 2), 128.4 (x 2), 129.2 (x 2), 131.0 (x 2), 134.0, 137.9, 
138.2, 138.8, 139.0, 153.2, 154.7, 158.3, 159.4 ppm; HR FAB MS [M-Br]
+
 calcd for 
C38H38BrN2O5PdS 819.0720, found 819.0193. 
 
Complex 4.5d.  A mixture of a glycosyl donor 4.4a (30.0 mg, 0.047 mmol) and freshly 
activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (3.0 mL) was stirred under argon for 
30 min at rt. PdBr2 (16.4 mg, 0.062 mmol) was added and the resulting mixture was 
stirred for 3 h at rt. The resulting dark brown mixture was diluted with CH2Cl2 (10 mL), 
the solid was filtered off, and the residue was washed successively with CH2Cl2. The fil-
trate (~40 mL) was then concentrated in vacuo to give the title complex as an bright yel-
low solid in 87% yield (37.1 mg, 0.041 mmol). Analytical data for compound 4.5d: Rf  = 
0.71 (methanol/ CH2Cl2, 1/ 19, v/v); Selected NMR data for 4.5d: 
1
H NMR: , 3.35-3.90 
(m, 4H, H-2, 3, 4, 5), 3.95-4.05 (m, 2H, H-6a, 6b), 4.45-5.00 (m, 7H, H-1, 3 x CH2Ph), 
5.68 (dd, 2H, 
2
J = 14.7 Hz, CH2Ph), 6.95-7.70 (m, 23H, aromatic), 8.82 (m, 1H, aro-
matic) ppm; 
13
C NMR: , 70.4, 74.3, 75.2, 75.5, 75.9 (x 2), 78.9, 81.0, 86.8, 87.7, 123.3, 
123.9, 127.5, 127.7, 127.8 (x 2), 127.9, 128.0 (x 2), 128.2 (x 2), 128.5 (x 6), 128.6 (x 2), 
129.1 (x 2), 131.7 (x 2), 134.0, 138.0 (x 2), 138.3, 152.2, 160.7 ppm; HR FAB MS [M-
Br]
+
 calcd for C39H39BrNO5PdS 818.0767, found 818.0712. 
184 
 
 
Complex 4.5e.  A mixture of a glycosyl donor 4.1a (30.0 mg, 0.051 mmol) and freshly 
activated molecular sieves (4 Å, 100 mg) in CH2Cl2 (3.0 mL) was stirred under argon for 
30 min at rt. PdBr2 (17.7 mg, 0.067 mmol) was added and the resulting mixture was 
stirred for 3 h at rt. 2,6-Didimethylpyridine (8.3 μL, 0.077 mmol) was added to the solu-
tion and stirred at rt for 5 h then concentrated in vacuo. The residue was purified by col-
umn chromatography (MeOH - CH2Cl2 gradient elution) to give the title compound as a 
light-yellow solid in 79% yield (37.5 mg, 0.037). Analytical data for 4.5e: Rf  = 0.92 
(methanol/CH2Cl2, 1/99, v/v);  
1H NMR: δ, 1.29 (t, 3H, J = 5.58 Hz SCH2CH3), 2.73 (m, 
2H, SCH2CH3), 3.43 (s, 3H, CH3), 3.46-3.53 (m, 2H, H-2, 5), 3.56 (s, 3H, CH3), 3.61-
3.75 (m, 2H, H-3, 4), 3.92 ( m, 2H, H-6a, 6b), 4.48 (d, 1H, J1.2 = 5.1 Hz, H-1), 4.62 (d, 
1H, 
2
J = 10.9 Hz, ½ CH2Ph), 4.73 (d, 1H, 
2
J = 10.2 Hz, ½ CH2Ph), 4.84-4.95 (m, 4H, 2 x 
CH2Ph), 5.59-5.72 (m, 2H, CH2Ph), 7.04-7.66 (m, 21H, aromatic), 8.92 (d, 1H, J = 5. 7 
Hz, aromatic) ppm; 
13
C NMR: , 15.2, 25.2, 28.0, 28.6, 70.6, 73.6, 75.2, 75.6, 75.9, 77.9, 
78.6, 81.8, 85.2, 86.7, 123.2, 123.3, 123.4, 123.8, 127.8, 127.9 (x 2), 128.0 (x 2), 128.1 (x 
2), 128.4 (x 2), 128.5 (x 4), 128.6 (x 2), 138.0 (x 2), 138.4, 138.5, 138.7, 151.9, 160.2, 
160.5, 161.2 ppm; HR FAB MS [M-Br]
+
 calcd for C42H48BrN2O5PdS  877.1502, found 
877.1489.   
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Figure A- 1 
1
H spectrum of tethered compound 2.1 in CDCl3 300 MHz 
 
Figure A- 2 
13
C spectrum of tethered compound 2.1 in CDCl3 75 MHz 
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Figure A- 3 COSY spectrum of tethered compound 2.1 in CDCl3 300 MHz 
A3 
 
 
 
Figure A- 4 
1
H spectrum of Methyl 4-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-
glucopyranosyl)-6-O-acetyl-2,3-di-O-benzyl-α-D-glucopyranoside in CDCl3 300 
MHz 
 
 
 
Figure A- 5 
13
C spectrum of Methyl 4-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-
glucopyranosyl)-6-O-acetyl-2,3-di-O-benzyl-α-D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 6 COSY spectrum of Methyl 4-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-
glucopyranosyl)-6-O-acetyl-2,3-di-O-benzyl-α-D-glucopyranoside in CDCl3 300 
MHz 
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Figure A- 7 
1
H spectrum of tethered compound 2.3 in CDCl3 300 MHz 
 
 
Figure A- 8 
13
C spectrum of tethered compound 2.3 in CDCl3 75 MHz 
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Figure A- 9 COSY spectrum of tethered compound 2.3 in CDCl3 300 MHz 
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Figure A- 10 
1
H spectrum of  Methyl 3-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-
glucopyranosyl)-6-O-acetyl-2,4-di-O-benzyl-α-D-glucopyranoside in CDCl3 300 
MHz 
 
 
 
Figure A- 11 
13
C spectrum of Methyl 3-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-
glucopyranosyl)-6-O-acetyl-2,4-di-O-benzyl-α-D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 12 COSY spectrum of Methyl 3-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-
glucopyranosyl)-6-O-acetyl-2,4-di-O-benzyl-α-D-glucopyranoside in CDCl3 300 
MHz 
 
 
 
A9 
 
Figure A- 13 
1
H spectrum of tethered compound 2.5 in CDCl3 300 MHz 
 
 
Figure A- 14 
13
C spectrum of tethered compound 2.5 in CDCl3 75 MHz 
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Figure A- 15 COSY spectrum of tethered compound 2.5 in CDCl3 300 MHz 
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Figure A- 16 
1
H spectrum of Methyl 6-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-
glucopyranosyl)-4-O-acetyl-2,3-di-O-benzyl-α-D-glucopyranoside in CDCl3 300 
MHz 
 
 
 
Figure A- 17 
13
C spectrum of Methyl 6-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-
glucopyranosyl)-4-O-acetyl-2,3-di-O-benzyl-α-D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 18 COSY spectrum of Methyl 6-O-(6-O-acetyl-2,3,4-tri-O-benzyl-α-D-
glucopyranosyl)-4-O-acetyl-2,3-di-O-benzyl-α-D-glucopyranoside in CDCl3 300 
MHz 
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Figure A- 19 
1
H spectrum of tethered compound 2.7 in CDCl3 300 MHz 
 
Figure A- 20 
13
C spectrum of tethered compound 2.7 in CDCl3 75 MHz 
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Figure A- 21 
13
C spectrum of tethered compound 2.7 in CDCl3 300 MHz 
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Figure A- 22 
1
H spectrum of tethered compound 2.8 in CDCl3 300 MHz 
 
 
Figure A- 23 
13
C spectrum of tethered compound 2.98 in CDCl3 75 MHz 
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Figure A- 24 COSY spectrum of tethered compound 2.8 in CDCl3 300 MHz 
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Figure A- 25 
1
H spectrum of tethered compound 2.9 in CDCl3 300 MHz 
 
 
 
Figure A- 26 
13
C spectrum of tethered compound 2.9 in CDCl3 75 MHz 
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Figure A- 27 COSY spectrum of tethered compound 2.9 in CDCl3 300 MHz 
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Figure A- 28 
1
H spectrum of tethered compound 2.10 in CDCl3 300 MHz 
 
 
Figure A- 29 
13
C spectrum of tethered compound 2.10 in CDCl3 75 MHz 
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Figure A- 30 COSY spectrum of tethered compound 2.10 in CDCl3 300 MHz 
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Figure A- 31 
1
H spectrum of tethered compound 2.11 in CDCl3 300 MHz 
 
 
 
Figure A- 32 
13
C spectrum of tethered compound 2.11 in CDCl3 75 MHz 
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Figure A- 33 COSY spectrum of tethered compound 2.11 in CDCl3 300 MHz 
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Figure A- 34 
1
H spectrum of Methyl 6-O-(2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl)-6-O-acetyl-2,4-di-O-benzyl-α-D-glucopyranoside in CDCl3 300 
MHz  
 
 
 
Figure A- 35 
13
C spectrum of Methyl 6-O-(2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl)-6-O-acetyl-2,4-di-O-benzyl-α-D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 36 COSY spectrum of Methyl 6-O-(2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl)-6-O-acetyl-2,4-di-O-benzyl-α-D-glucopyranoside in CDCl3 300 
MHz 
 
 
  
A25 
 
 
 
Figure A- 37 
1
H spectrum of tethered compound 2.18 in CDCl3 500 MHz 
 
 
Figure A- 38 
13
C spectrum of tethered compound 2.18 in CDCl3 125 MHz 
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Figure A- 39 COSY spectrum of tethered compound 2.18 in CDCl3 500 MHz 
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Figure A- 40 
1
H spectrum of Methyl O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-
(14)-O-(2,3-di-O-benzyl-α-D-glucopyranosyl)-(14)-2,3-di-O-benzyl-α-D-
glucopyranoside in CDCl3 600 MHz 
 
Figure A- 41 
13
C spectrum of Methyl O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-
(14)-O-(2,3-di-O-benzyl-α-D-glucopyranosyl)-(14)-2,3-di-O-benzyl-α-D-
glucopyranoside in CDCl3 150 MHz  
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Figure A- 42 COSY spectrum of Methyl O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-
(14)-O-(2,3-di-O-benzyl-α-D-glucopyranosyl)-(14)-2,3-di-O-benzyl-α-D-
glucopyranoside in CDCl3 600 MHz 
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Figure A- 43 
1
H spectrum of tethered compound 3.7 in CDCl3 300 MHz 
 
 
 
Figure A- 44 
13
C spectrum of tethered compound 3.7 in CDCl3 75 MHz 
1.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure A- 45 COSY spectrum of tethered compound 3.7 in CDCl3 300 MHz 
 
CDCl3 at 300 MHz 
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Figure A- 46 
1
H spectrum of tethered compound 3.9 in CDCl3 300 MHz 
 
 
Figure A- 47 
13
C spectrum of tethered compound 3.9 in CDCl3 75 MHz 
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Figure A- 48 COSY spectrum of tethered compound 3.9 in CDCl3 300 MHz 
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Figure A- 49 
1
H spectrum of tethered compound 3.10 in CDCl3 500 MHz 
 
Figure A- 50 
13
C spectrum of tethered compound 3.10 in CDCl3 175 MHz 
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Figure A- 51 COSY spectrum of tethered compound 3.10 in CDCl3 300 MHz 
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Figure A- 52 
1
H spectrum of tethered compound 3.12 in CDCl3 300 MHz 
 
 
Figure A- 53 
13
C spectrum of tethered compound 3.12 in CDCl3 75 MHz 
1.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Figure A- 54 COSY spectrum of tethered compound 3.12 in CDCl3 300 MHz 
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Figure A- 55 
1
H spectrum of macrocyclic compound 3.14 in CDCl3 300 MHz 
 
 
Figure A- 56 
1
H spectrum of macrocyclic compound 3.14 in CDCl3 75 MHz 
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Figure A- 57 COSY spectrum of macrocyclic compound 3.14 in CDCl3 300 MHz 
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Figure A- 58 
1
H spectrum of tethered compound 3.15 in CDCl3 600 MHz 
 
Figure A- 59 
13
C spectrum of tethered compound 3.15 in CDCl3 150 MHz 
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Figure A- 60 COSY spectrum of tethered compound 3.7 in CDCl3 600 MHz 
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Figure A- 61 
1
H spectrum of tethered compound 3.16 in CDCl3 300 MHz 
 
Figure A- 62 
13
C spectrum of tethered compound 3.7 in CDCl3 75 MHz 
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Figure A- 63 COSY spectrum of tethered compound 3.16 in CDCl3 300 MHz 
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Figure A- 64 
1
H spectrum of macrocyclic compound 3.17 in CDCl3 300 MHz 
 
Figure A- 65 
13
C spectrum of tethered compound 3.17 in CDCl3 75 MHz 
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Figure A- 66 COSY spectrum of tethered compound 3.17 in CDCl3 300 MHz 
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Figure A- 67 
1
H spectrum of tethered compound 3.18 in CDCl3 500 MHz 
 
Figure A- 68 
1
H spectrum of tethered compound 3.18 in CDCl3 125 MHz 
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Figure A- 69 COSY spectrum of tethered compound 3.18 in CDCl3 500 MHz 
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Figure A- 70 
1
H spectrum of tethered compound 3.25 in CDCl3 300 MHz 
  
 
Figure A- 71 
1
H spectrum of tethered compound 3.25 in CDCl3 75 MHz 
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Figure A- 72 COSY spectrum of tethered compound 3.25 in CDCl3 300 MHz 
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Figure A- 73 
1
H spectrum of tethered Methyl O-[2,3,4-tri-O-benzyl-6-O-(α,α,α-(4-t-
butyldimethylsilyloxyphenyl)dimethyltolyl phthalate)-D-glucopyranosyl]-(16)-
2,3,4-tri-O-benzyl-α-D-glucopyranoside in CDCl3 300 MHz 
Figure A- 74 
13
C spectrum of Methyl O-[2,3,4-tri-O-benzyl-6-O-(α,α,α-(4-t-
butyldimethylsilyloxyphenyl)dimethyltolyl phthalate)-D-glucopyranosyl]-(16)-
2,3,4-tri-O-benzyl-α-D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 75 COSY spectrum of Methyl O-[2,3,4-tri-O-benzyl-6-O-(α,α,α-(4-t-
butyldimethylsilyloxyphenyl)dimethyltolyl phthalate)-D-glucopyranosyl]-(16)-
2,3,4-tri-O-benzyl-α-D-glucopyranoside in CDCl3 300 MHz 
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Figure A- 76 
1
H spectrum of Methyl O-[2,3,4-tri-O-benzyl-6-O-(α,α,α-(4-t-
butyldimethylsilyloxyphenyl)dimethyltolyl phthalate)-D-glucopyranosyl]-(14)-
2,3,6-tri-O-benzyl-α-D-glucopyranoside in CDCl3 600 MHz 
  
 
 
Figure A- 77 
13
C spectrum of Methyl O-[2,3,4-tri-O-benzyl-6-O-(α,α,α-(4-t-
butyldimethylsilyloxyphenyl)dimethyltolyl phthalate)-D-glucopyranosyl]-(14)-
2,3,6-tri-O-benzyl-α-D-glucopyranoside in CDCl3 150 MHz  
A52 
 
 
 
Figure A- 78 COSY spectrum of Methyl O-[2,3,4-tri-O-benzyl-6-O-(α,α,α-(4-t-
butyldimethylsilyloxyphenyl)dimethyltolyl phthalate)-D-glucopyranosyl]-(14)-
2,3,6-tri-O-benzyl-α-D-glucopyranoside in CDCl3 600 MHz 
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Figure A- 79 
1
H spectrum of macrocyclic compound 3.31 in CDCl3 300 MHz 
  
 
Figure A- 80 
13
C spectrum of macrocyclic compound 3.31 in CDCl3 75 MHz 
A54 
 
 
Figure A- 81 COSY spectrum of macrocyclic compound 3.31 in CDCl3 300 MHz 
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Figure A- 82 
1
H spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-
picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
 
 
Figure A- 83 
13
C spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-
O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 125 MHz 
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Figure A- 84 COSY spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-
6-O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
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Figure A- 85 
1
H spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-
picoloyl--D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
 
 
Figure A- 86 
13
C spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-
O-picoloyl--D-glucopyranosyl)--D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 87 COSY spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-
6-O-picoloyl--D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
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Figure A- 88 
1
H spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-O-
picolinyl-D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
 
 
 
Figure A- 89 
13
C spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-6-
O-picolinyl-D-glucopyranosyl)--D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 90 COSY spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl-
6-O-picolinyl-D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
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Figure A- 91 
1
H spectrum of palladium complex 3.5a in CDCl3 300 MHz 
 
Figure A- 92 
13
C spectrum of palladium complex 3.5a in CDCl3 75 MHz 
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Figure A- 93 COSY spectrum of palladium complex 3.5a in CDCl3 300 MHz 
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Figure A- 94 
1
H spectrum of palladium complex 3.5b in CDCl3 300 MHz 
 
 
Figure A- 95 
13
C spectrum of palladium complex 3.5b in CDCl3 75 MHz 
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Figure A- 96 COSY spectrum of palladium complex 3.5b in CDCl3 300 MHz 
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Figure A- 97 
1
H spectrum of palladium complex 3.5c in CDCl3 300 MHz 
 
 
Figure A- 98 
13
C spectrum of palladium complex 3.5c in CDCl3 75 MHz 
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Figure A- 99 COSY spectrum of macrocyclic compound 3.5c in CDCl3 300 MHz 
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Figure A- 100 
1
H spectrum of  palladium complex 3.5d in CDCl3 300 MHz 
 
 
Figure A- 101 
13
C spectrum of palladium complex 3.5d in CDCl3 75 MHz 
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Figure A- 102 COSY spectrum of palladium 3.5d in CDCl3 300 MHz 
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Figure A- 103 
1
H spectrum of macrocyclic compound 3.5e in CDCl3 300 MHz 
 
 
 
 
 
Figure A- 104 
13
C spectrum of macrocyclic compound 3.5e in CDCl3 75 MHz 
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Figure A- 105 COSY spectrum of palladium complex 3.5e in CDCl3 300 MHz 
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Figure A- 106 
1
H spectrum of Methyl 2,3,6-Tri-O-benzyl-4-O-(2,3,4-tri-O-benzyl-6-
O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
 
Figure A- 107 
13
C spectrum of Methyl 2,3,6-Tri-O-benzyl-4-O-(2,3,4-tri-O-benzyl-6-
O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 108 COSY spectrum of Methyl 2,3,6-Tri-O-benzyl-4-O-(2,3,4-tri-O-
benzyl-6-O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 
MHz  
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Figure A- 109 
1
H spectrum of Methyl 2,4,6-Tri-O-benzyl-3-O-(2,3,4-tri-O-benzyl-6-
O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
 
 
Figure A- 110 
13
C spectrum of Methyl 2,4,6-Tri-O-benzyl-3-O-(2,3,4-tri-O-benzyl-6-
O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 111
 
COSY spectrum of Methyl 2,4,6-Tri-O-benzyl-3-O-(2,3,4-tri-O-
benzyl-6-O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 
MHz 
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Figure A- 112 
1
H spectrum of Methyl 3,4,6-Tri-O-benzyl-2-O-(2,3,4-tri-O-benzyl-6-
O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
 
 
Figure A- 113 
13
C spectrum of Methyl 3,4,6-Tri-O-benzyl-2-O-(2,3,4-tri-O-benzyl-6-
O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 114 
 
COSY spectrum of Methyl 3,4,6-Tri-O-benzyl-2-O-(2,3,4-tri-O-
benzyl-6-O-picolinyl-/D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 
MHz 
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Figure A- 115 
1
H spectrum of Methyl 2,3,4-Tri-O-benzoyl-6-O-(2,3,4-tri-O-benzyl-6-
O-picolinyl--D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
 
 
 
 
Figure A- 116 
13
C spectrum of Methyl 2,3,4-Tri-O-benzoyl-6-O-(2,3,4-tri-O-benzyl-
6-O-picolinyl--D-glucopyranosyl)--D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 117 COSY spectrum of Methyl 2,3,4-Tri-O-benzoyl-6-O-(2,3,4-tri-O-
benzyl-6-O-picolinyl--D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
 
 
 
ppm
3.54.04.55.05.56.06.5 ppm
3.5
4.0
4.5
5.0
5.5
6.0
6.5
A79 
 
 
 
 
Figure A- 118 
1
H spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3-di-O-benzyl-4,6-
di-O-picoloyl-/D-glucopyranosyl)--D-glucopyranoside in ¼ CDCl3/MeOD 300 
MHz 
 
 
Figure A- 119 
13
C spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3-di-O-benzyl-4,6-
di-O-picoloyl-/D-glucopyranosyl)--D-glucopyranoside in ¼ CDCl3/MeOD 75 
MHz 
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Figure A- 120 COSY spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3-di-O-benzyl-
4,6-di-O-picoloyl-/D-glucopyranosyl)--D-glucopyranoside in ¼ CDCl3/MeOD 
300 MHz 
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Figure A- 121 
1
H spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl--
D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz 
 
Figure A- 122 
13
C spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-benzyl--
D-glucopyranosyl)--D-glucopyranoside in CDCl3 75 MHz 
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Figure A- 123 COSY spectrum of Methyl 2,3,4-Tri-O-benzyl-6-O-(2,3,4-tri-O-
benzyl--D-glucopyranosyl)--D-glucopyranoside in CDCl3 300 MHz  
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Figure A- 124 
1
H spectrum of Methyl O-(2,3,4-tri-O-benzyl-6-O-picolinyl--D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl--D-glucopyranosyl)-(16)-2,3,4-tri-
O-benzyl--D-glucopyranoside in CDCl3 600 MHz 
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Figure A- 125 
13
C spectrum of Methyl O-(2,3,4-tri-O-benzyl-6-O-picolinyl--D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl--D-glucopyranosyl)-(16)-2,3,4-tri-
O-benzyl--D-glucopyranoside in CDCl3 75 MHz 
 
 
 
 
 
 
 
 
 
 
 
A85 
 Figure A-126 COSY spectra of Methyl O-(2,3,4-tri-O-benzyl-6-O-picolinyl--D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl--D-glucopyranosyl)-(16)-2,3,4-tri-
O-benzyl--D-glucopyranoside in CDCl3 300 MHz 
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